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consequences and solutions of
selection bias
The central topic of this thesis is selection bias in (quasi-)experimental re-
search. Selection bias is the bias introduced into a (quasi-)experimental study
by the selection of different types of individuals into experimental program(s)
and reference program(s). Consequently, the pre-existing differences between
treatment programs may explain the results of a study, as opposed to true treat-
ment effects (Heckman, 1979). The thesis is organized in three parts. The first
part focusses on statistical methods dealing with selection bias due to observed
differences between treatment programs (chapter 2, 3 and 4). The second part
of the thesis focusses on statistical methods dealing with selection bias due to
unobserved differences between treatment programs (chapter 5) and selection
bias due to non-compliance of patients within treatment programs (chapter 6).
The last part discusses selection bias in diagnostic testing settings (chapter 7).
The aim of this chapter is to discuss, in a very general way, the nature,
causes and consequences of selection bias problems in experimental and non-
experimental studies and ways to overcome these problems. Because selection
bias is studied here from the viewpoint of biased causal conclusions, Rubin’s
precise and well known model of causality provides an excellent starting point
for this discussion (Rubin, 1974). Next, a few general and traditional methods
for countering selection bias will be presented. These traditional approaches





1.1.1 Rubin′s causal model of counterfactual means
Researchers in the social, behavioral, and life sciences are conducting studies
to answer questions about the effectiveness of interventions such as educational
programs, social reforms, therapy programs or medications. By means of these
studies, researchers try to answer questions such as ”Is medication A better
than medication B?”, ”Does obesity lead to diabetes?”, ”Does measure A di-
minish the crime rate in a particular neighborhood more than approach B?”,
”Is teaching style A more effective than teaching style B?”.
Consider a study comparing two psychotherapy programs for patients with
personality disorders. (For a real world application of this example, see chap-
ter 2). The first program offers high intensity short-term psychotherapy (less
than six months with many therapeutic sessions) and the second program offers
low intensity long-term psychotherapy (more than 6 months with less contacts
per week). The psychotherapeutic institution providing both therapies is in-
terested which of the two therapy programs is most effective in reducing the
psychological problems of their patients. Formulated in a causal terminology,
the researchers want to know whether the short-term psychotherapy program
causes a higher reduction of psychological problems compared to the long-term
psychotherapy program. To answer such a causal question, the researchers
should design their study in a way that make causal interpretations of the
results possible.
Causality is a much debated topic, not only in philosophical, ontological
and epistemological discussions, but also in more down to earth methodolog-
ical and statistical disputes. Several different frameworks have been offered
to handle the notion of causality in empirical research, some of them widely
diverging, others at least partly overlapping. Crucial and often controversial
concepts in these causal accounts are manipulation, randomization, counterfac-
tuals, potential outcomes, structural equation models, and graphical modeling
(Rubin, 1974, 1978; Holland, 1986; Robins, 1986; Pearl, 1995; MacLachlan &
Krishnan, 2000; Cox & Wermuth, 2001; Lauritzen, 2001; Rosenbaum, 1995;
Morgan & Winship, 2007). Perhaps the most influential contribution in the
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social and behavioral sciences is Rubin’s causal model of potential outcomes
and his model will be used to define more precisely, what is meant by causality
and selection in this dissertation (Rubin, 1978).
Rubin’s causal model of potential outcomes is a counterfactual account of
causality and is based on the idea of assigning each treatment program or in-
tervention to each research unit under otherwise identical circumstances for
both assignments. Each treatment program potentially affects the outcome of
interest such as psychological scores on a standardized psychological test. In
our example, there are two populations of interest, namely patients following
the short-term psychotherapy program and patients following the long-term
psychotherapy program. Obviously, the reasoning of Rubin’s model is also ap-
plicable when more than two treatment programs are compared or in a classical
study comparing the effect of an experimental program with a reference pro-
gram (no treatment at all, standard program or placebo). The key assumption
of the counterfactual framework is that each individual in the population of
interest has a potential outcome under each program, even though, in practice,
each patient can only be observed under one psychotherapy program at any
point in time. For example, patients that completed the long-term psychother-
apy program have theoretical what-if psychological outcomes in the hypothet-
ical situation when completed the short-term psychotherapy program, and the
other way around. These what-if potential outcomes are counterfactual. The
potential outcomes of each individual are defined as the true values of the
outcome of interest that would result from exposure to the alternative causal
states. Let D denote the psychotherapy program, with value zero referring to
the long-term psychotherapy program (D = 0) and with the value one refer-
ring to the short-term psychotherapy program (D = 1) (Morgan & Winship,
2007). Let Yid represent the outcome score Y (response) of individual i within
psychotherapy program D. The potential outcomes of each individual i are
Yi0 and Yi1. Because both Yi0 and Yi1 exist in theory for each individual, an
individual causal effect (ICE), referred as δi, can be defined as the difference
between Yi0 and Yi1 as;
ICE = δi = Yi1 − Yi0 (1.1)
Because a patient cannot follow both psychotherapy programs under identical
circumstances at the same time, the outcome Yid of an individual i can only
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be observed under one and not under both psychotherapy programs. For pa-
tients in the long-term psychotherapy program (reference condition), only the
outcome Yi0 is observed and not the outcome Yi1. For patients in the short-
term psychotherapy program (experimental condition), only the outcome Yi1
is observed and not the outcome Yi0. In essence, this is a missing data prob-
lem (Rubin, 1976). The observed values for the outcome variable Y is Y0 for
patients following the long-term psychotherapy program and Y1 for patients
following the short-term psychotherapy program. The observed variable Y is
therefore defined as;
Y = Y0 if D = 0
Y = Y1 if D = 1
(1.2)
Because of the missing data problem, estimating the ICE, as defined in equation
1.1, is impossible. Therefore, the causal effects of the psychotherapy programs
cannot be observed or directly calculated at the individual level. Therefore, one
should focus on estimating the average causal effects where not the individual
scores are used to estimate the effects, but the expected or mean score (yet still
individual and impossible), averaged over the number of ’imaginal’ independent
and identical replications of the experiment. Let E(δ) denote the expected
treatment effect in the population, called the average causal effect. Since the
expectation of a difference is equal to the difference of two expectation the
average causal effect can be defined as;
E(δ) = E(Y1 − Y0)
= E(Y1)− E(Y0)
(1.3)
Since the expectation of the individual causal effect (E(δi)) is equal to the
average causal effect across individuals of a population (E(δ)), the subscript i
has been dropped in equation 1.3.
The average causal effect for the controls (ACC) is;
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E(δ|D = 0) = E(Y1 − Y0|D = 0)
= E(Y1|D = 0)− E(Y0|D = 0)
(1.4)
The average causal effect for the treated (ACT) is;
E(δ|D = 1) = E(Y1 − Y0|D = 1)
= E(Y1|D = 1)− E(Y0|D = 1)
(1.5)
In our example, the ACT is the expected what-if difference of psychological
problems if one could treat a randomly selected patient in both the long-term
and short-term psychotherapy programs. However, only E(Y0|D = 0) and
E(Y1|D = 1) are observed and not E(Y1|D = 0) and E(Y0|D = 1). Only
with the assumptions that E(Y1|D = 0) = E(Y0|D = 0) and E(Y0|D = 1) =
E(Y1|D = 1), the average causal effect can be estimated as in equation 1.4
and 1.5, by merely subtracting mean outcome of patients in the long-term
psychotherapy program from the mean outcome of patients in the short-term
psychotherapy program as;
E(δ) = E(Y1 − Y0)
= E(Y1)− E(Y0)
(1.6)
However, to make such inferences, patients in the long-term psychotherapy (ref-
erence) program should be completely comparable in all respects to patients
in the short-term psychotherapy (experimental) program, except for the re-
ceived psychotherapy program. This comparability implies that some explicit
assumptions should be met. These assumptions are:
1. Stable unit treatment value assumption (SUTVA): Individuals do not in-
terfere with each other; the observation of one individual should not be
affected by the treatment assignment of other individuals (Cox, 1958;
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Holland, 1986). There is no interference across treatments and the treat-
ment effect does not depend on the number of individuals receiving the
treatment (Morgan, 2001).
2. Additive effect assumption: The administration of the treatment raises
the response of an individual by a constant amount.
3. (Strongly) ignorable assumption: The assignment mechanism is strongly
ignorable if the two following assumptions are fulfilled;
(a) The responses Y0 or Y1 are independent of the treatment D, given
the observed variables X. In formula:
Y1, Y0 ⊥ D |X (1.7)
For randomized experiments, the treatment indicator D is forced
by design to be independent of the potential outcomes Y0 and Y1.
Treatment status is therefore independent of the potential outcomes
and the treatment assignment is said ignorable.
(b) Moreover, every individual has a known probability of receiving the
treatment or the reference program;
0 < (P (D = 1) < 1 (1.8)
If the assignment is strongly ignorable, as is the case in randomized
studies, it follows that the mean of the reference program can be
used as an estimate of the counterfactual mean of the experimental
program, and the other way around. Thus;
E(Y1|D = 0) = E(Y1|D = 1) and
E(Y0|D = 0) = E(Y0|D = 1) (1.9)
If the assignment is weakly ignorable, it follows that the mean of the
reference program, controlled for the observed variables X, can be
used as an estimate of the counterfactual mean of the experimental
program. Thus;
E(Y1|D = 0,X) = E(Y1|D = 1,X) and
E(Y0|D = 0,X) = E(Y0|D = 1,X) (1.10)
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Randomization is a wonderful way to meet the above assumptions. In random-
ized studies participants are assigned to the treatment programs by random
procedures such as flipping a coin. That implies that, with equal group sizes,
the probability of assignment to the short-term psychotherapy program, for
patients agreeing to participate in the study, is .50 for each patient. With
randomization it is expected that, with large sample sizes, both observed and
unobserved pre-treatment variables have, on average, the same values in all
treatment programs. The probability that this is actually true increases as
the sample size increases. Let us consider that, in our example, patients are
randomly assigned to either the short-term psychotherapy program (D = 1)
or long-term psychotherapy program(D = 0). Let Yid represent the psycho-
logical outcome score Y of patient i within therapy D. Since patients are
randomized into the therapies, one expects, especially in large sample sizes,
that the two psychotherapy groups are initially comparable on pre-treatment
variables such as age, gender, social economic class, initial level of depression
or motivation. With initial comparability, a significant difference in the mean
outcome depression scores between the two patient groups can be attributed
to the psychotherapy program received. The added value of the short-term
psychotherapy program to the standard long-term psychotherapy program (δ),
i.e. the average causal effect for the treated (ACT), can therefore be estimated
by subtracting the mean outcome of participants following the short-term psy-
chotherapy program (E(Y1)) from the mean outcome of patients following the
long-term psychotherapy program (E(Y0)) (Rubin, 1974).
1.1.2 Feasibility and shortcomings of randomized studies
Although randomized studies are considered the best way to achieve compa-
rability, and to obtain unbiased estimates of the average causal effect (ACE),
randomization is not always feasible or even desirable for a large number of
reasons:
1. Randomization only works well in samples that are not too small : Ran-
domization only realizes balance in pre-treatment characteristics with a
certain probability that will never be zero but also never reaches one. In
general, for very small groups, this probability will be very low. The larger
the sample sizes of the treatment programs, the higher this probability. In
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practice, this implies that even when the randomization procedure is car-
ried out flawlessly, no balance of pre-treatment variables may be achieved
due to small sample sizes. In some research designs, a sufficiently large
number of patients that are both willing and eligible to receive treatment
is very difficult or impossible to get.
2. Randomization may be unethical : In some research designs, it may be
unethical to assign individuals at random to different treatment programs.
Consider, for example, a study about the effect of cigarette smoking on
lung cancer. It may be very unethical to force individuals in one program
to smoke for some years and prevent individuals in the other program
from smoking.
3. Randomization may be impossible: It is not always possible to assign
patients at random to the different treatment programs. For example, it
is not possible to assign individuals at random to variables that cannot
be manipulated such as age, gender or to variables that occurred in the
past such as previous education.
4. Randomization may be impractical : It is not always practical to random-
ize individuals into the treatment programs. For example, in a study on
the effect of a new teaching method on the reading skills of children in
schools, it is hardly practicable to assign children within the same class
at random to different teaching methods.
5. Randomization may be very expensive and time-consuming : Randomized
studies require extensive planning and control and may therefore be very
expensive. Randomized studies may be very time-consuming and not be
desirable when quick answers are needed.
6. Randomized studies may be very different from natural situations: The
programs of randomized experiments may differ from real world situa-
tions in which the treatment is actually applied. Therefore, the results
from randomized experiments cannot always be generalized to natural
situations and are therefore not always the preferable research design.
7. Randomized studies may be imperfect : Even when randomization is per-
fectly carried out using a rather large number of individuals, the intended
Introduction: Causes, consequences and solutions of selection bias 9
comparability between the treatment programs might not be realized be-
cause of what happens later during the implementation of the research de-
sign. Important examples of imperfect randomized experiments are stud-
ies in which non-compliance with the experimental instructions and drop-
out occur. For example, patients may refuse to take their pre-described
medication or forget to take the medication on a regularly basis. In psy-
chotherapy research, it may happen that some patients do not show up
at psychotherapy sessions or decide to drop out from therapy before the
end of the study. It may even happen that patients switch to another
treatment because they think the other treatment has a more positive
effect on them. If, as to be expected, drop-out and non-compliance are
not random phenomena, the intended randomization plan fails (Shadish
& Cook, 2002).
1.2 Selection bias in quasi-experiments and obser-
vational studies
From the discussion in the previous section it follows that, for a number of eth-
ical and practical considerations, randomized studies cannot always be carried
out perfectly and are not always possible or even the best choice. Therefore, for
investigating the causal consequences of interventions, one often has to rely on
results from non-randomized studies, also named quasi-experiments or observa-
tional studies. In the literature, the terms quasi-experiments and observational
studies are often used interchangeably, but others view them as distinct research
designs. Both observational studies and quasi-experiments have in common
that the assignment into treatment programs is not random. However, some
scholars then make a difference in the sense that in quasi-experimental studies
the researcher has control on the form and content of the intervention (manip-
ulation) and on the ’experimental environment’, while in observational studies
this is not the case (Rosenbaum, 1995). In this dissertation, both observational
and quasi-experimental studies are treated as failed experiments, where non-
random allocation of individuals into treatment programs potentially causes
selection bias problems.
Since in non-randomized studies patients are not randomly assigned to the
treatment and reference program(s), the individuals in the programs may dif-
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fer, on average, on important pre-treatment characteristics. Variables that
influence treatment assignment are often called selection variables. As a conse-
quence non-random treatment assignment, patients groups may be non-comparable
before the start of the study. Consequently, the outcomes of a study may be
potentially explained because of pre-existing differences between the programs,
as opposed to the treatment itself. When one or more of these pre-treatment
characteristics are related to both the outcome and treatment allocation, the
estimate of the treatment effect by means of the ACE becomes confounded with
these selection variable(s). Such a pre-treatment variable that is associated to
both assignment and outcome is called a confounder. Within Rubin”s model,
based on mean differences estimation, without adjustment for this confounder
variable, the ACE estimated as in equation 1.3 might be biased, i.e. unequal
to the (expected) individual causal effect. This is the essence of selection bias
or confounding (Anderson et al., 1980). In terms of possibilities to correct for
selection bias it is important to make the distinction between overt and hid-
den bias (Rosenbaum, 1995). Overt bias is bias due to observed and measured
variables and hidden bias due to unobserved and unmeasured variables. In gen-
eral, there exists a range of statistical methods to correct for overt bias such
as matching, stratification and statistical control by regression analysis. The
main idea behind these correction procedures is the following; Let X denote a
vector of observed pre-treatment variables. Then, the average causal effect can
be estimated, controlled for the observed pre-treatment variables X as;
δ = E(Y1|X, D = 1)− E(Y0|X, D = 0) (1.11)
The concept of overt bias closely relates to the ignorability assumption. Ig-
norability implies that there is no bias, given the confounding variables. When
all confounding variables are observed and controlled for, overt bias is dealt
with in the analysis. However, when the confounding variables also include
unobserved (latent) variables, even after control on the observed selection vari-
ables, bias may arise (Dehejia & Wahba, 1999).
In the next section, three traditional methods are discussed that try to
achieve comparability in quasi-experimental research. All three methods con-
trol for overt bias and assume that every confounding variable is measured.
They all assume that treatment assignment is ignorable and does not depend
further on unmeasured variables. The methods discussed below are match-
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ing, stratification and statistical equating. In chapter 2, 3 and 4, an alterna-
tive method controlling for overt bias, named the propensity score method, is
discussed, illustrated and extended. In chapter 5, methods dealing with the
problem of hidden bias are discussed.
1.3 Basic remedies of overt bias
1.3.1 Matching
With matching one attempts to achieve comparability by pairing each individ-
ual from the experimental program with one (or more) individuals from the
reference program, with respect to the individuals’ observed characteristics X.
As a result, in the matched data, the distribution of the observed characteris-
tics X are equally distributed across the treatment programs. Matching can
be conducted with or without replacement and individuals in the experimental
condition may be paired with more than one reference individual. With match-
ing, the mean outcome of individuals from the reference program E(Y0) that
are matched with individuals from the experimental program, can be used as
an estimate of the counterfactual mean of the experimental program and visa
versa. Therefore, in the matched data-set, the ACE can still be estimated as
in equation 1.3.
In exact matching, one pairs each individual in the experimental program
with an individual from the reference program with exactly the same value
on X. Sometimes, however, exact matching is not possible, because there is
no similar individual available in the reference program. In that case, several
alternative matching methods exists. The most common matching techniques
are nearest available matching and caliper matching. The essence of these
methods are described below.
In nearest available matching, a match is formed by finding the closest
possible similar individual in the reference program for each individual in the
experimental program. Let Xi and Xj denote the score on an independent
variable X for an individual in the experimental condition i and a reference
individual j, respectively. An individual i is then matched with the reference
individual j which has the minimum distance on (a set of) some observed
variable(s) X. In formula this is denoted as;
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min |Xi −Xj | (1.12)
In random-order nearest available matching, individuals are ordered on (a
set of) some observed variable(s) X from highest to lowest (or visa versa). For
each individual in the experimental condition, the closest reference individual
is found. When a reference individual is closest to two individuals in the ex-
perimental condition, the match is formed randomly. The main problem with
nearest available matching is that pairs can still differ a lot on X, because
there is no restriction on the distance within matched pairs. Therefore, a vari-
ant has been developed in which only a predefined difference on a variable X
is tolerated, named caliper matching. With caliper matching, only reference
individuals with a predefined difference on a variable are tolerated. A pair can
only be matched if the difference on X is no more than a predefined tolerance
σ as;
|Xi −Xj | < σ (1.13)
As a consequence, some individuals in the experimental condition cannot be
matched with reference individuals because they differ too much. The main
advantage of caliper matching is that it allows to use more reference individuals
when the matches are good and less when matches are poor. Thereby, this
method ensures that pairs do not differ a lot from each other. This may lead to
less bias compared to nearest available matching. However, when the tolerance
is small, this method requires a large number of reference individuals to find
matches for each individual in the reference program (Anderson et al., 1980).
When no matches are found, the individual is excluded from the analysis and
no full use is made of the available data (Cochran & Rubin, 1973). There also
exists some alternative matching techniques such as discriminant matching or
mahalanobis distance matching. More can be read about these methods in
Heckman, Ichimura, and Todd (1997) and Heckman, Ichimura, Smith, and
Todd (1998). The extent to which matching leads to bias reduction depends
mainly on three factors; first on the distributional overlap regarding X between
the two samples, second on the ratio of the population variances and third on
the size of the reference sample. With almost no overlap, reference individuals
differ a lot from individuals in the experimental condition. If matches can be
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formed at all, the matched pairs will differ a lot from each other. Thereby, the
further the population means are separated, the larger the number of reference
individuals must be to find close matches, unless the variances are such that
the two population distributions overlap substantially (Anderson et al., 1980).
Note that with matching, internal validity problems might occur, since only
the overlapping respondents are used to estimate the treatment effect.
1.3.2 Stratification
Stratification is an alternative strategy to control for observed baseline dif-
ferences. With stratification, several groups of individuals are formed, based
on the same set of observed variables X. As a result, within each group or
strata, individuals are more or less equal on X. Note that also here, the key
assumption is made that X includes all confounding variables and no variables
are missed. In exact stratification, the strata are homogenous in the observed
characteristics in X. In practice, this implies that individuals from both the
reference and the experimental programs, with exactly the same pre-treatment
variables, are grouped in one stratum. This is, however, only attainable when
the number of covariates and/or the number of categories are low (Rosenbaum,
1995). Therefore, exact stratification is not always possible and individuals
within a stratum differ more or less from each other on X. The more individ-
uals differ within a stratum, the more bias will eventually arise.
After stratification, one way to estimate average causal effects is by weight-







where nk denotes the number of treatment or reference patients in the kth stra-
tum (k=1,2,3...K) and N the total number of patients in the study. Cochran
(1968) showed in a simulation study that defining five strata is often sufficient
to remove 90% of the bias.
The main problem of stratification is that when the number of covariates
increases, the number of strata increases exponentially and the probability of
finding good matches decreases. This is called the dimensionality problem (De-
hejia & Wahba, 1999). The first part of this thesis discusses and illustrates the
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propensity score (PS) method. The PS can be used to overcome the dimension-
ality problem. With the PS method, only a single score (the PS) can be used
for matching and stratification, instead of a number of covariates. In chapter
2, the PS method for two-way comparisons will be discuss and illustrated. In
chapters 3 and 4, the PS method is extended to studies comparing more than
two treatments.
1.3.3 Statistical equating
Regression adjustment techniques try to achieve comparability in the statistical
analysis through statistical equating. Multiple regression adjustment has the
advantage over matching that it uses all available data and, in theory, can be
used when the distributions of the two programs do not overlap completely
(Campbell, 1999). The basic multiple regression model assumes that there
exists a linear relationship between the outcome variable and the covariates X
with identical slopes, but possible different intercepts for both the experimental
program and the reference program; the variables in X do not interact with
the effect of D on Y . The linear regression equation for the treatment effect δ
is equal to;
Yi = α+ βX + δD + εi (1.15)
where X is a set of confounding variables, α the mean of the reference program
where all covariates have the value of zero, δ the effect of the intervention D
and εi the individual error term.
Estimating causal effects with standard multiple regression adjustment im-
plies some basic assumptions such as a constant and linear effect of Y on X,
without interactions. However, departures from these assumptions can be dealt
with in more complex models. Since, in randomized studies, one assumes that
there are no pre-treatment differences between treatment programs, multiple
regression adjustment seems unnecessary. However, also in randomized stud-
ies, regression analysis with covariates reduces the error variance and more effi-
cient estimates of the effect can be obtained. Statistical equating, for example
by regression adjustment, may be preferable over matching and stratification
methods if the relation between the covariates and the outcome is linear or if
the researcher is confident that non-linearity can easily be accounted for in the
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model. Non-linear models can become, however, very complex and matching
and stratification methods are then preferable (Maxwell & Delaney, 2004).
1.4 Contents of this thesis
The goals of this thesis are to compare, illustrate and present statistical meth-
ods that reduce selection bias in social, behavioral and medical research.
Chapter 2 discusses the dimensionality problem of matching and stratifi-
cation in situations where the number of pre-treatment variable is large. As
an alternative method, the propensity score method (PS) is discussed. The
propensity score is the probability of assignment into the experimental group,
given a set of pre-treatment variables. The propensity score method is illus-
trated step-by step with data coming from a large a Dutch research project,
named the ”Study on Cost-Effectiveness of Personality Disorder Treatment”
(SCEPTRE ). Since the propensity score is mainly used in two-arm studies,
for illustrative purposes, the data are divided into a short-term psychotherapy
program (up to six months) and a long-term psychotherapy program (more
than six months), although the original treatment variable contained more cat-
egories.
The standard propensity score method has been well developed for (quasi-)
experiments comparing two treatment programs. In chapter 3, the multiple
propensity score method is discussed for studies comparing multiple (more
than two) programs. The method is illustrated step-by step using the data
from the SCEPTRE study, where the effectiveness of five different therapies
for patients with cluster C personality disorders are compared, differing in
setting and duration. This application exemplifies how to handle selection bias
in more complicated, but often occurring real world research situations.
In chapter 4, the results from the large and complicated SCEPTRE study
are discussed from a more clinical point of view. The multiple propensity
score is used to compare the effectiveness of five different therapies, differing in
setting and duration, for patients with cluster C personality disorders. Since
the study had a repeat testing structure, the multiple propensity scores are
included into a random intercept multilevel model. In this model, the results
are adjusted for both dependency of the data due to repeat testing and for
the confounding effect of a large number of observed pre-treatment differences
16 Chapter 1
across the psychotherapy programs.
In chapter 5, attention is paid to two statistical methods that control for
hidden bias in observational studies. These methods are (1) the original Heck-
man two-step method and (2) its extended version using Structural Equation
Modeling (SEM). In four artificial data-sets, the performances of both meth-
ods are compared to the results of regression analysis and the propensity score
method. In addition, the SCEPTRE data are used to compare and illustrate
the methods.
In chapter 6, a method is presented to prevent bias due to non-compliance
in randomized studies. If, as to be expected, non-compliance is not a random
phenomena, the intended randomization plan fails and bias may arise. In gen-
eral, with non-compliance, researchers perform either an ”Intention To Treat
Analysis” or an ”As Treated Analysis” or both. An alternative model based
on a latent class extension of the instrumental variable approach is presented.
In the final chapter 7, a different kind of selection problem is discussed that
occurs in diagnostic testing, named verification bias. When the verification of
true disease status by a gold standard test is performed only for a part of the
sample, based on previous testing results, the estimates of the sensitivity and
specificity may be biased. Data coming from a large study performed in the
Netherlands are used to illustrate how to account for verification problems in
a repeat testing situation.
Chapter 2




Randomized controlled trials are considered the best scientific proof of effective-
ness. There is increasing concern, though, about their feasibility in psychother-
apy research. A quasi-experimental study design is discussed for situations in
which a randomized controlled trial is not feasible. Here, as an alternative
strategy, the propensity score (PS) method is used to correct for selection bias.
Data from a Dutch research project, named ”Study on Cost-Effectiveness of
Personality Disorder Treatment” (SCEPTRE ), is used as an illustrative ex-
ample. The sample consisted of 749 psychotherapy patients with personality
pathology. It is tested whether the PS method was useful and applicable. Dif-
ferences between 2 treatment groups (short vs. long treatment duration) in
pre-treatment characteristics before and after PS correction is examined. This
revealed the impact of the PS on outcome differences. The PS offered sta-
tistical control over observed pre-treatment differences between patients in a
non-randomized study. When a randomized controlled trial is not possible, this
quasi-experimental design using the PS could be a feasible alternative. Its ad-
vantages and limitations are discussed. If implemented carefully, this method
∗This chapter has been published as: Bartak, A., Spreeuwenberg, M.D., Andrea, H.,
Busschbach, J.J.V., Croon, M.A., Verheul, R., Emmelkamp, P.M.G. & Stijnen, T. (2009).
Psychotherapy and Psychosomatics, 78, 26–34.
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is promising for future effectiveness research.
2.2 Introduction
The first randomized study in medicine was conducted by Amberson, McMa-
hon, and Pinner (1931) in 1931 by flipping a coin. Now, randomized controlled
trials are considered the gold standard for comparing the effectiveness of psy-
chotherapeutic treatment methods. Randomization assumes that all known
and unknown characteristics of the participants are balanced between the ex-
perimental groups, except for the treatment condition. With randomization,
treatment effects can theoretically be estimated by merely subtracting the mean
responses of the treatment groups (Rubin, 1997).
In many cases, though, randomization may be difficult, unethical or im-
possible, especially in psychotherapy research (Black, 1996; Westen, Novotny,
& Thompson-Brenner, 2004; Leichsenring, 2004; Castonguay & Beutler, 2006;
Maat, Dekker, Schoevers, & Jonghe, 2007). Here, patients’ and clinicians’
personal preferences regarding treatment allocation may work against random-
ization. The resulting high number of excluded subjects makes the general-
ization of such results difficult (Brewin & Bradley, 1989). Hence, research on
treatment effects in various (para)medical fields often requires well-designed
and carefully conducted non-randomized studies (Forstmeier & Rueddel, 2007;
Chiesa & Fonagy, 2007). Shadish and Cook (2002) called these studies quasi-
experimental, based on their resemblance to true experiments, except for the
random assignment of participants to treatments. In these quasi-experimental
designs, the researcher has some influence on the manipulation of treatment and
measurement. This is in contrast to pure observational studies, where the size
and direction of a relationship among variables are simply observed (Shadish
& Cook, 2002). In case of non-random allocation to treatment, persons with
different treatments can differ on pre-treatment characteristics. This selection
bias affects the estimates of the treatment effect.
Rosenbaum (1995) distinguishes 2 types of bias: hidden bias, due to unob-
served differences in pre-treatment variables, and overt bias, due to observed
differences in pre-treatment variables. Hidden bias is the most difficult to deal
with. Overt bias can be corrected with various statistical methods, by incorpo-
rating known initial differences into the statistical analysis. The most widely
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used methods that deal with overt bias are matching, stratification and re-
gression adjustment (Rosenbaum, 1995; Frangakis & Rubin, 2002; Rubin &
Thomas, 1996). In matching, each individual in the experimental group is
paired with the most similar individual in the reference group. After matching,
the groups as a whole are assumed to be as similar as possible on the matched
characteristics. In stratification, subgroups of patients are formed based on
baseline variables. In psychotherapy research, however, there is usually a large
number of variables to match or stratify on, making it almost impossible to find
patients or groups similar on all these variables. This is called the dimension-
ality problem. Regression analysis with covariates, a third tool to compensate
for overt bias, has limitations as well: when many pre-treatment variables are
used as covariates, statistical-modeling problems and a loss of power arise. A
promising alternative method to correct for overt bias is the propensity score
(PS) method (Rosenbaum, 1995; Rosenbaum & Rubin, 1983).
2.3 Propensity score
Rosenbaum and Rubin (1983) suggested using the PS method to reduce the di-
mensionality problem. The PS method reduces the entire collection of observed
pre-treatment variables (X) to a single score. The estimated PS is defined as
the conditional probability of assignment to a particular treatment, given a
set of observed pre-treatment characteristics. Let D denote treatment group
membership, where D = 0 denotes the reference condition and D = 1 denotes
the experimental condition. Then, PS is defined as:
PS = P (D = 1|X) (2.1)
Rosenbaum and Rubin (1983) proved that, given the value of the PS, assign-
ment to treatment no longer depends on baseline variables. The PS is a score
balancing all observed pre-treatment variables among patients with the same
value of the PS. In this way, the PS method can put overt bias under sta-
tistical control. Different from the conventional approach, i.e. controlling for
or matching on many baseline variables, the PS enables researchers to deal
with one composite, single variable which is much easier and, in regression
analysis, preserves power. The PS has so far been used in medicine, social
sciences and economics (Connors et al., 1996; Lieberman et al., 1996; Lytle
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et al., 1999; Potosky et al., 2000; Stenestrand & Wallentin, 2001; Chan et al.,
2002; Mehta, Pascual, Soroko, & Chertow, 2002; Wolfe & Michaud, 2004; Lech-
ner, 1999; Jalan & Ravallion, 2003; Dranove & Lindrooth, 2003; Gibsons, 2003;
Yoshikawa, Magnuson, Bos, & Hsueh, 2003; Leow, Marcus, Zanutto, & Boruch,
2004; Guo, R, & Gibbons, 2006). The United States Food and Drug Adminis-
tration recommended the PS as a tool to overcome selection bias in treatment
studies (Jung, Chow, & Chi, 2007). In psychotherapy research, however, the PS
is not widely known. To the best of our knowledge, only a handful of pioneering
studies have used this instrument for selection bias control in non-randomized
studies (Kachele, Kordy, & Richard, 2001; Robinson, Harper, & Schoeny, 2003;
Hill, Waldfogel, Brooks-Gunn, & Han, 2005; Golkaramnay, Bauer, Haug, Wolf,
& Kordy, 2007).
2.4 Aim
The aims of this study are (1) to investigate if the PS method is applicable
in psychotherapy research and (2) to outline a step-by-step protocol for the
psychotherapy researcher to facilitate use of the PS in comparative outcome
studies when randomization is unfeasible. The PS method is applied to a
case study, the research project SCEPTRE (Study on Cost-Effectiveness of
Personality Disorder Treatment) (Bartak et al., 2010). Two treatment groups
are compared from SCEPTRE, using the PS to correct for known baseline
differences. The two treatment groups selected for comparison are short versus
long psychotherapy duration, as this distinction is straightforward and simple
to understand. Results should only be interpreted as an illustration, not as a
relevant clinical message. All statistical techniques presented in this chapter
are easily done in common statistical packages such as SPSS.
2.5 Method
2.5.1 Participants
Patients were recruited from 6 mental health care centers in the Netherlands
offering outpatient, day hospital and/or inpatient psychotherapy for patients
with personality pathology. Out of 2,540 patients who were admitted to the
centers from March 2003 to March 2006, 1,047 were selected for treatment, i.e.
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short- or long-duration psychotherapy in various settings. Before treatment
allocation, all patients were assessed with a routinely distributed assessment
battery including self-report questionnaires. A semi-structured interview was
conducted to diagnose personality disorders with DSM-IV criteria. Of the 1,047
patients selected for treatment, 298 patients had not yet completed a follow-up
measure, so no outcome score could be calculated. These were excluded from
the analysis, leaving 749 patients. Of these, 507 (67.7 percent) were female.
The mean age was 34.24 years (SD 9.93, range 1762). This sample is divided
into 2 groups: one group allocated to short-term therapy (up to 6 months), the
other group allocated to long-term therapy (more than 6 months).
2.5.2 Measures
The baseline assessment measured a long list of social, economic and diag-
nostic variables carefully selected by both clinicians and researchers, based on
literature and clinical knowledge (see tables 2.1 and 2.2).
Psychiatric symptomatology was measured with the Symptom Checklist 90
Revised, Dutch version (SCL-90) (Arrindell & Ettema, 2003; Derogatis, 1977,
1986). In this study, the Global Severity Index of the SCL-90 (GSI; the mean
score of all 90 items) is used as the primary outcome measure, with higher
scores indicating more distress. To measure the type and degree of person-
ality pathology the 4 higher-order factors of the Dimensional Assessment of
Personality Pathology Basic Questionnaire, Dutch version (DAPP-BQ): (1)
emotional dysregulation, (2) dissocial behaviour, (3) inhibition and (4) com-
pulsivity (Kampen, 2002; Livesley & Jackson, 2002) were used. Psychosocial
functioning was measured with the Outcome Questionnaire 45, Dutch version
(OQ-45) (Lambert et al., 1996). Of this self-report measure, 2 subscales were
included: (1) interpersonal relations and (2) social-role functioning. Health-
related quality of life was assessed with the EuroQoL EQ-5D (Brooks, R, &
Charro, 2003). Personality disorders were assessed with the Structured Inter-
view of DSM-IV Personality, Dutch version (SIDP-IV) (Pfohl, Blum, & Zim-
merman, 1997; DeJong, Brink, Harteveld, & Wielen, 1993; DeJong, Derks, Oel,
& Rinne, 1986). The severity of personality pathology was measured with 5
higher-order domains of the Severity Indices of Personality Problems (SIPP):
self-control, social concordance, identity integration, relational functioning and
responsibility (Andrea et al., 2007; Verheul et al., 2008). To measure patients
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motivation for treatment, the two scales of the Motivation for Treatment Ques-
tionnaire (MTQ-8): need for help and readiness to change (Beek & Verheul,
2008) were used.
2.6 Results
2.6.1 Results of the case study
To avoid bias in the estimation of the treatment effect, the influence of known
pre-treatment differences was corrected. This was done by stratification of the
sample based on the PS. This process took 9 steps, described below.
Step 1: Effect estimation before correction
Before correction for known pre-treatment differences, the treatment effect is
estimated by conducting a linear regression analysis. In this näıve estimate
the only independent variable was group membership (short vs. long), the de-
pendent variable was outcome, being defined here as the level of psychiatric
symptomatology (GSI) at the first measurement following baseline. The un-
corrected treatment effect β was 0.20 (SE = 0.05; p < 0.001).
Step 2: Balance check before correction
The 2 treatment groups were compared on pre-treatment variables before strat-
ification. Note that this step is neither relevant for variable selection for the
PS, nor for further analysis. It is only important here to be able to demon-
strate the influence of propensity correction on the balance between groups.
This demonstration can be done in several ways. For illustration purposes, a
comparison of overall regression coefficients is shown. A number of regression
analysis are conducted with group membership as an independent variable and
pre-treatment characteristics as dependent variables (linear regression analysis
for continuous variables, see table 2.1 , and multinomial logistic regression anal-
ysis for categorical variables, see table 2.2 ). The 2 patient groups (short- vs.
long-term treatment) differed significantly on 19 of the 34 baseline variables.
This implies that, without correction for these differences, the 2 groups were
not readily comparable - a problem that may be dealt with using the PS.



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.2: Differences in categorical variables between short-term and long-
term treatment groups
Variable Demographic data, % Odds ratio treatment
duration (short versus long)
Short-term Long-term before PS after PS
(n=331) (n=328) correction correction
Gender
Female 65.3 68.9 1.00a 1.00a
Male 34.7 31.1 1.18 1.01
Civil status
Married 27.5 18.0 1.00a 1.00a
Widowed /divorced 13.3 10.1 0.86 1.07
Never married 59.2 72.0 0.54∗∗ 1.04
Living situation
Alone 39.0 38.4 1.00a 1.00a
With partner (with or without child) 44.4 29.3 1.50∗ 0.98
With child without partner 5.7 6.4 0.88 1.02
With parent(s) 4.2 17.7 0.24∗∗∗ 1.14
With other people 6.6 8.2 0.80 1.02
Childcare
No care for children 72.5 80.5 1.00a 1.00a
Care for children 27.5 19.5 1.56∗ 0.95
Work situation
Unemployed 33.2 36.3 1.00a 1.00a
Study or paid work 66.8 63.7 1.14 0.99
Level of education
Low 19.3 28.0 1.00a 1.00a
Middle 22.7 17.7 1.86∗∗ 0.94
High 58.0 54.3 1.55∗ 0.89
Previous outpatient treatment
No 17.2 22.6 1.00a 1.00a
Yes 82.8 77.4 1.40 1.00
Previous inpatient treatment
No 83.4 79.9 1.00a 1.00a
Yes 16.6 20.1 0.79 1.03
Previous medication treatment
No 53.8 52.7 1.00a 1.00a
Yes 46.2 47.3 0.96 1.17
Alcohol abuse
No 84.5 87.2 1.00a 1.00a
Yes 15.5 12.8 1.25 0.80
Drug abuse
No 86.1 77.4 1.00a 1.00a
Yes 13.9 22.6 0.55∗∗ 1.10
Preference for treatment setting
Outpatient 12.1 22.9 1.00a 1.00a
Day hospital 30.9 24.8 2.36∗∗∗ 0.68
Inpatient 35.5 29.4 2.29∗∗ 0.85
Do not know 21.5 22.9 1.78∗ 0.67
Preference for treatment duration
Up to 6 months 43.5 25.3 1.00a 1.00a
Longer than 6 months 26.9 37.2 0.42∗∗∗ 0.99
Do not know 29.6 37.5 0.46∗∗∗ 1.04
Treatment setting
Outpatient 18.7 34.1 1.00a 1.00a
Day hospital 31.7 30.2 1.92∗∗ 0.99
Inpatient 49.5 35.7 2.53∗∗∗ 0.96
∗ p < 0.05, ∗∗ p < 0.01, ∗ ∗ ∗ p < 0.001.
a Category is reference category; for regression purposes all categorical variables were translated
into dummy variables,whereby the first category always serves as a reference category
with an odds ratio of 1.00.
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Figure 2.1: Overlap op the PS in the two treatment groups (short/long)
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Step 3: Variable selection for PS estimation
To estimate the PS, all baseline variables related to outcome (GSI) are used.
To identify these variables, a number of linear regression analysis are conducted
with the GSI as the dependent variable and each potential confounder as an
independent variable. The following variables emerged as primary candidates
for the estimation of the PS: level of personality pathology (i.e. emotional dys-
regulation, dissocial behavior and inhibitedness), motivation for treatment (i.e.
need for help), quality of life, psychological capacities (i.e. self-control, social
concordance, identity integration, relational functioning and responsibility),
level of psychiatric symptomatology, functioning (i.e. interpersonal and social-
role functioning), number of cluster A, B and C personality disorders, working
situation, level of education, previous inpatient treatment, patient preferences
for treatment duration and setting of treatment. Sociodemographic variables
were added to the PS model as well, because they are considered highly rel-
evant in psychotherapy research: age, gender, marital status, living situation
and responsibility for the care of children.
Step 4: Exclusion of incomplete cases
In this example, only patients with no missing values on the selected potential
confounders (see Step 3) were included in the PS analysis. The final sample
therefore consisted of 659 patients. Alternatively, imputation techniques might
be used to fill in the missing values in estimation variables.
Step 5: PS estimation
The PS was estimated in a logistic regression analysis. All selected potential
confounders were used as independent variables, and group membership as the
dependent variable. One can estimate and save these probabilities for each
subject, e.g. by using the option ”save predicted probability” in SPSS.
Step 6: Inspection of overlap and exclusion of non-overlapping cases
For the short-term treatment group (n = 331), the PS ranged between 0.03
and 0.98; for the long-term treatment group (n = 328), the PS ranged between
0.10 and 0.99 (see figure 2.1). The PS range that both groups cover is between
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0.10 and 0.98. Patients with a PS outside this common range (n = 24) were
excluded from the stratification, leaving a sample of 635 patients.
Step 7: Stratification of the sample based on the PS
The sample of 635 patients was divided into 5 equal subgroups with similar
PS (so-called strata, see table 2.3 ) (Cochran, 1968). 4 dummy variables were
created based on these 5 groups.
Table 2.3: Distribution of patients across the 5 strata
Stratum Short-term Long-term Total
1 104 23 127
2 78 49 127
3 62 65 127
4 48 79 127
5 17 110 127
Total 309 326 635
Step 8: Balance check after correction
To know if the stratification of the sample based on the PS resulted in a bal-
ance of pre-treatment variables between the 2 treatment groups, differences in
pre-treatment variables were checked again. This might be done for instance by
comparing groups per stratum, but to keep in line with the illustrative analysis
of step 2, the corrected differences between treatment groups was calculated by
performing a number of regression analysis: this time with group membership
and the 4 dummy variables indicating stratum membership as independent
variables and pre-treatment characteristics as dependent variables. The regres-
sion coefficients in tables 2.1 and 2.2 (with stratum membership as covariate)
indicated that - on average across all strata - there were no longer significant
differences in pre-treatment variables. The estimated PS seemed to balance, in
a satisfactory way, the observed significant pre-treatment differences between
the short-term and the long-term groups. In case differences in pre-treatment
variables between groups are more persistent, one can try to re-estimate the
PS, for instance by including interaction terms or non-linear relationships and
restart at step 5.
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Step 9: Effect estimation after correction
After taking into account the influence of known pre-treatment characteristics
using the PS, a corrected estimate of the treatment effect can be calculated.
This can be done in different statistical ways, for instance by weighting the 5
treatment effects of the different strata. To keep in line with the analysis in step
1, a linear regression analysis was used with the GSI as the dependent variable,
but this time group membership and the 4 dummy variables indicating stratum
membership were the independent variables. The effect of the treatment group
on outcome was reduced from β = 0.20 (SE = 0.05; p < 0.001) before PS
correction to β = 0.15 (SE = 0.06; p < 0.05) after PS correction. This shows
that, when observed pre-treatment differences were not taken into account, the
treatment effect was overestimated. Stratification of the sample based on the
PS reduced this bias.
2.6.2 Alternatives to stratification: PS in regression analysis
and matching
The results of 2 alternative methods for adjusting a treatment effect estimation
using the PS are presented below.
Regression analysis
A linear regression analysis was performed with the GSI as the dependent
variable, and the PS (as a continuous covariate) and the variable treatment
group as independent variables. After controlling for the PS by including it as
a covariate in the regression analysis, the effect of treatment group membership
was reduced from β = 0.20 (SE = 0.05; p < 0.001) before the correction to
β = 0.14 (SE = 0.06; p < 0.05) after the PS correction. This is similar to the
result of adjustment by stratification.
Matching
Each subject from the long-term group (this was the smallest group) was
matched with a subject from the short-term group, based on nearest avail-
able PS. Each subject from the short-term group only served once as matching
partner for a subject from the long-term group (sampling without replacement).
To ensure similarity in the matched pairs, caliper matching was used, i.e. all
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pairs with a PS difference larger than 0.10 were removed from the analysis
(Quade, 1982). This meant only 179 matched pairs (358 individuals) remained
in the analysis. After matching, the 2 groups showed no difference on any of
the observed pre-treatment variables. To keep in line with the previous analy-
sis, a regression analysis was conducted in the matched sample, with the GSI
as the dependent variable, and the variable group membership as the indepen-
dent variable. The effect of treatment group membership was reduced from
β = 0.20 (SE = 0.05; p < 0.001) before matching to β = 0.15 (SE = 0.07;
p < 0.05) after matching (alternatively, a paired t–test might be conducted
in the matched sample). Though the matching procedure was successful in
balancing and correcting for observed pre-treatment differences, a substantial
amount of information was lost due to a reduced sample size. In other (bigger)
samples, matching might still be a useful strategy to correct for overt bias,
especially when the control pool is large.
2.7 Discussion
Randomization in general and its application in psychotherapy research have
been criticized by different authors for various reasons. Non-randomized stud-
ies, however, face the serious problem of selection bias. As a result, a need
is felt for alternative and complementary research designs in the field of psy-
chotherapy, like quasi-experimental designs. The PS method offers a solution
to one part of the problem, overt bias, by balancing the treatment groups with
regard to observed pre-treatment differences. To overcome selection bias, the
PS method offers advantages compared to traditional methods.
First, the PS provides better insight in the selection process. Modeling
treatment selection in a logistic regression analysis clarifies which variables
affect selection and to what degree.
Second, it is easier to match or stratify on a single score (like the PS) than
on a range of pre-treatment characteristics. The same holds true for regression
adjustment techniques. Use of the single score PS enhances statistical power,
as compared to many covariates in a regression analysis.
Third, both the overlap in the distribution of the PS and balance of base-
line variables after correction can be investigated and used as a descriptive tool
(Rosenbaum & Rubin, 1983). The PS method, like any statistical correction
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method for selection bias, is only helpful given a considerable balance of pre-
treatment variables. After all, comparing very different subject groups in an
outcome study is irrelevant, both scientifically and clinically. The PS helps to
identify subjects differing widely on their pre-treatment characteristics (and, as
a consequence, on their PS). Determining the (essential) overlap of the distri-
butions and balance with classical covariate regression analysis is cumbersome
and therefore probably rarely done. As a last advantage, it is mentioned that
the PS method can be applied in different ways (stratification, matching and
in a regression analysis). Therefore, it can be tailored to sample characteristics
and researchers insights and decisions.
Obviously, the PS method is not without limitations and has to be used
responsibly (Yue, 2007). A researcher using the PS should take into account
the following recommendations.
First, the PS only corrects for observed pre-treatment characteristics, not
for unobserved (unknown) variables, hampering true cause-effect analysis. This
is called the ignorability or no unobserved confounders assumption. Even when
using the PS carefully, results may still be biased due to unobserved variables.
This is why, before starting a study, as many confounders as possible should be
identified and measured in a reliable way. This reduces the risk that important
variables are overlooked. It is recommended to consult several experts from
both the clinical and statistical fields to gain insight into the most relevant pre-
treatment variables. Experts consensus and statistical relevance should guide
the choice for potential confounders. Interestingly, when prognostic factors
are well understood and controlled for, and inclusion/exclusion criteria are
the same, randomized and non-randomized studies can have similar outcomes
(McKee et al., 1999; Benson & Hartz, 2000; Concato, Shah, & Horwitz, 1968).
Second, be careful when selecting variables to estimate the PS. Brookhart
et al. (2006) tested several ways of selecting relevant variables in a simulation
study. Their findings suggest that all variables related to study outcome should
be included in the PS model, whether or not these variables influence treatment
assignment. In this study, their advice was followed. However, in the field there
is still discussion on which is the best method for selecting the variables for the
PS model (Austin, Grootendorst, & Anderson, 2007).
Third, the sample size of a study has to be sufficiently large, especially for
stratification purposes, to allow for a meaningful correction of bias by means
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of the PS. Otherwise, several strata might be populated exclusively by patients
with the same treatment condition, making comparison impossible. A high
number of missing values on baseline variables causes problems as well. As
the PS method uses a combination of many variables, just one missing variable
leads to a missing PS, excluding this patient from all further analysis. Well-
chosen imputation methods can be used to fill in missing values and guarantee
a sufficient sample size without losing statistical precision. The availability of
all essential data is the first condition for a meaningful application of the PS
method, just as for any other statistical correction method.
To conclude, the PS method is a powerful way of simultaneously adjust-
ing for many observed confounders in non-randomized studies, thereby most
probably reducing bias in treatment comparisons. If used in a responsible and
thoughtful way, the PS method used in quasi-experimentation offers a strong
research design in situations where randomization is not possible. Therefore,
the PS method is a promising tool for future psychotherapy research.
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The multiple propensity score
as control for bias in the
comparison of more than two
treatment arms: An
introduction from a case
study in mental health∗
3.1 Summary
The propensity score method (PS) has proven to be an effective tool to reduce
bias in non-randomized studies, especially when the number of (potential) con-
founders is large and dimensionality problems arise. The PS method introduced
by Rosenbaum and Rubin is described in detail for studies with two treatment
options. Since in clinical practice one is often interested in the comparison of
multiple interventions, there was a need to extend the PS method to multi-
ple treatments. It has been shown that, in theory, a multiple PS method is
possible. So far, its practical application is rare and a practical introduction
lacking. A practical guideline to illustrate the use of the multiple PS method is
provided with data from a mental health study. The multiple PS is estimated
∗This chapter has been published as: Spreeuwenberg, M.D., Bartak, A., Croon, M.A.,




with a multinomial logistic regression analysis. The multiple PS is the prob-
ability of assignment to each treatment category. Subsequently, to estimate
the treatment effects while controlling for initial differences, the multiple PSs,
calculated for each treatment category, are included as extra predictors in the
regression analysis. With the multiple PS method, balance was achieved in
all relevant pre-treatment variables. The corrected estimated treatment effects
were somewhat different from the results without control for initial differences.
The results indicate that the multiple PS method is a feasible method to ad-
just for observed pre-treatment differences in non-randomized studies where
the number of pre-treatment differences is large and multiple treatments are
compared.
3.2 Introduction
Results from randomized controlled trials (RCTs) are considered the highest
level of scientific evidence, since one can expect that with randomization, on av-
erage, all patient characteristics are balanced between treatment groups. The-
oretically, this implies that, after randomization, treatment effects can be di-
rectly estimated, without control for initial differences (Shadish & Cook, 2002).
Nevertheless, randomized study designs have the drawback that they are often
difficult to conduct in clinical practice. Not only do medical ethical commit-
tees often object to randomization, random allocation is also often hampered by
both clinicians and patients preferences (Maat et al., 2007; Westen et al., 2004;
Mosis, Dieleman, Stricker, Lei, & Sturkenboom, 2006). In particular, when dif-
ferences in treatment options are substantial, the intended randomization plan
either fails or leaves the researcher with small research samples. Therefore, in
most research fields, one regularly has to rely on results from non-randomized
studies, also called quasi-experimental designs (Shadish & Cook, 2002).
In quasi-experimental designs, owing to non-random allocation, possible dif-
ferences between pre-treatment variables of patients in treatment groups can
lead to bias in the estimated treatment effect, also called selection bias or con-
founding (Winship & Mare, 1992). Rosenbaum (1995) distinguished between
overt bias and hidden bias. Overt bias is bias owing to observed pre-treatment
differences and hidden bias to unmeasured and unobserved differences (Rosen-
baum, 1991). Traditionally, for two treatment comparisons, overt bias is con-
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trolled statistically by means of regression analysis, matching or stratification.
When many variables are present to match or stratify, however, it is impossible
to find patients who are similar in terms of all these variables. This is called
the dimensionality problem (Rosenbaum, 1995; DÁgostino, 1998). Moreover,
the number of covariates one can afford in a regression model is limited and
depends strongly on the number of observations. Therefore, there is a need
to find statistical methods that are able to control for many pre-treatment
characteristics. For two-way comparisons (for instance, placebo versus a new
treatment) the propensity score (PS) has been described as a valid solution
(Bartak et al., 2009; Rubin, 1974; Thomas, 1992). The PS method can be
extended to multiple comparisons (e.g. treatment A, B and Placebo). For
multi-valued treatments, Imbens (2000) suggested the use of multiple or gen-
eralised PS. Although, theoretically, the multiple PS has proven effectiveness,
the method is not often encountered in clinical practice. In this chapter, it is
illustrated how the multiple PS method can be used. The multiple PS method
is demonstrated step-by-step with data from a mental health study.
3.3 The (multiple) propensity score method
With the PS method, a large collection of observed pre-treatment variables can
be used to estimate a single score, the PS (Rosenbaum & Rubin, 1983). This
score is the probability of assignment to the experimental condition, given a set
of pre-treatment variables. In randomized studies, the PS is supposed known
(mostly 50 percent). In non-randomized studies, the PS score can, for example,
be estimated by a logistic or probit regression analysis. With the assumption of
ignorability, meaning that X includes all important pre-treatment variables, it
can be shown that treatment assignment and covariates are independent, given
the PS (Rubin, 1974, 1997, 1976). This implies that control on the PS through
regression adjustment, matching or stratification removes the bias associated
with the differences in observed pre-treatment differences (DÁgostino, 1998;
Bartak et al., 2009; Thomas, 1992; Heckman et al., 1997; Ho, Imai, King, &
Stuart, 2007; Lu, Zanutto, Hornik, & Rosenbaum, 2001; Morgan & Harding,
2006; Rubin, 1997). It has been proven that the PS is a balancing score since,
after control on the PS, the distribution of the covariates is assumed the same
for the experimental group and the reference group. Accordingly, with the PS
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method one can easily check this balancing effect and advise the investigator
whether the causal question can be answered by the data at hand (Rubin,
1997).
Until recently, the PS method has been mostly used for two treatment set-
tings. In many cases, however, one might be interested in the comparison of
more than two treatments. Rubin proposed to create separate PS models for
each paired treatment comparison (Rubin, 1997; Luellen, Shadish, & Clark,
2005). If these models are not constrained, however, the probability of choos-
ing all treatment arms will end up greater than 1. In addition, the parameter
estimates obtained in these separate models are less efficient than those ob-
tained by fitting models simultaneously within a multinomial regression model
(Agresti, 2002). For nominal treatments, as is often the case in mental health
research, Imbens (2000) suggested the use of multiple PS, defined as the con-
ditional probability of receiving a particular level of the treatment given a set
of observed pre-treatment variables. The multiple PS can be estimated with a
multinomial logistic or probit regression. Here, for each subject, the probability
of receiving each treatment category given the observed covariates is estimated.
Imbens (2000) proved theoretically that, just like the original PS, the multiple
PS is a balancing score and that, instead of conditioning on the entire set of
covariates X, it is sufficient to condition on the multiple PS. Therefore, the
multiple PS can be used to correct for initial baseline differences and leads to
valid estimates in multiple treatment comparisons. Simulation studies using
subclassification in the multiple propensity score support this finding (Imai &
Dyk, 2004). Note that the assumption of ignorability is crucial in this aspect,
since it is assumed that all possibly confounding variables are observed and
used in the multiple PS estimation (Heitjan & Rubin, 1991). Recently, a few
studies have used the multiple PS for matching and subclassification (Frisco,
Muller, & Frank, 2007; Zanutto, Lu, & Hornik, 2005). Matching and stratifica-
tion on many multiple PSs are difficult to conduct in clinical practice, however,
especially when the number of treatments compared is large, and may result
in very small groups. Therefore, in this study, a step-by-step application of the
multiple PS method using regression analysis is presented.
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3.4 Aim
The aims of this chapter are (1) to investigate if the multiple PS method is
applicable in psychotherapy research and (2) to outline a step-by-step protocol
for the psychotherapy researcher to facilitate use of the multiple PS in com-
parative outcome studies when randomization is unfeasible. The multiple PS
method is applied to a case study, the research project SCEPTRE (Study on
Cost-Effectiveness of Personality Disorder Treatment) (Bartak et al., 2009).
5 treatment groups from SCEPTRE are compared, using the multiple PS to
correct for known baseline differences. Results should only be interpreted as
an illustration, not as a relevant clinical message.
3.5 Methods
3.5.1 Participants
To illustrate the use of a multiple PS, a sample of 361 patients is used, who all
enrolled in different forms of psychotherapy in six mental health care institutes
in the Netherlands. Patients were divided into five therapy groups, which
differed in treatment duration (up to six months (short) or more than six
months (long)), and treatment setting (outpatient, day hospital or inpatient).
The five therapies were long outpatient, short day hospital, long day hospital,
short inpatient, and long inpatient treatment.
3.5.2 Measures
The baseline assessment included measurements for all variables that were iden-
tified as potential confounders of the treatment-outcome association, i.e. age,
gender, civil status, living situation, care of children, employment, level of ed-
ucation, duration of psychological complaints, treatment history, alcohol and
drug abuse, motivation, treatment preferences, level of psychiatric symptoma-
tology, level of personality pathology, interpersonal functioning, social role func-
tioning, quality of life, number of DSM-IV Axis II cluster A disorders, number
of DSM-IV Axis II cluster B disorders, number of DSM-IV Axis II cluster C
disorders, and psychological capacities. This list of variables had been care-
fully chosen by both clinicians and researchers, and was based on the existing
literature and clinical knowledge. Psychiatric symptomatology was measured
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with the Global Severity Index (GSI) and used as primary outcome measure
(Arrindell & Ettema, 2003; Derogatis, 1986). Three treatment institutes con-
ducted their follow-up measures at 12, 24, and 36 months after baseline. The
three remaining treatment institutions conducted their follow-up measures at
the end of treatment, 6 and 12 months after the end, and again at 36 months
after baseline. For specific details of this study the reader is referred to the
literature (Bartak et al., 2009, 2010). For illustrative simplicity, the mean GSI
score of all follow-up measures is used as primary outcome measure.
3.6 Statistical analysis and results
The analyses were done with SPSS for Windows, version 15.0 (SPSS Inc.,
Chicago, IL, USA). The multiple PS was applied to the data in the follow-
ing steps.
Step 1: Effect estimation before correction
In the näıve model, the treatment effects were estimated in a multiple regression
analysis without any correction for pre-treatment differences. The dependent
variable was the GSI outcome score. As independent variables four dummy
variables indicating treatment group membership were included, with the short
inpatient treatment as reference category. See table 3.1 for the estimated pair-
wise treatment effects in the näıve model. Without control for initial baseline
differences the mean GSI score in the short inpatient treatment was lower than
the GSI score in the short day hospital (p < 0.05), long outpatient treatment
(p < 0.05), the long day hospital treatment (p < 0.05) and the long inpatient
treatment (p < 0.05). No other significant differences between the treatment
groups were found.
Step 2: Balance check before correction
First is checked to what extent the five treatment groups differed initially.
Note that this is not relevant for variable selection for the multiple PS, nor for
further analysis; the reason why it is done here is that it gives us an idea of the
initial comparability between the five treatment groups. For each continuous
variable an ANCOVA is conducted with treatment group as fixed factor. For
the dichotomous variables a logistic regression analysis is conducted with the




































































































































































































































































































































































categorical treatment variable as independent variable. For nominal variables,
a multinomial logistic regression analysis is conducted and the significance of
the log-likelihood ratio test for treatment reported. See table 3.2 for the mean
and standard deviation of the continuous variables in each treatment group and
the p-values for significance before correction on the multiple PS. See table 3.3
for the percentages of levels of the categorical variables in each group and
the p-values for significance. Sixteen out of 24 distributions of the continuous
variables differed between the groups. For the categorical variables 8 out of 16
variables differed between the five treatment groups. This implies that, without
correction for these differences, the five treatment groups initially differed in
many pre-treatment variables and were not comparable in many ways.
Step 3: Variable selection for multiple PS estimation
As suggested, all baseline variables related to outcome were used for estimating
the multiple PS (Lu et al., 2001; Brookhart et al., 2006). To identify these
variables, several linear regression analysis are conducted with the GSI outcome
score as dependent and each potential confounder as independent variable. All
variables with a p-value smaller than 0.10 were selected for the estimation of
the multiple PS. These variables are denoted with † in tables 3.2 and 3.3.
Step 4: Multiple PS estimation
Since in this study the treatment categories are nominal, the multiple PSs are
estimated by multinomial regression analysis with all variables related to out-
come as independent variables and group membership as dependent variable.
The likelihood ratio test of the model, compared with the ”empty” model was
χ2 = 220.20, df = 96, p < 0.001. The pseudo R2 of Nagelkerke was 45.7%. The
multiple PSs are the estimated predicted probabilities of assignment to each
treatment group, calculated for each subject. Because in this study five psycho-
logical treatments are compared, five multiple PSs are estimated as suggested
by Imbens (2000). Since all these PSs add up to 1 and are complementary,
only four out of five multiple PSs are needed in the further analysis. Note
that a main assumption of multinomial regression analysis is the Independence


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.3: Percentages of levels of the categorical variables in the treatment
groups and P-values for the differences before and after correction on the
multiple PS
P-value
Long Short day Long day Short Long before after
outpatient hospital hospital inpatient inpatient Multiple Multiple
PS PS
(N=64) (N=76) (N=72) (N=58) (N=91) correction correction
Gender 0.080 0.435
Female 62.5 77.6 79.2 63.8 65.9
Male 37.5 22.4 20.8 36.2 34.1
Civil status 0.000∗ 0.000∗
Married 28.1 21.1 15.5 33.7 11.0
Widowed/divorced 20.3 14.5 10.7 8.4 2.2
Never married 51.6 64.5 73.8 57.8 68.8
Living situation 0.000∗ 0.001∗
Alone 32.8 28.9 36.1 46.6 41.8
With partner 48.4 43.4 36.1 44.8 18.7
With child 9.4 9.2 5.6 1.7 1.1
without partner
With parent(s) 6.2 9.2 13.9 3.4 22.0
With other people 3.1 9.2 8.3 3.4 16.5
Childcare 0.000∗ 0.006∗
No care for children 61.4 72.4 83.3 77.6 93.4
Care for children 35.9 27.6 16.7 22.4 6.6
Work situation† 0.474 1.000
Unemployed 40.6 40.8 27.8 37.9 35.2
Study or paid work 59.4 59.2 72.2 62.1 64.8
Level of education 0.318 0.814
Low 22.6 26.3 25.2 15.8 17.6
Middle 23.4 22.4 21.5 14.0 16.5
High 50.0 51.3 53.3 70.2 65.9
Previous outpatient 0.001∗ 0.003∗
treatment†
No 31.3 11.8 20.8 13.8 5.5
Yes 68.8 88.2 79.2 86.2 94.5
Previous inpatient 0.360 0.999
treatment†
No 81.3 86.8 84.7 74.1 79.1
Yes 18.8 13.2 15.3 25.9 20.9
Previous medication 0.010∗ 0.195
No 61.4 55.3 62.5 36.2 47.3
Yes 35.9 44.7 37.5 63.8 52.7
Alcohol abuse 0.067 0.046∗
No 93.7 85.5 73.6 84.5 89.0
Yes 6.3 14.5 26.4 15.5 11.0
Drug abuse 0.047∗ 0.385
No 84.5 84.2 76.4 91.4 72.5
Yes 15.6 15.8 23.6 8.6 27.5
Preference setting† 0.000∗ 0.000∗
Outpatient 53.1 6.6 8.3 1.7 1.1
Day hospital 10.9 61.8 54.2 20.9 20.9
Inpatient 1.6 14.5 15.3 61.5 61.5
Do not know 34.3 34.4 22.2 16.5 16.5
Preference duration† 0.000∗ 1.000
Up to 6 months 12.5 36.8 26.9 26.4 30.8
≥ 6 months 40.6 28.9 21.2 58.5 44.0
Do not know 46.9 34.2 51.9 44.0 25.3
Diagnosis avoidance 0.070 0.638
No 43.8 46.1 36.1 32.8 26.4
Yes 56.3 53.9 63.9 67.2 73.6
Diagnosis dependent 0.340 0.906
No 85.9 72.4 76.4 81.0 74.7
Yes 14.1 27.6 23.6 19.0 25.3
Diagnosis obsessive 0.160 0.831
compulsivity
No 39.1 46.1 52.8 56.9 57.1
Yes 60.9 53.9 47.2 43.1 42.9
∗ P < 0.05. PS indicates propensity score. †Variables related to outcome with a P < 0.10 .
The multiple propensity score as control for bias 43
of Irrelevant Alternatives Assumption (IIA) which means that adding irrele-
vant outcome categories does not affect the odds ratio among the remaining
outcomes. With the module mlogtest of the computer package STATA this
assumption is checked. In our case, adding irrelevant outcome categories did
not influence the odds of treatment. When, however, the IIA assumption is
violated, multinomial probit analysis can be used. In the case when treatment
categories are defined by an ordinal value such as treatment dosage, ordinal
logistic regression can be used as an alternative estimation method (Lu et al.,
2001; Joffe & Rosenbaum, 1999; Wang, Donnan, Steinke, & MacDonald, 2001).
Step 5: Check for overlap of the distributions
Before the multiple PSs are included in the regression analysis, it is advisable to
inspect the distributions of the multiple PSs, as non-overlapping distributions
will make the analysis like comparing apples and oranges. That is, for treatment
comparability, it is important that each patient in a therapy group also had a
certain probability of assignment to the other therapy groups. A lack of overlap
between the distributions of the multiple PSs can yield imprecise estimates of
the treatment effect that is only applicable for a subgroup. Figure 3.1 shows
the distributions of the multiple propensity scores. In the comparison of the
ranges of the multiple propensity scores for subjects assigned to each treatment
group there is considerable overlap. For the comparison in the overlap of two
distributions Cochran and Rubin (1973) defined a distance score (d) where the
value depends on the mean and the variance in two distributions. This method
can be used for each pairwise comparison.
Step 6: Balance check after correction
The use of the multiple PS is considered successful when balance is achieved in
the distribution of all observed covariates between the five treatment groups.
The similarity of the covariates can be assessed with significance testing. For
each continuous variable an ANCOVA is conducted with treatment group as
fixed factor. To correct the comparison for the PS four out of five multiple PSs
are added along with its mutual interactions as covariates. Table 3.2 shows the
p-values for significance testing of the treatment groups differences before and
after correction on the multiple PS. For the dichotomous variables a logistic
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.1: Box-plots for overlap of the multiple PS between the 5 treatments
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with four multiple PSs as independent variables. For nominal variables multi-
nomial logistic regression analysis is used with treatment as factor treatment
and the four multiple PSs as covariates. Table 3.3 shows p-values for signif-
icance of treatment group differences for the categorical variables before and
after correction on the multiple PS. Tables 3.2 and 3.3 reveal that control on
the multiple PS satisfactorily balances the distribution of all covariates used
for estimating the PS. After control on the multiple propensity score there was
no difference between the variables included in the multiple PS. This implies
that further analysis is possible.
Step 7: Effect estimation after correction
To estimate the treatment effect, taking into account the influence of pre-
treatment characteristics, the näıve model was extended by including the mul-
tiple propensity scores in the model. The GSI score was used as dependent
variable and as independent variables the following covariates were included:
four dummy variables indicating group membership, four multiple PSs and
their product terms. See table 3.4 for each estimated pairwise treatment ef-
fect, after correction on the multiple PS. In accordance with the näıve model,
the mean GSI score in the short inpatient treatment was lower than the GSI
score in the short day hospital treatment (p < 0.05), long outpatient treatment
(p < 0.05), the long day hospital treatment (p < 0.05) and the long inpatient
treatment (p < 0.05). No other differences between the treatment groups were
found. In comparison of the corrected and uncorrected treatment effects, it
is seen that the uncorrected treatment effects were only slightly different (see
tables 3.1 and 3.4). This implies that the role of overt bias was only small in
this study. An explanation is that the variables included in the study were
not strong confounders. As the propensity score method often yields the same
results as traditional multiple regression analysis, also a traditional multiple re-
gression analysis is done with all variables that were originally included in the
multiple PS as extra predictors in the näıve model. The results are presented
in table 3.5. As can be seen, the estimates from this analysis are comparable
to the estimates provided by the multiple propensity scores.
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3.7 Discussion
The present study introduces the multiple PS methodology by presenting a
practical step-by-step approach using data from a mental health study. The
study results indicate that the multiple PS can correct for observed pre-treatment
differences, thereby reducing the influence of selection bias in non-randomized
studies. The results indicate a superiority of the short-term inpatient treat-
ment.
As Bartak et al. (2010) suggested, the superiority of the short-term inpa-
tient treatment can be explained by the combination of short hospitalization,
thereby preventing iatrogenic effects, and a high level of therapeutic intensity
and pressure. This makes inpatient psychotherapeutic treatment an interesting
option for patients with Cluster C personality disorder.
Even though the multiple PS is a strong tool for correction of initial dif-
ferences, one has to keep in mind several considerations while using it. First,
one has to take into account that the true multiple PSs remain unknown.
Only when balance of confounders between treatment groups is observed, a
researcher knows that the multiple PS succeeded in controlling for bias and
further analysis can take place (Ho et al., 2007).
Second, the (multiple) PS, like virtually all statistical methods used for
observational data, relies strongly on the ignorability assumption and thus on
the assumption that hidden bias is absent. Researchers are often unaware of
the presence of the influence of unobserved variables on the results of their
study and can therefore not fully rely on the results. To reduce the risk of
hidden bias, it is important to choose carefully a list of potential confounders
that should be measured before the start of the study. In the present study,
expert panels from both the clinical and statistical fields were used to identify
possible confounders.
Third, it is emphasized that, although the multiple PS step-by-step ap-
proach seems straightforward, one has to keep in mind that the method should
be used with care. This applies especially to the selection of variables included
in the multiple PS. Brookhart et al. (2006) state that variables which are only
related to treatment assignment should not be included and all variables re-
lated to outcome should be included in the estimation of the (multiple) PS.
Rubin and Thomas (1996) state that no prognostic variable should be left out
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unless this variable is clearly balanced and that it is advisable to include it in
the PS model even when it is not statistically significant. In the present study,
the advice of Brookhart et al. (2006) is followed and variables related to out-
come are included. A conservative selection rule was followed with a p-value
smaller than 0.10. Another consideration is the way the balancing effect of the
variables is shown after control on the multiple propensity scores. With two
treatments, it was straightforward to show this balancing effect, for example
by making strata on the propensity score and by checking for differences within
strata. With more than two (K) treatments there is no state of the art on how
to show the balancing effect. In principle, balance can be shown by making
K times K strata and showing the balancing effect within each stratum. In
this study comparing five treatments, however, this was not doable. When the
researcher is very careful, however, in estimating the multiple propensity score
and has considered all possible interaction terms, at a certain point s/he should
rely on the fact that the multiple propensity score was successful in balancing
the important pre-treatment variables. P-values for significance testing are a
useful way to illustrate the balancing effect but, owing to its dependency on the
sample size, should be interpreted with care. Note that the purpose of adding
variables and their interactions into the propensity score method is to obtain
a better estimation. The purpose of (multiple) propensity score estimation is
mainly for point estimation and the model selection process is superfluous in
the propensity score model.
Fourth, in this study matching was not performed, as it was impossible
to match on all five multiple propensity scores, which resulted in small treat-
ment samples. Therefore, a regression analysis was adopted to correct for the
multiple PSs.
The purpose of the present study was to provide hands-on guidelines for
the clinical researcher who is faced with the impossibility of randomization in
studies when trying to answer relevant clinical questions. It is illustrated that,
in this study, the multiple PS could be implemented in the statistical process
to control for a large set of confounders, and also when multiple treatments are
compared. To ease the use of this promising method, an easy to follow step-by-
step approach is presented. Hopefully, this will make this method accessible to a
broad audience and foster its application, thereby enhancing the appreciation of
well-conducted non-randomized studies. By using advanced statistical methods
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to avoid bias such as the multiple PS method, researchers take responsibility
for reducing the reasonable criticism of non-randomized studies. This might
increase the scientific status of these studies and will help to answer relevant





for patients with cluster C
personality disorder: Results
of a large prospective
multicentre study ∗
4.1 Summary
No previous studies have compared the effectiveness of different modalities of
psychotherapeutic treatment, as defined by different settings and durations,
for patients with cluster C personality disorders. The aim of this multicenter
study was to compare the effectiveness of 5 treatment modalities for patients
with cluster C personality disorders in terms of psychiatric symptoms, psy-
chosocial functioning, and quality of life. The following treatment modalities
were compared: long-term outpatient (more than 6 months), short-term day
∗This chapter has been published as: Bartak, A., Spreeuwenberg, M.D., Andrea, H., Holle-
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Busschbach, J.J.V., Verheul, R., Stijnen, T., & Emmelkamp, P.M.G. (2010). Psychotherapy
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Figure 4.1: Patient flow
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hospital (up to 6 months), long-term day hospital, short-term inpatient, and
long-term inpatient psychotherapy. The study was conducted between March
2003 and June 2008 in 6 mental health care centers in the Netherlands, with a
sample of 371 patients with a DSM-IV-TR axis-II cluster C diagnosis. Patients
were assigned to 5 different modalities of psychotherapeutic treatment, and
effectiveness was assessed at 12 months after baseline. An intention-to-treat
analysis was conducted for psychiatric symptoms (Brief Symptom Inventory),
psychosocial functioning (Outcome Questionnaire-45), and quality of life (EQ-
5D), using multilevel statistical modeling. As the study was non-randomized,
the propensity score method was used to control for initial differences. Patients
in all treatment groups had improved on all outcomes 12 months after baseline.
Patients receiving short-term inpatient treatment showed more improvement
than patients receiving other treatment modalities. Psychotherapeutic treat-
ment, especially in the short-term inpatient modality, is an effective treatment
for patients with cluster C personality disorders.
4.2 Introduction
An estimated 2.6% of the general population is affected by cluster C personal-
ity disorders (PD): avoidant, dependent, and obsessive-compulsive PD (Coid,
Yang, Tyrer, Roberts, & Ullrich, 2006). This cluster of PD is associated with
significant functional impairment and a high economic burden, yet studies in-
vestigating treatment effectiveness in this patient population are scarce (Skodol
et al., 2002; Skodol, Johnson, Cohen, Sneed, & Crawford, 2007; Grant et al.,
2004; Skodol, Johnson, Cohen, Sneed, & Crawford, 2008; Duggan, Huband,
Smailagic, Ferriter, & Adams, 2007). As in research on other psychological dis-
orders, the available studies on cluster C PD typically compare treatments that
are identical in treatment setting and duration. Investigators have compared
different outpatient treatments, different day hospital treatments, and differ-
ent inpatient treatments (Emmerik, Kamphuis, & Emmelkamp, 2008; Alden,
1989; Emmelkamp et al., 2006; Hellerstein et al., 1998; Stravynski, Belisle,
Marcouiller, Lavallee, & Elie, 1994; Svartberg, Stiles, & Seltzer, 2004; Win-
ston et al., 1994; Karterud et al., 2003; Wilberg et al., 1999; Gude & Vaglum,
2001; Teusch, Bohme, Finke, & Gastpar, 2001). One recent study in Norway
compared outpatient and day hospital treatment for patients with all forms of
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PD, and found no significant superiority of one treatment over another at 8
months after the start of treatment (Arnevik et al., 2009). However, so far,
no study has compared the effectiveness of treatments across widely differing
settings and durations. In this chapter, treatment modality was specified as a
combination of treatment setting (i.e. outpatient, day hospital, or inpatient)
and duration (i.e. short-term or long-term), as these are the most important
aspects regarding treatment costs, a crucial aspect in times of restricted health
care budgets.
It is likely that one of the reasons this comparison has not been under-
taken previously is the difficulty of random assignment to different treatment
modalities in clinical samples due to practical or ethical constraints (Black,
1996). Furthermore, even if researchers were successful in setting up and start-
ing a randomized treatment modality study, its external validity would be
doubtful because a high number of patients would refuse to participate (Zeeck
et al., 2009). Therefore, quasi-experimental studies using statistical correction
models to counter selection bias are increasingly being found in the literature
(Facchinetti, Ottolini, Fazzio, Rigatelli, & Volpe, 2007; Forstmeier & Rued-
del, 2007; Golkaramnay et al., 2007; Grossman, Tiefenthaler-Gilmer, Raysz, &
Kesper, 2007).
The aim of the present quasi-experimental study was to compare the effec-
tiveness of different treatment modalities for patients with cluster C PD in a
naturalistic setting, thereby insuring high external validity. In fact, treatment
modality might be an overlooked factor in psychotherapy effectiveness research.
4.3 Method
4.3.1 Participants
Participants (n = 371) were recruited from consecutive admissions to 6 men-
tal health care centres in the Netherlands (Centre of Psychotherapy De Vier-
sprong, Halsteren; Altrecht, Utrecht; Zaans Medical Centre, Zaandam; Centre
of Psychotherapy De Gelderse Roos, Lunteren; GGZWNB, Bergen op Zoom &
Roosendaal; Centre of Psychotherapy Centrum, Amsterdam). These institu-
tions offer outpatient, day hospital, and/or inpatient psychotherapeutic treat-
ment for patients with personality pathology. From March 2003 to March 2006,
1,379 patients completed the intake procedure and were selected for treatment
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(figure 4.1).
Of these, 146 patients (10.6%) were excluded from the study for not meet-
ing one of the following inclusion criteria: age between 18 and 70 (n = 13),
significant personality pathology (n = 34), and referral for psychotherapeutic
treatment aimed at personality problems (n = 99). Nine patients (0.7%) met
one of the following exclusion criteria: insufficient command of the Dutch lan-
guage (n = 6), organic cerebral impairment (n = 1), mental retardation (n =
1), and schizophrenia (n = 1). This left 1,224 participants, of whom 100 (8.2%)
refused to participate. Another 31 patients (2.5%) could not participate due
to logistic reasons (e.g. no appointment could be made to provide informed
consent), and 133 patients (10.9%) were excluded due to missing or unreliable
baseline data. Thirty-eight patients (3.1%) received less than 2 treatment ses-
sions or less than 2 days of inpatient or day hospital therapy, and were therefore
excluded. The remaining 922 patients were informed about the study and its
procedure, provided written informed consent, and entered the study. Of those,
466 patients (50.5%) had 1 or more cluster C PD.
In the absence of explicit guidelines for treatment assignment in PD, the
selection procedure was based on the expert opinion of clinicians who used their
clinical experience combined with patient data from standardized instruments
(Manen, 2008; Vervaeke & Emmelkamp, 1998). To elucidate the criteria used
for the assignment process, the research group recently conducted a study with
intake clinicians from the participating treatment centers. They found evidence
of substantial (implicit) consensus among clinicians concerning the criteria used
for treatment decision-making. For example, focality of problems (focal or
broad spectrum of problems) and ego strength were found to be related to
decisions about a short or long treatment duration for a substantial number of
intake clinicians (Manen, 2008).
Patients were assigned to 1 of 6 treatment modality groups: 18 to short-
term outpatient (up to 6 months), 96 to long-term outpatient (more than 6
months), 85 to short-term day-hospital, 103 to long-term day hospital, 63 to
short-term inpatient, and 101 to long-term inpatient treatment. The short-
term outpatient group was excluded from the analysis for 2 reasons: (1) only
a minority of patients (3.9%) were assigned to this short and low-frequency
treatment modality, as could be expected in a PD patient population; (2) these
patients differed significantly from patients in the other treatment groups on
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a high number of pre-treatment variables, indicating a dissimilar and most
importantly a structurally less sick patient population, incomparable with
the rest of the sample. A comparison with this treatment modality would
most probably also fail when trying to design a randomized trial, as short-
term outpatient therapy differs most from all other modalities in terms of its
relatively low impact on patients lives compared to other treatment modalities.
In the end, 448 participants were included in the study. Follow-up data were not
available for 77 patients (17.2%; patients who did not respond to any follow-up
assessment or patients where follow-up measurements were not yet available).
There was no difference in psychiatric symptoms at baseline between patients
with follow-up data and those without (this holds true for both the comparison
in the total sample and the comparisons within the 5 treatment groups). The
final sample consisted of 371 patients to be included in the analysis.
4.3.2 Treatment
The 6 mental health care centers offer a variety of psychotherapeutic treat-
ments tailored to a PD patient population. Their treatments differ according
to several features. As this study focused on different treatment modalities in
terms of setting and duration, the following 5 treatment groups were compared:
* Patients in long-term outpatient treatment (n = 68, 18.3% of the study
sample). These patients come for individual (76.5%) or group (23.5%)
psychotherapy sessions, for up to 2 sessions per week (mean 0.8 ses-
sions/week, SD 0.51, median 0.5) for more than 6 months (mean duration
15.4 months, SD 6.36, median 12.0).
* Patients in short-term day hospital treatment (n = 77; 20.8% of the
study sample). These patients come to the institutions at least 1 morn-
ing/afternoon per week (mean 3.2 days/week, SD 1.51, median 3.0) for
up to 6 months (mean duration 5.4 months, SD 1.32, median 6.0) and
receive different forms of psychotherapeutic and psychosocial treatment,
but sleep at home.
* Patients in long-term day-hospital treatment (n = 74, 19.9% of the study
sample). These patients come to the institutions at least 1 morning/afternoon
per week (mean 3.3 days/week, SD 1.42, median 3.0) for more than
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6 months (mean duration 12.1 months, SD 2.41, median 12.0) and re-
ceive different forms of psychotherapeutic and psychosocial treatment,
but sleep at home.
* Patients in short-term inpatient treatment (n = 59, 15.9% of the study
sample). These patients stay at the institutions 5 days a week for up to
6 months (mean duration 4.2 months, SD 1.48, median 3.0) and receive
different forms of psychotherapeutic and psychosocial treatment.
* Patients in long-term inpatient treatment (n = 93, 25.1% of the study
sample). These patients stay at the institutions 5 days a week for more
than 6 months (mean duration 10.2 months, SD 1.98, median 10.0) and
receive different forms of psychotherapeutic and psychosocial treatment.
Day hospital and inpatient programs typically consist of group psychotherapy
as a core element, mostly in combination with one or more non-verbal or expres-
sive group therapies, individual psychotherapy, sociotherapy within the thera-
peutic community, coaching for social problems, community meetings, and/or
pharmacological treatment. The psychotherapists are all licensed psychiatrists
or psychologists. On average, they had 14.9 years (SD 10.1) of postgraduate
clinical experience. The treatments under study can be considered highly rep-
resentative of regular clinical practice in the Netherlands, as therapists did not




An extensive standard assessment battery of instruments was administered to
the patients before treatment assignment. PD were measured using the Dutch
version of the Structured Interview for DSM-IV Personality (DeJong et al.,
1986; Pfohl et al., 1997). This interview covers the 11 formal DSM-IV-TR
axis II diagnoses including PD not otherwise specified, 2 appendix diagnoses
(i.e. depressive and negativistic PD), and self-defeating PD. Interviewers were
masters level psychologists, who were trained thoroughly by one of the authors
(R.V.), and who received monthly booster sessions to avoid deviation from the
interviewer guidelines. Inter-rater reliability was evaluated in 25 video-taped
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interviews, which were rated by 3 observer-raters. Percentage of agreement
between observer- raters ranged from 84 (avoidant PD) to 100% (schizoid)
(median 95%). Intra-class correlation coefficients for the sum of DSM-IV PD
traits present (i.e. scores 2 or 3) ranged from 0.60 (schizotypal) through 0.92
(antisocial) (median 0.74). To measure patient characteristics at baseline, the
assessment battery also included 3 self-report instruments. The first of those
was the Dutch version of the Dimensional Assessment of Personality Pathology-
Basic Questionnaire (DAPP-BQ), for measuring the type and degree of person-
ality pathology (Kampen, 2002; Livesley & Jackson, 2002). Patients scores on
this questionnaire for the 4 higher-order factors were used: emotional dysregula-
tion, dissocial behaviour, inhibition, and compulsivity. To measure the severity
of personality pathology 5 higher- order domains of the Severity Indices of Per-
sonality Problems (SIPP) were used: self-control, social concordance, identity
integration, relational capacities, and responsibility (Verheul et al., 2008). To
measure patients motivation for treatment, the 2 scales of the Motivation for
Treatment Questionnaire (MTQ-8) were used: need for help and readiness to
change (Beek & Verheul, 2008).
Outcome measures
The primary outcome measure was general psychiatric symptomatology. This
was measured using the Dutch version of the Brief Symptom Inventory, a vali-
dated self-report scale derived from the Symptom Checklist 90 Revised (Dero-
gatis & Melisaratos, 1983; Beurs & Zitman, 2006; Derogatis, 1986; Arrindell
& Ettema, 2003). In this study, the mean score of the 53 items of the Brief
Symptom Inventory were used, i.e. the Global Severity Index (GSI), ranging
from 0 to 4. Psychosocial functioning was measured with 2 subscales of the
Outcome Questionnaire-45 (OQ- 45): (1) interpersonal relations and (2) social
role functioning (Lambert et al., 1996). Health-related quality of life was mea-
sured using the EuroQol EQ-5D (EQ-5D) (Brooks et al., 2003). All 4 outcome
measures, the GSI, OQ-45 interpersonal relations, OQ-45 social role, and EQ-
5D, were assessed at baseline and several follow-up points. Three treatment
centers conducted their follow-up at approximately 12, 24, and 36 months af-
ter baseline; the other 3 treatment centers conducted their follow-up at the
end of treatment, approximately 6 and 12 months afterwards, and again at
36 months after baseline. The use of different assessment points was due to
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logistic reasons, and was taken into account by choosing multilevel modeling
as the statistical method for the analysis.
Table 4.1: Variables used for propensity score estimation, outcome GSI
Variable Content
Age patients age
DAPP-BQ Emotional dysregulation unstable affective responding, interpersonal problems
DAPP-BQ Inhibition deriving little enjoyment from intimate relationships
MTQ-8 Need for help patients expressed desire for external help
MTQ-8 Readiness to change willingness for treatment-seeking behaviour
EQ-5D quality of life
SIPP Self-control capacity to tolerate, use and control ones
own emotions and impulses
SIPP Identity integration coherence of identity; the ability to see oneself
and ones own life as stable, integrated and purposive
SIPP Relational capacities capacity to genuinely care about others as well as
feeling cared for by them, to be able to communicate
personal experiences, and to hear and engage with the
experiences of others often but not necessarily in the
context of a long-term intimate relationship
SIPP Responsibility capacity to set realistic goals, and
achieve these goals in line with the
expectations generated in others
GSI level of psychiatric symptoms
OQ-45 Symptom distress level of symptom distress
OQ-45 Relational functioning level of interpersonal functioning
OQ-45 Social role functioning level of social and work functioning
Dimensional score cluster C PD dimensional score of cluster C PD characteristics
Total dimensional score all PD dimensional score of all PD characteristics
Avoidant PD diagnosis of avoidant PD
Dependent PD diagnosis of dependent PD
Obsessive-compulsive PD diagnosis of obsessive-compulsive PD
Statistical analysis
First, the uncorrected results on all 4 outcome measures at 12 months after
baseline were examined. Multilevel modeling was used to deal with: (1) the
dependency of repeated measures on the same subject in time and (2) longitudi-
nal data with observations unequally spaced in time (see Outcome measures).
To estimate the uncorrected treatment effect at 12 months after baseline, a
random intercept and random slope model was used with time as level I and
patient number as level II. This resulted in a final best-fitting model with the
following independent variables: dummy variables indicating group member-
ship, time, and interaction between group membership and time. Subsequently,
the within-group effect sizes (Cohens d) were calculated to describe change from
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baseline to 12 months in each group (Cohen, 1988).
However, since this is a non-randomized study, the comparison of the groups
had to be corrected for the influence of confounders, i.e. initial patient differ-
ences. To adjust for these differences and avoid bias in effect estimation, the
’multiple propensity score’ was included in the analysis. The classic propensity
score is defined as the conditional probability of assignment to 1 of 2 treat-
ment groups given a set of observed pre-treatment variables (Rosenbaum &
Rubin, 1983). The multiple propensity score is an extension of the classic
propensity score to more than 2 treatment groups (Imbens, 2000). Statistical
inclusion of possible confounders in the outcome analysis controls selection bias
due to known confounders while comparing multiple groups. To identify rele-
vant confounders, a long list of social, economic, and diagnostic variables was
considered, carefully selected by both clinicians and researchers, based on the
literature and clinical knowledge (Spreeuwenberg et al., 2010). All variables
significantly related to a specific outcome were used to estimate the multiple
propensity scores in a multinomial regression analysis, with group member-
ship as a dependent variable (see table 4.1 for the variables included in the
GSI propensity score; complete list of potential/identified confounders for all
outcome variables available upon request).
One major advantage of the propensity score method, as compared to other
correction techniques, is the fact that the overlap in propensity score distribu-
tions (and thus the overlap in relevant variables) between treatment groups
can be easily judged and visualized. From looking at the overlap between
the 5 treatment groups it appeared that, in spite of some differences, these
groups were readily comparable. For a detailed description of this method and
its use in psychotherapy research, see Bartak et al. (2009). A more sophis-
ticated multilevel model, now including multiple propensity scores, was used
to compare change in outcome variables across treatment groups. Dependent
variables were the change scores (from baseline) observed during follow-up for
each of the outcome measures. Independent variables were dummy variables in-
dicating group membership, time, interaction between group membership and
time, and the multiple propensity scores (with their mutual interactions). This
model estimated differences in change scores at 12 months after baseline in
pairwise comparisons of the 5 treatment groups. If significant differences in
change scores were found, the between-group effect sizes were calculated.
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To render the outcome estimates at 12 months more reliable, optimum
use of the potential of this data-set was made by including all available data
collected up to 800 days after baseline. Data collected after that point was not
used in order to prevent bias of the 12-month data due to changes much later
in the process. The number of available follow-up measures was as follows: up
to 800 days, 30.5% of the total sample had 1 follow-up measure, 36.7% had 2
follow-up measures, and 32.9% had 3 follow-up measures. The analysis were
performed using SPSS 15.0 for data preparation and Proc Mixed of SAS 9.1.3
for multilevel modeling (SASS Institute, Cary, N.C., USA).
4.4 Results
Sample characteristics
Of the 371 patients, 29.6% were male and 70.4% were female. The mean age
was 33.5 years (SD 9.5). The highest level of education was low for 22.9%,
medium for 19.4%, and high for 57.7%. Furthermore, 70.4% were unmarried,
21.3% were married, and 8.4% were divorced or widowed. The majority, 66.6%,
had pure cluster C PD (i.e. no comorbid cluster A or B PD), 23.7% had a
combination of cluster C PD and cluster B PD, 4.0% had a combination of
cluster C PD and cluster A PD, and 5.7% had a combination of cluster C PD
and both cluster A and B PD. A majority (63.3%) had a diagnosis of avoidant
PD, 49.3% had a diagnosis of obsessive-compulsive PD, and 22.6% a diagnosis
of dependent PD.
Uncorrected outcome
One year after baseline, patients in all treatment groups showed improvement
in terms of psychiatric symptoms (GSI), the primary outcome measure. This is
shown in table 4.2 and figure 4.2. Within-group effect sizes of the uncorrected
scores ranged from 0.62 (medium effect, short-term day hospital group) to 1.78
(huge effect, short-term inpatient group).
Improvements were also seen in terms of psychosocial functioning and qual-
ity of life (table 4.2). Effect sizes for these outcome measures were somewhat
lower compared to psychiatric symptoms, but a positive change in psychosocial
functioning and quality of life was evident.
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Corrected comparison
After correction for all relevant pre-treatment differences, improvement between
baseline and assessment at 12 months proved to be significant for patients in
all treatment groups on all 4 outcome measures (p < 0.001).
The short-term inpatient group showed significantly more improvement in
psychiatric symptoms (GSI) than 3 other groups: the short-term day hospital
group (β = 0.38, p = 0.0059, 95% CI 0.11-0.65), the long-term day hospital
group (β = 0.43, p = 0.0032, 95% CI 0.15-0.71), and the long-term inpatient
group (β = 0.31, p = 0.0248, 95% CI 0.04-0.57) (table 4.3). Between-group
effect sizes (Cohens d) were 0.54, 0.57, and 0.40, respectively. This indicates































































Figure 4.2: GSI uncorrected mean scores ± SD at baseline and 12-month follow-
up
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Table 4.2: Uncorrected outcomes (mean ± SD) and effect sizes in 5
treatment groups for all outcome variables
Variable Treatment group Baseline 12 months Within-group effect
size, Cohen’s d
GSI Long outpatient (n = 68) 1.49 ±0.69 1.07 ±0.65 0.63
Short day hospital (n = 77) 1.44 ±0.63 1.04 ±0.67 0.62
Long day hospital (n = 74) 1.68 ±0.61 1.12 ±0.94 0.71
Short inpatient (n = 59) 1.75 ±0.52 0.76 ±0.60 1.78
Long inpatient (n = 93) 1.77 ±0.72 1.03 ±0.68 1.06
OQ-45 Long outpatient (n = 68) 15.84 ±4.27 12.98 ±4.42 0.66
Social role Short day hospital (n = 77) 15.20 ±4.52 13.59 ±4.53 0.36
Long day hospital (n = 74) 16.79 ±4.75 13.39 ±5.29 0.68
Short inpatient (n = 59) 17.78 ±3.84 12.41 ±4.83 1.24
Long inpatient (n = 93) 16.97 ±4.64 12.42 ±5.31 0.92
OQ-45 Long outpatient (n = 68) 22.22 ±5.98 19.37 ±6.43 0.46
Inter- Short day hospital (n = 77) 20.93 ±5.24 18.17 ±5.90 0.50
personal Long day hospital (n = 74) 22.89 ±6.41 18.41 ±8.05 0.62
relations Short inpatient (n = 59) 23.97 ±5.63 17.54 ±6.77 1.04
Long inpatient (n = 93) 24.09 ±5.24 18.38 ±6.59 0.96
EQ-5D Long outpatient (n = 68) 0.58 ±0.24 0.73 ±0.16 0.74
Short day hospital (n = 77) 0.60 ±0.25 0.69 ±0.24 0.37
Long day hospital (n = 74) 0.50 ±0.27 0.72 ±0.22 0.90
Short inpatient (n = 59) 0.49 ±0.27 0.78 ±0.21 1.21
Long inpatient (n = 93) 0.51 ±0.26 0.68 ±0.25 0.67
treatment versus other treatment groups.
In terms of social role functioning, the short-term inpatient group improved
significantly more than 2 other groups the short-term day hospital group (β
= 2.51, p = 0.0067, 95% CI 0.71-4.31) and the long-term day hospital group
(β = 2.05, p = 0.0476, 95% CI 0.02-4.07) with between- group effect sizes of
0.49 and 0.38, respectively. The improvement in interpersonal functioning was
significantly higher in the short-term inpatient group than in one other group
the short-term day hospital group (β = 2.54, p = 0.0319, 95% CI 0.22-4.86)
with a between group effect size of 0.39. Quality of life improved significantly
more in the short-term inpatient group than in 2 other groups: the short-term
day-hospital group (β = 0.15, p = 0.0009, 95% CI 0.06-0.23) and the long-
term inpatient group (0.15, p = 0.0009, 95% CI 0.06-0.23) and the long-term
inpatient group (β = 0.11, p = 0.0113, 95% CI 0.03-0.19). Between-group effect
sizes were 0.6 and 0.42, respectively.
All results were based on intention-to-treat analysis (ITT), whereby ITT
is defined as assignment and a minimal exposure to the intended treatment
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who actually stayed in the intended treatment modality group during their
treatment (n = 298, 80.3% of the ITT sample, ranging from 66.2% for short-
term day hospital to 89.7% for long-term outpatient treatment). These results
followed the same pattern as the results from the ITT analysis: significant
change within all treatment groups and a superiority of short-term inpatient
treatment across all outcome measures (data available on request).
4.5 Discussion
This is the first study comparing the effectiveness of 5 modalities of psychother-
apeutic treatment in a large population of patients with cluster C PD, as a
contribution to the search for effective treatments for this patient group. Pa-
tients in all treatment groups had improved psychiatric symptoms, psychosocial
functioning, and quality of life after 12 months. Most improvement was ob-
served in the short-term inpatient group. This finding held when pre-treatment
differences were controlled for with the propensity score.
Strengths and limitations
A clear strength of the present study is its external validity and clinical utility:
it was conducted in regular clinical practice, not under experimental conditions
(Hodgson, Bushe, & Hunter, 2007). A second strength is the rigorous statistical
control of potential confounders, using the multiple propensity score methodol-
ogy. Finally, a major asset of this study is its large number of patients. All this
enabled the comparison of different psychotherapeutic treatment modalities
while keeping sufficient statistical power.
Despite these strengths, the present findings have to be interpreted con-
sidering several limitations. First, even though all observed pre-treatment dif-
ferences were controlled for, it cannot be ruled out that results have been
influenced by unobserved confounders. To diminish this constraint as much
as possible, a broad range of possible confounders was carefully selected and
measured, based on both clinical and empirical knowledge, including variables
identified in the literature as significant predictors of therapy outcome or pro-
cess such as severity of baseline psychopathology, previous hospitalization, and
substance misuse (Bartak et al., 2009; Gunderson et al., 2006; Links, Mitton,
& Steiner, 1993; McGlashan, 1985; Ogrodniczuk et al., 2008; Plakun, 1991;
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Ryle & Golynkina, 2000). In line with these earlier findings, previous hospital-
ization and substance misuse for example were significantly related to one of
the secondary outcome measures, interpersonal functioning, and were therefore
included in the propensity score for this measure. However, even when con-
siderably reducing the possibility of important confounders being overlooked,
not all possible variables could be covered in interviews and questionnaires at
baseline, and therefore several variables, such as self-harm, were not measured
(Chiesa & Fonagy, 2007).
Second, for ethical reasons, a reference group receiving no treatment at
all was not included. Yet, several previous studies showed that specialized
psychotherapeutic treatment yields better outcomes than various control con-
ditions (for example waiting list controls) (Alden, 1989; Emmelkamp et al.,
2006; Winston et al., 1994).
Third, research compliance differed between the treatment groups compared
with most missing follow-up observations in the long-term treatment groups
(figure 4.1). This might cause a problem of internal validity if non-response
is not random, but related to systematic bias in effect estimation (positive or
negative). However, there are 2 reasons why systematic bias seems unlikely:
(1) responders and non-responders did not differ in psychiatric symptoms at
baseline, and therefore it seems that they do not represent 2 structurally differ-
ent groups of patients; (2) during the frequent telephone contact the authors
had with non-responding patients to remind them to send back their question-
naires, these patients reported both negative and positive outcomes as reasons
why they did not respond: some of them argued that their problems had wors-
ened and that therefore they felt they did not have enough energy to fill in
the questionnaires, others argued that their life had changed in a positive way
and that therefore they did not want to be reminded of their time in therapy
by filling in the questionnaires. Keeping this in mind, it seems unlikely that
non-response was related to systematic negative or positive bias.
Fourth, this study does not rule out the possibility that treatment charac-
teristics other than setting and duration played a role in the differential effec-
tiveness of the 5 treatment modalities, e.g. frequency of sessions or theoretical
orientation of treatment. This might represent a potential threat to internal
validity. This is especially true for the role of theoretical orientation as a possi-
ble factor in the superiority of short-term inpatient treatment: most short-term
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inpatient programs were based on psychodynamic principles. This concern is
somewhat mitigated by previous studies comparing different theoretical orien-
tations where no differences were found (Svartberg et al., 2004). However, to
test the differential effect of modality and other treatment characteristics, a
combined research design combining all these factors is needed.
Future directions and implications
What are the implications of the present results for future research, for practice
guidelines, and for everyday clinical practice?
For patients with cluster C personality pathology, the short-term inpa-
tient treatment clearly was associated with the highest improvement within
12 months. For this patient group, this modality of therapy seems to be the
treatment backed up by the best available evidence in absence of long-term
follow-up data. Replication of these results in a long(er)-term follow-up study
is of vital importance to draw final conclusions. There might be a bias in favor
of short-term treatment because patients in the long-term treatment groups
might still be in therapy at 12 months. Long-term follow-up after termination
of all treatment programs is therefore warranted. Another question is whether
the benefit in terms of effectiveness is worth the potential cost differences when
evaluated with recently upcoming state-of-the-art cost-effectiveness analysis
(Leichsenring et al., 2009; McCrone et al., 2007). From these analysis within
this study sample, it appeared that the mean direct treatment costs of the
5 treatment modalities were EUR 10,005 (SE 1,134) for long-term outpatient
treatment, EUR 16,813 (SE 1,361) for short-term day hospital treatment, EUR
27,648 (SE 2,654) for long-term day hospital treatment, EUR 25,933 (SE 859)
for short-term inpatient treatment, and EUR 49,260 (SE 2,435) for long-term
inpatient treatment (Skodol et al., 2008). It would be interesting to compare
the cost-effectiveness of short-term inpatient psychotherapeutic treatment with
that of manual-based outpatient treatments such as cognitive-behavioral ther-
apy (Emmelkamp et al., 2006). A state-of-the-art cost-effectiveness analysis
would include medical costs incurred outside the treatment institution, produc-
tivity costs, and other indirect costs. This kind of analysis and its economic
interpretation is beyond the range of this study and needs considerable research
in the future.
If the superiority of short-term inpatient psychotherapeutic treatment holds
68 Chapter 4
at long-term follow-up, in cost-effectiveness analysis, and in comparison with
other evidence- based manual-based treatments, this treatment modality might
be considered as the treatment of choice for this patient group. This would be
a thought-provoking finding, as previous studies in cluster B PD patients have
found outpatient and day hospital treatments to be very effective in this popu-
lation (Chiesa, Fonagy, & Gordon, 2009; Clarkin, Levy, Lenzenweger, & Kern-
berg, 2007; Giesen-Bloo et al., 2006; Bateman & Fonagy, 2001). Even though
no study compared one of these modalities directly with inpatient therapy,
one might speculate that different therapy modalities are effective for different
groups of patients. It could be that the success of short-term inpatient treat-
ment in a cluster C PD sample is embedded in the combination of only short
hospitalization, thereby preventing iatrogenic effects, and a high level of ther-
apeutic intensity and pressure. Patients with cluster C personality pathology
might be able to handle the high pressure of this treatment modality better
than (pure) cluster B PD patients, who probably have a lower tolerance for
therapeutic pressure, resulting in more early drop-outs and thus a less effective
treatment. They might instead need less pressure with a longer treatment du-
ration (Bateman & Fonagy, 2001; Lorentzen & Hoglend, 2008). Future studies
may verify this hypothesis. However, even when superiority of short-term inpa-
tient treatment for cluster C PD patients has been confirmed in the literature,
patients caring for children might still not be assigned to inpatient treatment.
Also, patients with a high severity of psychiatric symptoms or a low level of
ego strength might not be able to handle the pressure of intensive inpatient
treatment. It is recommended to investigate these potential matching factors
further as this would enable clinicians to make specific treatment recommen-
dations for different subgroups of cluster C PD patients and to develop new
clinical practice guidelines.
In conclusion, this study suggests that psychotherapy, especially in a short-
term inpatient modality, is an effective treatment for patients with cluster C
PD. This makes inpatient psychotherapeutic treatment an interesting option for
patients with avoidant, dependent, and obsessive-compulsive PD. The present
findings can contribute to more adequate and tailored health care for this vul-
nerable patient group, as implementing effective treatments may reduce the
considerable burden to individuals and society as a whole.
Chapter 5





In psychotherapeutic research, traditional methods that counter for overt bias
are often used in quasi-experimental study designs. As an alternative, to ac-
count for possible hidden bias, the original two-step Heckman method and its
extended version using structural equation modeling are discussed. The per-
formances of multiple regression analysis, the propensity score method, the
original Heckman maximum likelihood method and its extended version using
structural equation modeling (SEM) are compared in four artificial data-sets.
In addition, to illustrate the methods, data from a mental health study are
used as a real world example. The original Heckman method is very sensitive
to mis-specification of the selection model and to violations of the normality
of error-terms assumption. When a randomized controlled trial is not possible,
methods other than those dealing with overt bias could be considered. When
good indicators for a ’latent tendency to participate in the study’ are available,
the extended version of the Heckman method using SEM analysis is preferred
over the Heckman method.




An important research area in the social sciences is the comparison of treatment
programs. In comparative research studies, randomized control trials (RCT’s)
are considered gold standard. In RCT’s, participants are assigned to the treat-
ment programs by random procedures such as flipping a coin. With randomiza-
tion, it is expected that both observed and unobserved pre-treatment variables
have, on average, the same values in all treatment groups. The probability that
this is actually true increases as the sample size increases. Let us consider a
study comparing two therapies for depression (D). Each patient i is randomly
allocated to either the new therapy (D = 1) or standard therapy (D = 0 ).
Let Yid represent the depression outcome score Y of patient i within therapy
D. Since patients are randomized into the therapies, one expects, especially in
large sample sizes, that the two treatment groups are initially comparable on
variables such as age, gender, social economic class, initial level of depression,
or motivation. With initial comparability, a significant difference in the mean
outcome depression scores between the two patient groups can be attributed
to the therapy program received. The added value of the new therapy against
the standard therapy (δ), i.e. the average causal effect for the treated (ACT)
can therefore be estimated by subtracting the mean outcome of participants in
the new therapy (E(Y1)) from the mean outcome of patients in the standard
therapy (E(Y0)) (Rubin, 1974). In the formula the ACT is:
ACT = E(Y1)− E(Y0) (5.1)
In clinical practice, however, it is not always possible to randomly assign pa-
tients to treatments, as randomization may be unethical, difficult, costly, or
impossible. Therefore, quasi-experimental or observational studies are often
conducted where patients select themselves into the treatment options (Shadish
& Cook, 2002). When mainly male patients with a low social economic back-
ground choose the standard therapy, but mainly women with a high social
economic background choose the new therapy, selection has occurred. Vari-
ables related to this selection process such as gender or social economic status,
are named selection variables. Variables that influence the outcome value are
usually named independent variables. Confounding variables are variables that
influence both the selection process and the outcome value, which without con-
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trol, will lead to bias in the estimated treatment effect. With confounding,
estimating the ACT as in equation 5.1 will lead to biased estimated treatment
effects. Selection bias is the bias introduced into a (quasi-)experimental study
by the selection of different types of subjects into the reference and experimen-
tal condition(s) (Heckman, 1979; Winship & Mare, 1992). Rosenbaum (1995)
distinguishes between overt and hidden bias. Overt bias results from differ-
ences in observed and measured pre-treatment variables, whereas hidden bias
results from differences in unobserved and unmeasured characteristics between
treatment groups.
The aim of this study is to discuss the essence and assumptions of two statis-
tical methods dealing with hidden bias in their statistical analysis, namely the
traditional Heckman two-step method and its extended version using structural
equation modeling (SEM). The results from these two methods are compared
with traditional methods for overt bias, such as multiple regression analysis
and propensity score methods. The remainder of the chapter is organized as
follows: in section 5.2, the methods for overt bias such as matching, stratifica-
tion and propensity score methods are discussed. In section 5.3, the traditional
Heckman two-step method is discussed and its extended version based on SEM
modeling presented. Section 5.4 discusses the results of the analysis of artificial
data where the performances of multiple regression analysis and the propensity
score method are compared to the Heckman two-step method and SEM anal-
ysis. In section 5.5, data from the Dutch research project SCEPTRE (’Study
on cost-effectiveness of personality disorder treatment’) is used as a real world
example (Bartak et al., 2009).
5.3 Overt bias
Traditionally, most statistical methods focus on reducing overt bias. The basic
idea underlying all these methods is to make treatment groups as compara-
ble as possible on all observed pre-treatment variables. The most common
methods are matching, stratification, statistical control by means of multiple
regression analysis, and propensity score methods. With matching, one at-
tempts to achieve comparability by pairing each patient in the experimental
group with one or more similar patient(s) in the reference group. With stratifi-
cation, several groups of patients are formed based on the same set of observed
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pre-treatment variables. As a result of stratification, within each group or
strata patients have, in principle, the same distribution of the pre-treatment
variables. With multiple regression analysis, overt bias may be reduced by
adding extra covariates into the multiple regression equation. Traditional mul-
tiple regression analysis is, however, a statistical method that implies a linear
relationship between the independent variables and the dependent variable,
with no interaction effects. When the relationships become more complex with
non-linear relations or many interaction effects, matching or stratification may
be more simple and easier-to-use methods to handle this complexity. However,
matching and stratification will become difficult when the number of variables
to match or stratify on increases. In that case, it may be impossible to find
patients who are similar on all these variables. To reduce this ’dimensionality
problem’, Rosenbaum and Rubin (1983) proposed the use of a single score, the
propensity score (PS), which can be used for matching, stratification and mul-
tiple regression adjustment. The PS is defined as the probability of assignment
to the experimental condition, given all observed pre-treatment variables. The
PS can be estimated by means of a probit analysis as:
P (D = 1|X) = Φ(α0 +α1X) (5.2)
where Φ is the cumulative distribution function of the standard normal distribu-
tion, α0 the multiple regression constant, α the multiple regression coefficients,
and X a vector of observed pre-treatment variables. There exist alternative
estimation methods for the estimation of PS such as logit or discriminant anal-
ysis. With balance, conditional on the PS, the assignment into the treatment
programs does not depend further on pre-treatment variables and is treated
as random. For that reason the ACT can, in quasi-experimental studies, be
estimated after control on the PS as:
ACT = E(Y1|PS,D = 1)− E(Y0|PS,D = 0) (5.3)
The main disadvantage of all statistical methods described above is, however,
that they strongly rely on the assumption that the assignment into the treat-
ment programs only relies on measured variables and does not depend on vari-
ables that are unmeasured (Rubin, 1976). This implies that one has to know
and measure all confounding variables. When the PS does not include all
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important variables, even after control of the PS, the assignment cannot be
treated as random. Then, estimating the ACT as in equation 5.3 will yield
biased estimated treatment effects. Therefore, it is important that researchers
select and measure all potential confounding variables before the start of their
study. Careful selection and measurement of the baseline variables from both a
practical and statistical point of view is therefore very important. Nonetheless,
researchers are never sure that all important confounder variables are included
in their studies.
5.4 Hidden bias
The traditional Heckman two-step method is most influential in taking hid-
den bias into account in the analysis (Rubin, 1976). Based on the correlation
between the error-terms of the selection and outcome models, an extra term,
meant to capture the influence of the unknown variables, is estimated and in-
cluded as an extra predictor in the outcome model. Because of the strong
reliance on the assumption of normally distributed error-terms, however, the
method has received some criticism. Therefore, as an alternative method, a
modified version of the Heckman two-step method using structural equation
modeling (SEM) is presented in this chapter. In this section, both the Heckman
two-step method and its extended version using SEM are explained (Heckman,
1979; Bollen, 1989).
5.4.1 The original Heckman two-step method model
The basic idea of the Heckman two-step method is that assignment into treat-
ment programs is not random, but depends on a latent, unobserved variable,
which can be seen as a latent variable reflecting the ’tendency to participate
in the experimental condition instead of in the reference condition’ (Heckman,
1979). The original Heckman two-step model distinguishes a selection and an
outcome model. In the selection model, this latent variable D∗ is explained
by a set of pre-treatment variables X such as need for help or motivation. In
formula the relation between D∗ and X is expressed as:
D∗ = α0 +αX + εd∗ (5.4)
where α represent the set of the multiple regression coefficients which explain
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the strength of the direct effects ofX onD∗ and εd∗ the error-term; the variance
of the error-term is denoted as σ2εd∗ . To determine the measurement scale of
D∗, the mean value of the error-term of D∗ (εd∗) is, without loss of generality,
arbitrarily set equal to zero with a standard deviation equal to one. It is
assumed that when an individual i participates in the experimental condition
(e.g. the new therapy) (Di = 1), its value on D
∗ is larger than zero (D∗i ≥ 0).
When an individual does not participate in the experimental condition but in
the standard therapy (Di = 0), its value on D
∗ is smaller than zero (D∗i < 0).
When X includes all selection variables, the error-term εd∗ is uncorrelated with
all variables in X. However, when hidden bias is present, it implies that one
or more selection variables are unmeasured and not included in X. These








Figure 5.1: Graphical representation of the Heckman method
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In the outcome model, the outcome score (Y ) of participants in either the
experimental or the reference condition is explained by the therapy program
(D) and the values on X. The outcome equation can therefore be written as:
Y = β0 + δD + βX + εy (5.5)
where β0 is the multiple regression constant, δ the estimated average causal
effect (ACE), β a set of multiple regression coefficients related to the pre-
treatment variables X, and εy the error-term of the equation. The model
assumes that εd∗ and εy may be correlated by a factor rho (ρ).
For participants in the reference condition, the expected value of the outcome
score Y is:
E(Y |X, D = 0) = β0 + βX + E(εy|D = 0) (5.6)
and for participants in the experimental condition, the expected value of the
outcome score Y is:
E(Y |X,D = 1) = β0 + δD + βX + E(εy|D = 1) (5.7)
As D = 0 is an indicator of a negative value for the latent variable ’tendency
to participate in the experimental condition’, equation 5.6 can be rewritten as:
E(Y |X, D = 0) = E(Y |X, D∗ < 0) = β0 + βX + E(εy|D∗ < 0) (5.8)
Because in the selection model D∗ is modeled as D∗ = α0 + αX + εd∗ , this
equation can again be rewritten as:
E(Y |X, D∗ < 0) = β0 + βX + E(εy|α0 +αX + εd∗ < 0) =
= β0 + βX + E(εy|εd∗ < −(α0 +αX))
(5.9)
Since D = 1 is an indicator of a positive value for the latent variable ’tendency
to participate in the experimental condition’, for participants in the experimen-
tal condition, equation 5.7 can be rewritten as:
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E(Y |X, D = 1) = E(Y |X, D∗ ≥ 0) = β0 + δD + βX + E(εy|D∗ ≥ 0) (5.10)
which can be rewritten as:
E(Y |X, D∗ ≥ 0) = β0 + δD + βX + E(εy|α0 +αX + εd∗ ≥ 0) =
= β0 + δD + βX + E(εy|εd∗ ≥ −(α0 +αX))
(5.11)
When all important variables are included in the selection and outcome models
and no hidden bias is present, then it follows that; (a) the error-terms of the
selection equation (εd∗) and outcome equation (εy) are not correlated, (b) the
expected value of (εd∗) is equal to zero, and (c) the joint distribution of the
error-terms in the outcome models εy is assumed to follow a bivariate normal
distribution with a mean expected value of zero and a standard deviation of
one.
When hidden bias is present and confounding variables are missed, however,
it follows that; (a) these variables are correlated with the error-term εd∗ , (b)
the two error-terms of the selection and the outcome model are correlated by
a factor rho (ρ), (c) the expected value of (εd∗) is not equal to zero, and (d)
estimating the ACT as in equation 5.6 leads to biased estimated treatment
effects.
With the assumption that the error-terms in the outcome models follow
a strict bivariate normal distribution, the expected value of the error-terms of
the outcome equation of the participants in the experimental condition and the
reference condition can be rewritten as:









where φ denotes the standard normal density and Φ the cumulative distribution
function (Heckman, 1979). When the error-terms of the selection and outcome
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equation are uncorrelated (ρ =0), the expected error-terms are both zero for
all subjects. When the error-terms are correlated, due to a variable that is
omitted from the analysis, the expected error-terms are non-zero.
The main idea of the original Heckman two-step method is to estimate
an extra term for all subjects, named lambda, and add this to the outcome
model to protect against the biasing effect of an unmeasured variable. By
adding this term in the multiple regression equation, the expected value of the
error-term is zero again for all subjects. Here, a main assumption is that all
confounding variables that are omitted from the analysis are uncorrelated to
the other variables in X. Then, for each participant i, the term lambda (γ) is
estimated in the following ways;










To correct for hidden bias, the estimated lambda term is added in the outcome
equation as an extra variable in the model. Then, according to the model of
Heckman, the new outcome equation is;
Y = β0 + δD + βX + ργ + εy (5.16)
where ρ represents the partial regression coefficient of the lambda term. With
overt bias, the correlation between the error-terms εd∗ and εy is zero and the
lambda term will disappear from equation 5.16. With hidden bias, the correla-
tion between the error-terms is unequal to zero and the influence of the lambda
term increases. A t-test for the regression coefficient of lambda (ρ) can be used
to test if hidden bias is present. See Heckman (1979) and Greene (1981) for the
corrected standard errors of the estimated treatment effect δ. The estimation
method of the original two-step approach of Heckman is limited information.
First the selection is modeled, followed by the outcome equation. As an al-
ternative, a full information maximum likelihood estimation method can be
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applied to estimate the selection and the outcome model simultaneously. Sta-
tistical packages such as (StataCorp, 2001) offer this full information maximum
likelihood (ML) approach.
5.4.2 Evaluation of the original Heckman two-step method
A first consideration when using the original Heckman two-step method is its
strong reliance on the assumption of normal distributed error-terms and on
linearity assumptions (Winship & Mare, 1992). A key assumption of the Heck-
man method is that the error-terms in the selection and outcome equation
follow a bivariate normal distribution. This assumption is needed for a con-
sistent estimate of the lambda term and implies a linear relationship between
both error-terms. If the relation between εd∗ and εy is non-linear or εd∗ is
not normally distributed, the lambda term is misspecified and the model will
yield biased estimated treatment effects. Goldberger (1983) showed that, with
the Heckman method, even small violations of the normality assumption lead
to bias. Because error-terms represent unmeasured variables, a normal distri-
bution cannot be guaranteed and never be validated. For that reason, some
researchers have questioned the use of the Heckman method. In the econo-
metric field, semi-parametric and non-parametric adaptations of the Heckman
method have been developed (Olsen, 1980).
A second limitation concerns the two multicollinearity problems that arise
when using the Heckman method. The first multicollinearity problem is a
consequence of the high correlation between the dummy variable indicating
treatment and the lambda term in the outcome equation (Puhani, 2000). Due
to this multicollinearity, statistical tests will have power problems. The second
multicollinearity problem arises when exactly the same variables are used in
the selection equation and in the outcome equation. To avoid this problem, it
is advisable to use at least one variable in the selection equation that is not
in the outcome equation. This is called the exclusion restriction (Yamagata &
Orme, 2005),.
Third, just like other statistical methods, the Heckman method depends
largely on the specification of the model. If the outcome equation is not well
specified it will result in biased estimated treatment effects.
Fourth, the Heckman method relies strongly on the assumption that the
confounder variables omitted from the analysis are uncorrelated with the in-
Countering hidden bias in psychotherapy research 79
dependent or confounding variables that are explicitly included in the model.
This assumption will often not be met in practice.
In the Heckman approach, the dummy variable (D) that indicates whether
a participant receives either the reference condition or the experimental con-
dition, is used as the only indicator for the latent variable D∗. In the next
section, an alternative model, SEM analysis, is presented in which more indi-
cators for the latent variable D∗ are used. As a consequence, a more stable and
flexible model can be obtained in which relationships between the variables can










Figure 5.2: Graphical representation of the SEM analysis
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5.4.3 Structural equation modeling (SEM)
In this section, structural equation modeling (SEM) is discussed as an alter-
native for estimating treatment effects when hidden bias is present. SEM is
a general statistical modeling technique with which to establish ’causal’ rela-
tionships among variables. It consists of a system of (logit) multiple regression
equations that are analyzed simultaneously in one model. A key feature of SEM
is that some indicator variables are understood to represent a ’latent construct’,
that cannot be directly measured but only inferred from the observed measured
variables. Both the independent and dependent variables in the model can be
continuous, discrete or present a latent (unobserved) variable. SEM analysis
is an estimation model that minimizes the difference between observed sample
covariances and the covariances predicted by the model (Bollen, 1989).
Figure 5.2 shows a path diagram of an SEM analysis applicable to obser-
vational studies. It is an extension of the Heckman method in the sense that it
allows for more than one indicator variable for the latent variable D∗. These
indicator variables I are observed variables that may contain a set of proxy
variables for the tendency to participate such as motivational aspects or a wish
for treatment. Again, there are some pre-treatment variables X influencing
the latent variable D∗. The latent variable D∗ can be seen as a latent variable
measuring the tendency to participate in the experimental condition. This la-
tent variable is not directly measured, but rather assessed indirectly by some
indicator variables I. See Bollen (1989) for ways to obtain an identifiable latent
variable model. In our model, the latent variable determines which treatment
a subject receives, as indicated by a dummy variable D. The outcome variable
Y is influenced by the dummy variable indicating treatment and possibly by
some other independent variables X. Notice that latent variables are graph-
ically given by circles and observed variables by rectangles. The lines in the
path diagram represent direct relations between variables: lack of a line be-
tween variables implies that no direct relationship between these variables is
hypothesized, given that all appropriate prior and intervening variables are hold
constant. Lines have either single or double headed arrows. A line with one
arrow represents a direct relationship between two variables, controlled for the
other variables in the model. The variable with one arrow pointing to it is the
dependent variable. A line with a double headed arrow allows for covariance
between the two variables with no implied direction of effect.
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The model graphically displayed in figure 5.2 can also be represented in a
series of multiple regression and logit equations as:
D∗ = α0 +αX + εd∗
I = θ0 + θD
∗ + εi
if (D∗ < 0), then D = 0
if (D∗ ≥ 0), then D = 1
Y = β0 + δD + βX + εy
(5.17)
where α represents the direct effects of X on D∗, θ the direct effect of D∗ on
I, δ the estimated treatment effect of D on Y , β the set of partial regression
coefficients of X on Y , and εd∗ , εi and εy represent the error-terms. A common
model assumption is that all error-terms have an expected value of zero for all
subjects and are uncorrelated to each other. However, when confounding vari-
ables are omitted from the analysis that are independent of the other variables,
it fuses into the disturbance terms εd∗ and εy. For that reason, a covariance be-
tween the error-terms εd∗ and εy is allowed for. In figure 5.2, this covariance is
represented by a line with a double headed arrow, connecting the error-term εd∗
of the latent variable ’tendency to participate in a study’ with the error-term
εy of the outcome equation of Y . In SEM all equations can be simultaneously
analyzed and the parameters of the model in SEM are estimated by Maximum
Likelihood. There exist some statistical packages that facilitate SEM analysis
with dichotomous outcome variables such as Mplus or Latent Gold (Muthén &
Muthén, 2008; Vermunt & Magidson, 2000). In Mplus, a step-function cannot
be determined. However, the deterministic relationship between D and D∗ can
be approached by a logit equation with the regression coefficient of D on D∗,
fixed to a very large value. Mplus also provides robust ML estimates when
the assumption of normally distributed error-terms is violated. Fit measures
such as chi-square, RMSEA or CFI are provided to asses the fit of models or
to compare models with each other. A main advantage of SEM analysis over
the Heckman method is that it provides a more flexible model. The model can
be extended to more indicators for D∗ (either continuous or dichotomous) or
with more complex relationships between variables such as a direct relationship
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between indicators and the outcome.
5.5 Analysis on artificial data
The aim of the analysis on the artificial data-sets is to compare the results from
the original Heckman method and its extended version using SEM analysis with
the results from multiple regression analysis and the propensity score method.
Analysis on the artificial data is performed to answer the following questions;
Which method is best to use when a variable is omitted in the analysis that
influences the outcome, the selection or both? Do these methods show much



























Figure 5.3: Graphical representation of the population model used to simulate
the artificial data
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Table 5.1: Summary of the four artificial data-sets
Correlation between Distribution of
independent variables X the error-terms
data-set 1 0 Normal
data-set 2 0.5 Normal
data-set 3 0 Kurtosis
data-set 4 0 Skewed
5.5.1 Description of the four artificial data-sets
In this study four very large artificial data-sets are generated. The sample size
of a single data-set was 10,000. See figure 5.3 for the graphical representation
of the population model that is used to generate the four artificial data-sets.
In each data-set, three independent variables X1, X2 and X3 were generated.
These variables were normally distributed with a mean of zero and a variance
of one. Variables X1 and X2 influenced a continuous latent variable D
∗ which
represents the ’tendency to participate in the experimental condition’. This
latent variable influenced three indicator variables I1, I2 and I3 with an effect
coefficient of one. Indicators I1, I2 and I3 are also influenced by an error
term, but not D∗. The latent variable D∗ determines the dummy variable
D completely: when D∗ < 0, the participant i is assigned to the reference
condition (D = 0), whenD∗ ≥ 0, the participant is assigned to the experimental
condition (D = 1). The outcome Y is directly influenced by the treatment
variable D and independent variables X2 and X3. The relationship between D
and Y is seen as the treatment effect δ which is equal to 0.7. In the population
model, the correlation between the error-terms εd∗ and εy was equal to zero.
In table 5.1 the four artificial data-sets are described. In the first artificial
data-set the values of the inter-correlations among the independent variables
X1, X2 and X3 were equal to zero. In the second artificial data-set these values
were equal to 0.5. The performances of the methods between these two data-
sets are compared to investigate the influence of omitting a variable that relates
to other independent variables in the model. In the third artificial data-set
the correlation between the independent variables was equal to zero, but with
non-normally distributed error-terms εd∗ and εy with a kurtosis distribution of
0.75. In the fourth artificial data-set the correlation between the independent
variables is equal to zero, but the error-terms εd∗ and εy were simulated with
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generate a distribution with non-normal distributions.
Each artificial data-set was analyzed using five statistical methods: (1) tra-
ditional multiple regression analysis, (2) multiple regression analysis with the
propensity score, (3) the original Heckman two-step method, (4) the original
Heckman method using maximum likelihood estimation and (5) the extended
version of the Heckman method using SEM analysis. With traditional multiple
regression analysis, an ordinary least squares multiple regression was used to
estimate the parameters of the model, with Y as the dependent variable and
D and X as independent variables. With the propensity score method, the
estimated the propensity score was estimated using logistic multiple regression
analysis with a set of X as independent variables and D as the dependent
variable. Then, the PS was included in a multiple regression analysis with Y
as the dependent variable and D and the PS as independent variables. See
Bartak et al. (2009) for more details about this procedure. In the Heckman
two-step method, the lambda was estimated and included into the multiple
regression equation with Y as the dependent variable and D, X and lambda
as independent variables. In the Heckman maximum likelihood estimation, the
parameters of both the selection model and outcome model are estimated simul-
taneously using (robust) ML. With SEM, the data is analyzed simultaneously
using (robust) ML, as described in the previous section with three indicators
for D∗. Since the relation between D and D∗ is deterministic and resembles a
step-function, the partial regression coefficient γ was fixed to a very large value
(γ=20). The results of all these methods are compared in situations where (1)
no additional variables inX or I are included in the analysis (the näıve model),
(2) all additional variables in X or I are included in the analysis (the correct
model), (3) a variable related to the selection was omitted from the analysis
(X1 missing), (4) a variable related to both selection and outcome was omitted
from the analysis (X2 missing), and (5) a variable related to only the outcome
was omitted from the analysis (X3 missing).
The estimated treatment effect, the standard error of the estimated treat-
ment effect, and the absolute bias were used to compare the performance of all
methods. R was used to simulate the three artificial data-sets. R, Mplus, ver-
sion 5.21 (Muthén & Muthén, 2008) and STATA (StataCorp, 2001) were used
to analyze the data (R Development Core Team, 2005; Muthén & Muthén,
2008; StataCorp, 2001).
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5.5.2 Results of the analysis on the four artificial data-sets
The results of the analysis on the four artificial data-sets are given in table
5.2. In artificial data-set 1, the correlations between the independent variables
were equal to zero. The näıve estimate of the treatment effect, without in-
cluding independent variables, was 1.026 (se 0.029) and not equal to the true
treatment effect of 0.7. As expected, both multiple regression adjustment and
the propensity score give unbiased results when all independent variables are
included in the model or when a variable is missed in the analysis that relates
only to the selection or only to the outcome. However, when a true confounder
variable is missed in the model that relates both to the selection and to the
outcome value, these methods give biased results. As expected, the Heckman
method and SEM analysis give rather unbiased results when a true confounder
variable is missed in the analysis. The Heckman method is more sensitive to
misspecification of the selection model than SEM analysis.
In artificial data-set 2, the correlations between the three independent vari-
ables X1, X2 and X3 were equal to 0.5. Since both the Heckman method and
SEM analysis rely on the assumption that the missing confounder variables is
independent of the other independent variables in the model, it was no sur-
prise that, by analyzing data-set 2, both methods provide biased results when
a confounder variable (X2 missing) or a variable only related to the outcome
(X3 missing) are omitted from the analysis. This bias and the standard error
of the estimated treatment effects are, however, much smaller for SEM analysis
then for the Heckman method.
In artificial data-sets 3 and 4 the distribution of the error-terms were sim-
ulated with a non-normal distribution and with no correlation between the
independent variables X1, X2 and X3. In these situations, traditional multiple
regression analysis and the propensity score method follow the same pattern
of results as in artificial data-set 1, with slightly larger standard errors of the
estimates. Both the Heckman method and SEM analysis fail when a true
confounder is missed in the analysis and for the Heckman method when the se-
lection model is misspecified. The effects of non-normal distributed error-terms
is much larger for the Heckman method compared to SEM analysis.
To summarize, in situations where a true confounder is missed in the analy-
sis that is unrelated to other variables in the model, both the original Heckman
method and the Heckman method provide unbiased results. Compared to the
Countering hidden bias in psychotherapy research 87
original Heckman method, its extended version using SEM analysis provides
much more robust estimators of the treatment effect in situations where the
missed confounder variable relates to other variables in the model. This is
explained by the fact that a part of rho is explained in the model by the inter-
correlations. As in the Heckman model the estimation of the lambda term
depends heavily on the normality assumption of the error-terms; this method
is less robust compared to SEM analysis regarding violations of this assump-
tion. SEM analysis relies less heavily on this assumption and the model can
easily be extended and changed according to the specific design of the research.
In the next section, a real world example will be discussed that compares
the results of traditional multiple regression analysis and matching on the PS
with the results of the robust maximum likelihood Heckman method and the
extended version using SEM analysis. The data comes from a large a Dutch
research project named the ’Study on cost-effectiveness of personality disorder
treatment’ (SCEPTRE ) (Bartak et al., 2009, 2010).
5.6 Case study
5.6.1 Method
Patients were recruited from six mental health care centers in the Netherlands
offering outpatient, day hospital and/or inpatient psychotherapy for patients
with personality pathology. Out of 2,540 patients who were admitted to the
centers from March 2003 to March 2006, 1,047 were selected for treatment,
i.e. short or long duration psychotherapy in various settings. Before treatment
allocation, all patients were assessed with a routinely distributed assessment
battery of tests including self-report questionnaires. A semi-structured inter-
view was conducted to diagnose personality disorders with DSM-IV criteria. Of
the 1,047 patients selected for treatment, 298 patients had not yet completed a
follow-up measure, so no outcome could be calculated. For illustrative purposes
this sample is divided into two groups: one allocated to short-term therapy (up
to six months), the other group to long-term therapy (more than six months)
(Bartak et al., 2009).
The baseline assessment measured a long list of social, economic and di-
agnostic variables carefully selected by both clinicians and researchers, based
on literature and clinical knowledge. In this study, the Global Severity Index
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(GSL) of the SCL-90 (the mean score of all 90 items) is used as the primary
outcome measure, with higher scores indicating more distress (Arrindell & Et-
tema, 2003; Derogatis, 1986). To measure the type and degree of personality
pathology, the four higher-order factors of the ’Dimensional assessment of per-
sonality pathology basic questionnaire’, Dutch version (DAPP-BQ) are used :
emotional dysregulation, dissocial behavior, inhibition and compulsivity (Lives-
ley & Jackson, 2002; Kampen, 2002). Psychosocial functioning was measured
with the ’Outcome questionnaire 45’, Dutch version (OQ-45) (Lambert et al.,
1996).
Of this self-report measure, two sub-scales were used: interpersonal rela-
tions and social-role functioning. Health-related quality of life was assessed
with the EuroQoL EQ-5D (Brooks et al., 2003). Personality disorders were
assessed with the ’Structured interview of DSM-IV personality’, Dutch ver-
sion (SIDP-IV) (Pfohl et al., 1997). The severity of personality pathology
was measured by five higher-order domains of the ’Severity indices of person-
ality problems’ (SIPP): self-control, social concordance, identity integration,
relational functioning and responsibility (Andrea et al., 2007; Verheul et al.,
2008). For the indicators of the latent variable ’tendency to participate in long-
term psychotherapy’, two scales of the ’Motivation for treatment questionnaire’
(MTQ-8) were included which both measure motivation to treatment: need for
help and readiness to change, and a measurement of the individual wish for
treatment duration (short versus long) (Beek & Verheul, 2008). The indicator
variable ’wish for treatment duration’ was not available for 311 patients. These
patients were excluded from the analysis, leaving 438 patients.
5.6.2 Statistical analysis
To obtain a ’näıve’ idea of the results before adjustment for both overt and hid-
den bias, the mean outcomes between the two treatment groups were compared
using a multiple regression analysis. Here, the GSI score was used as the depen-
dent variable and treatment duration as the independent variable. Correction
of the treatment effect for observed pre-treatment differences and thus for overt
bias, was done by; (1) multiple regression analysis using a dummy variable of
treatment duration (short versus long) along with all variables relating to out-
come as independent variables, and (2) the PS method as described by Bartak
et al. (Bartak et al., 2009). Here, the PS is estimated by a logistic multiple
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Table 5.3: Overview of variables relating to the selection and/or to the
outcome value
Variables relating to selection Variables relating to outcome
P-value < 0.10 P-value < 0.10
Age, years X
Personal Pathology (DAPP-BQ)




Quality of Life (EQ-5D) X
Psychological capacities (SIPP)
Self-control X X
Social concordance X X
Identity integration X X
Relational functioning X X
Responsibility X
Psychiatric symptomatology (SCL-90) X X
Functioning (OQ-45)
Interpersonal functioning X X
Social role functioning X
Axis II diagnosis (SIDP-IV)
Number of cluster A disorders X X
Number of cluster B disorders X X












regression analysis with the dummy variable ’treatment duration’ as the de-
pendent variable and all variables related to outcome as independent variables.
This PS is included into a multiple regression analysis with treatment duration
and the PS as independent variables and the GSI outcome value as the depen-
dent variable. To correct for possible hidden and overt bias, both the original
Heckman two-step method using robust maximum likelihood (Heckman, 1979)
and the extended version using SEM analysis was used. The statistical package
STATA (StataCorp, 2001) with modules psmatch2 for matching, treatreg for
the Heckman method and the statistical package Mplus (Muthén & Muthén,
2008) for the SEM analysis were used.
5.6.3 Results
The ’näıve’ effect of short versus long psychotherapy was 0.240 (95% CI: 0.120–
0.361, p-value < 0.001). With multiple regression analysis including all vari-
ables relating to the GSI score, the estimated treatment effect was 0.131 (95%
CI: 0.014-0.249, p-value < 0.05). With the propensity score method, all vari-
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ables relating to the outcome value (see table 5.3) were used for the PS esti-
mation. After correction on the PS all important pre-treatment variables were
balanced among the treatment groups. For further information see (Bartak
et al., 2009). The estimated treatment effect using multiple regression analysis
with PS was 0.13 (95% CI: 0.129-0.250, p-value < 0.001). With the robust ML
Heckman method, all variables related to the selection were included in the
selection model and the variables relating to the outcome value were included
in the outcome model (see table 5.3 for the variables relating to the outcome
and/or to the selection). The multiple regression coefficient of lambda was 0.15
(95% CI: -0.055–0.346, p-value > 0.05), but not significant (p > 0.05). The
correlation between the error-terms of the selection and outcome equation (rho)
was 0.243 (χ2df=1=1.99, p-value > 0.05). After including lambda in the regres-
sion model, the estimated treatment effect was -0.08 (95% CI: -0.395-0.238,
p-value > 0.05), but not significant. According to the VIF-index (VIF > 10)
there was multicollinearity between the lambda term and the dummy variable
indicating treatment, resulting in very high standard errors. The exclusion of
one relevant variable in the selection equation influenced the estimated treat-
ment effect to a large extent and even, in some cases, changed the sign of the
treatment effect. This implies that the Heckman method, in this case, was
very sensitive to the specification of the selection model. With SEM analy-
sis, indicators for the latent variable where two scales of the ’Motivation for
treatment questionnaire’ (MTQ-8), namely ’need for help’ and ’readiness to
change’, and the measurement of the individual wish for treatment duration
(short versus long). All variables related to the selection influenced this latent
variable. The latent variable, in turn, influenced the three indicator variables
and the treatment variable. To approach a deterministic step-function, the
partial (logistic) regression coefficient of the latent variable and the treatment
variable was, arbitrarily, equal to the high value of 20. The GSI outcome value
was, in turn, influenced by the treatment variable and all other variables that
influenced the outcome value (see table 5.3). The estimated treatment effect
was -0.112 (95% CI: -0.394-0.170, p-value > 0.05). The correlation between the
latent variable and the outcome value given all other variables was estimated as
0.027 (p-value > 0.05). To summarize, although with the traditional methods
favored the short-term therapy, the methods countering for hidden bias did not
confirm this conclusion. However, these results should only be interpreted as
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an illustration rather than a relevant clinical message.
5.7 Conclusions
In psychotherapeutic research, a lot of attention is paid to methods that control
for overt bias in quasi-experimental study designs, such as multiple regression
analysis and propensity score methods. Nevertheless, even though researchers
may be very careful in the selection of variables they want to include in the
study, it seems almost impossible to account for every possible confounder.
Reasons such as financial constraints, time and, even more importantly, no
knowledge of variable effects mean that important variables go unmeasured.
This chapter discusses statistical methods to overcome hidden bias. It discussed
the traditional Heckman approach and presented its extended version of using
structural equation modeling. By analyzing artificial data-sets and a real world
example, the performance of both methods were compared to the traditional
methods.
The simulation study confirms that methods dealing with overt bias, such
as traditional multiple regression analysis and the PS method, fail when a
true confounder is missed in the analysis. In the unique situation where this
missing confounder does not correlate with all other independent variables in
the model, both the Heckman method and SEM analysis provide unbiased re-
sults. When this correlation exists, however, both the Heckman method and
its extended version using SEM fail to correct for the hidden bias in the study.
The Heckman method is, however, especially sensitive to misspecification of
the selection model and to violations of the assumption of normal distributed
error-terms. Overall, SEM is less sensitive to these assumptions and provides
less bias compared to the Heckman method. As in SEM analysis all relations
between the variables can easily be modelled, it is a much more flexible model.
In the illustrative example, methods assuming overt bias revealed a positive
effect for short-term treatment compared to long-term treatment. Neverthe-
less, both the robust Heckman maximum likelihood method and the extended
version using SEM could not reject the null-hypothesis of no treatment effect.
Based on the simulation study and the illustrative example, it is concluded
that the strong reliance on normally distributed error-terms along with the in-
dependency assumption implies that the Heckman method is difficult to use in
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practice. When good indicators for the latent tendency to participate in the
study are available, the extended version of the Heckman method using SEM
analysis could be considered as a feasible alternative.
Chapter 6




In randomized experiments, the equivalence of the treatment and control groups
may be threatened when subjects fail to comply to their instructions in the
various groups. Traditional methods for handling differential non-compliance
behavior like Intention-to-treat, Analysis-as-treated, or Per-protocol analysis
have been shown to be defective in several respects. An alternative is the In-
strumental variable approach which yields an unbiased estimate of the complier
average causal effect. This approach can be recast in terms of a latent class
model. In the present chapter several extensions of that latent class model are
presented. These extensions pertain to situations in which (a) the outcome
variable is only measured indirectly via indicator variables, (b) the experimen-
tal intervention has more than two levels, and/or (c) a factorial design has
been implemented. The methods proposed in this chapter are applied to data
from an experiment that studied the effects of various physical programs on
the cognitive functioning in the elderly.




In experimental settings where subjects are assigned to either a reference or an
experimental group, participants do not always strictly follow their treatment
instructions or requirements. Non-compliance occurs when a patient fails to
fulfill the requirements of a prescribed treatment condition. Because of some
patients’ non-compliance, an originally randomized experiment may loose the
characteristics of a true experiment, and more appropriate statistical methods
than the standard ones are needed in order to estimate the effect of a treatment.
Consider an experiment with one experimental and one reference group, and
assume that each participant in the study is randomly allocated to one of the
two groups. As a consequence of this randomization process, one may expect
that participants in the experimental and reference group are, on average, com-
parable at the start of the experiment. Let R denote this random assignment
to the experimental groups, where R = 0 denotes random assignment into the
reference group, and R = 1 random assignment into the experimental group.
Within the context of Rubin’s causal model (Rubin, 1974), one may define two
potential outcomes which would be observed if a subject were assigned to a
particular condition. Let Y0 denote the potential outcome when a subject as-
signed to the reference group, and let Y1 represent the same subject’s potential
outcome when assigned to the experimental group. The two variables Y0 and
Y1 are not both observed: for subjects in the reference condition only the scores
on Y0 are observed, whereas for subjects in the experimental condition only the
scores on Y1 are available.
For estimating the effect of the intervention, the assumption is made that
the potential outcomes (Y0, Y1) are independent of the assignment R, given
covariates X. This ignorability assumption (Rubin, 1974) can be represented
as
(Y1, Y0)⊥R|X. (6.1)
Because each participant is only observed in one condition, individual effects of
the treatment cannot be determined. In order to estimate the average causal
effect (ACE), inferences have to made about the mean outcome of participants
in the condition they were not assigned to. This mean is called the counterfac-
tual mean. When the ignorability assumption is valid, the average causal effect
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(ACE) can be determined by comparing the mean outcome of the reference
group with the mean outcome of the experimental group. The mean outcome
of the reference group is then used as an estimate of the counterfactual mean
of the experimental group. Let δ denote the ACE of a treatment, then
δ = E(Y0)− E(Y1) . (6.2)
A major problem is, however, that patients do not always follow their treat-
ment requirements. For example, participants who are randomly assigned into
the experimental condition may not show up in the intervention, or reference
participants may obtain the treatment outside the experimental set-up. As a
consequence, the treatment actually received by participants is not always the
same as the treatment they were assigned to, and the estimation of the ACE
as in equation 6.2 could yield biased results.
Intention-to-treat analysis (ITT) is the most frequently used method to
estimate treatment effects in a study with non-compliance. ITT is a strategy
for the analysis of randomized controlled studies that compares patients in the
groups to which they where originally randomly assigned. This means that all
the patients are included in the statistical analysis, regardless of the (amount
of) treatment actually received, or even regardless of whether they withdrew
or not from the study. Let E(Y |R = 0) and E(Y |R = 1) denote the means or
expected values of the outcome variable of participants assigned to the reference
group and experimental group, respectively. ITT then estimates the ACE as
δITT = E(Y |R = 1)− E(Y |R = 0). (6.3)
Although ITT is a frequently used method, it has some clear drawbacks (Nagelk-
erke, Fidler, Bernsen, & Borgdorff, 2000). For example, when people who ex-
perience better results are more likely to follow their treatment requirements,
ITT may yield biased estimates of the treatment effect. Bias may also oc-
cur when different side-effects, resulting from different treatment conditions,
influence compliance behavior.
A first alternative to ITT is the ’as-treated’ analysis (AT), where partici-
pants are classified by the treatment actually received, instead of by the treat-
ment they were assigned to. Let D denote the treatment actually received by
participants, where D = 0 denotes that they actually received the reference
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condition and D = 1 that they actually received the treatment. In AT the
ACE is estimated as
δAT = E(Y |D = 1)− E(Y |D = 0) (6.4)
where E(Y |D = 0) and E(Y |D = 1) denote the mean outcomes in the groups
receiving the reference and the experimental condition, respectively. Unfortu-
nately, this method is also not without its own problems. For example, when
the most treatment resistant patients in the less effective treatment groups
switch to the more effective treatment, they may decrease the average level of
improvement for the more effective treatment and the ACE will be underesti-
mated.
In stead of the ITT or AT estimator of the causal effect, the ’per protocol’
estimator (PP) is occasionally being used. This estimator, which is defined as
δPP = E(Y |R = D = 1)− E(Y |R = D = 0) , (6.5)
only considers data from patients who completed the treatment protocol as
originally planned.
As an alternative to the ITT, AT, and PP analysis, Angrist, Imbens,
and Rubin (1996) proposed an instrumental variables approach for estimat-
ing causal effects when assignment to a binary treatment is randomized, but
compliance with the treatment is not perfect. Suppose that in a regression
analysis of Y on X, the error term may be correlated with X so that ordinary
regression analysis yields a biased estimate of the regression coefficient. How-
ever, suppose that a third variable Z is available that it is uncorrelated with
the error term but has a non-zero covariance with X. Such a variable is called
an instrumental variable. An unbiased estimate of the regression coefficient of




In Angrist et al. (1996) the binary variable R is treated as an instrumental
variable for estimating the average causal effect of D on Y in the subpopulation
of compliers, the complier average causal effect (CACE). Their estimator is
given by
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δCACE =
E(Y |R = 1)− E(Y |R = 0)
E(D|R = 1)− E(D|R = 0)
. (6.6)
Angrist et al. (1996) prove that under some assumptions their approach pro-
vides an unbiased estimate of the CACE. These assumptions are:
* The stable unit treatment value assumption, which states that the poten-
tial outcomes for a particular individual are unrelated to the treatment
status of other individuals;
* Random assignment: Individuals are randomly assigned to the control
and treatment conditions;
* Exclusion restriction: The response distribution of Y is independent of
R given D, so that the only effect that R has on Y is via D;
* The variable R has an effect on D so that they are not completely inde-
pendent;
* Monotonicity: No individual does exactly the opposite of his assignment.
In Angrist and Imbens (2005), similar results were obtained when the treatment
variable has several intensity levels.
The aim of the present chapter is to discuss the non-compliance model
from a latent variable point of view. After discussing how the instrumental
variable approach of Angrist et al. (1996) can be rephrased as a latent class
model, several extensions of this basic model will be introduced. First, the
situation in which the outcome status is not measured by a single variable but
by several outcome variables will be discussed. In this extension of the model,
the basic outcome variable will be treated as a latent variable measured via a
set of indicator variables. Next, the situation in which the treatment variable
has more than two levels will be considered. Finally, it will be shown how the
basic latent class model can be extended to cover non-compliance in factorial
experiments. In a final section a combination of the various extensions of the
latent class model will be applied to a real data set.
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6.3 The instrumental variables approach as a latent
class model
That the instrumental variables approach can be formulated in terms of a latent
class model was already made clear by Imbens and Rubin (1997a), Little and
Yau (1998), and Forcina (1975). Angrist et al. (1996) distinguished between
four types of subjects with respect to their compliance behavior: compliers,
never-takers, always-takers, and defiers. Compliers are subjects who always
strictly follow their treatment instructions and for which then D = R holds.
When compliers are assigned to the experimental group (R = 1), they actually
receive the experimental treatment (D = 1); when they are assigned to the
reference condition (R = 0), they receive the reference treatment (D = 0).
Never-takers are subjects who never undergo the experimental treatment, even
when assigned to the experimental condition; for never-takers always D = 0
holds, whatever the value of R. Always-takers, on the other hand, are subjects
who always undergo the experimental treatment, even when assigned to the
reference condition; for these subjects always D = 1 holds, whatever the value
of R. Finally, defiers are those individuals who do exactly the opposite of their
assignment; for these subjects D = 1−R holds.
In the most general latent class formulation, these four types of subjects
are considered as the values of a nominal latent variable Compliance type C;
they represent four latent classes or sub-populations of subjects. Table 6.1
shows how the conditional probability p(D = 1|C = c,R = r) of receiving
the treatment varies as a function of latent class membership C and assigned
treatment R, where the first latent class(C = 1) denotes compliers, the second
latent class (C = 2) never-takers, the third class (C = 3) always-takers and the
fourth class (C = 4) defiers.
Table 6.1: Conditional probability p(D = 1|C = c,R = r) as a function
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All the conditional probabilities Pr(D = 1|C = c,R = r) are known
constants being equal to either zero or one. The conditional probabilities
Pr(D = 0|C = c,R = r) of not receiving the experimental treatment are
the complements of the former.
Let π1, π2, π3 and π4 denote the population proportion of compliers, never-
takers, and always-takers, and defiers, respectively. These latent class prob-
abilities πi for i = 1, · · · , 4 are unknown parameters and, hence, have to be
estimated.
The variables R and D are observed but the variable C, representing latent
class membership, is not. Moreover, knowledge of a participant’s values on R
and D does not allow to unequivocally determine the latent class he belongs
to. Table 6.2 contains the theoretical allocation probabilities Pr(C = c|R =
r,D = d), i.e. the probability that someone belongs to a particular compliance
status class given his response pattern on R and D.
Table 6.2: Allocation probabilities p(C = c|R = r,D = d)



















From table 6.2 it is clear that knowing the value of R and D for a subject
is not sufficient to determine his compliance status. For each combination of
values for R and D a subject may still belong to two of the four classes so
that the compliance status of any subject can only partially be deduced from
his compliance behavior. For example, a subject who was randomized into the
reference group (R = 0) but did not receive the treatment (D = 0) can either
be a complier or a never-taker.
To obtain an applicable latent class model for non-compliance in experimen-
tal studies, further assumptions about the distribution of the response variable
Y and the latent class structure are needed. Here it is assumed that Y is a
metric variable, so that its mean or expected value can be defined. In principle,
the expected value of Y for a particular participant may depend on the value of
the latent class C that participant belongs to, the treatment R he was assigned
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to, and the treatment D he actually underwent. So, in general 4×2×2 different
means µcrd could be considered. However, the exclusion restriction made by
Angrist et al. (1996) states that any effect that R has on Y is an indirect one
over D. So, the expected values of Y only depend on the latent class C and
effective treatment D, and can be represented by the symbol µcd. Moreover, in
the class of the never-takers (Class 2) only µ20 is identified since a participant
in this class is never observed under D = 1. Similarly, participants in the class
of always-takers (Class 3) are never observed under D = 0, so that for this
class only µ31 is identified. Table 6.3 shows which expected values of Y remain
to be estimated.







In the class of compliers both the mean µ10 of the reference condition and
the mean µ11 of the experimental condition can be estimated. The difference
µ11 − µ10 is an estimate of the complier average causal effect. In a similar way
one could define the DACE (defier average causal effect) as µ41−µ40. However,
the monotonicity condition made by Angrist et al. (1996) is equivalent to the
assumption that the class of defiers is empty, so that π4 = 0 in the present nota-
tion, and the DACE is not identified. In general then, one is only interested in
estimating the CACE. In the approach of Angrist et al. (1996) the randomized
assignment variable R acts as an instrumental variable for estimating the effect
of D on Y .
The full four-class formulation was already discussed by Imbens and Rubin
(1997b) who proposed a Bayesian approach to estimate the causal effect in ex-
periments with non-compliance. Also Little and Yau (1998) and Yau and Little
(2001) used the latent class framework for the estimation of the CACE. Their
analysis is based on a latent class model that is both a simplification and an
extension of the model described above. It is a simplification because only two
of the four classes are retained in the model: both the classes of always-takers
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and defiers are assumed to be empty. On the other hand, their model is an
extension of the latent class model described above since it also incorporates
explanatory covariates on which the expected value of the outcome variables
Y and the compliance probability π1 may depend. Assuming multivariate nor-
mality for the conditional distribution of Y given the covariates, maximum
likelihood estimates of the model parameters are obtained by means of the
EM algorithm treating latent class membership as missing data. Imbens and
Rubin (1997a) showed that, assuming a normally distributed outcome variable
with equal variance in all classes, the instrumental variable approach is also
capable of estimating the marginal distributions of the outcome distributions
of treatment and control subjects in the subpopulation of compliers. However,
neither, the joint distribution of Y0 and Y1 nor the distribution of their differ-
ence Y1−Y0 are identified, but, as the authors remarks, this is also not possible
in randomized between-subjects experiment where all subjects comply to their
treatment assignment.
Nagelkerke et al. (2000) also used assignment treatment R as an instrumen-
tal variable to estimate the effect of the actual treatment D on the outcome
variable Y in the presence of confounding variables that affect both D and Y .
Let E be the residual variable from the regression analysis of D on R. They
show that, if there is no other effect of R on Y other than via D, and if the
confounders do not moderate the effect of D on Y , the effect of D on Y can
be estimated in a regression analysis by including E as an additional covariate
in the model. A similar approach was taken by Ten Have, Joffe, and Cary
(2003) for estimating the marginal causal log-odds ratio for binary outcomes
under treatment non-compliance in a randomized trial. As Little and Yau
(1998), they assumed a two latent class model for non-compliance: compliers
and never-takers. In their model they also incorporated covariates for response
and compliance type latent class membership.
6.4 Fitting latent class models for data with non-
compliance
In this chapter, several extensions of the basic latent class model for non-
compliance will be presented. All these models can be formulated as mixture
regression models and be fitted to real data by means of Mplus 5.0 (Muthén
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& Muthén, 2008). By considering the model depicted in figure 6.1 the basic







Figure 6.1: The instrumental variable model as a latent class model
In figure 6.1, R represents the randomly assigned treatment condition with
R = 0 for the reference and R = 1 for the experimental condition. C rep-
resents the latent class variable representing compliance behavior. Although
later some of these classes will be considered empty, it is initially assumed that
the nominal variables C has four different values representing compliers, never-
takers, always-takers and defiers, respectively. The symbol X represents a set
of explanatory variables, some of which may affect the probability of belonging
to a particular latent class while others may affect only the distribution of the
outcome variable Y . Since its values are randomly defined, R is independent of
both C and X. The variable D represents the effective treatment a participant
was subjected to with D = 0 for no intervention and D = 1 for intervention.
As shown in table 6.1 above, D is a deterministic function of C and R. The
outcome variable Y is affected by D and some of the explanatory variables in
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the set represented by X. The subset of variables from X having an effect on
Y may partially or completely overlap with those affecting latent class mem-
bership. Since the variable R has no direct effect on Y , but only an indirect
one over D, the model depicted here satisfies the exclusion restriction.
For a continuous outcome variable Y , it is generally assumed that its con-
ditional distribution is normal with its expected value a linear function of D
and the relevant predictor variables from X. If D is taken as a binary variable
with D = 0 for the reference condition and D = 1 for the experimental condi-
tion, the relationships between the expected value of Y and D and X are class
specifically given by a series of four regression equations:
E(Y |X = x,C = 1) = α01 + δ1D + x′α1 ,
E(Y |X = x,C = 2) = α03 + x′α2 ,
E(Y |X = x,C = 3) = α03 + x′α3 ,
E(Y |X = x,C = 4) = α04 + δ4D + x′α4 . (6.7)
Since the participants in the second and third class are only observed under
one condition (either the reference or experimental condition, respectively),
the effect of D is not defined in these two classes. The effect of D can only
be assessed in the first class of compliers and the fourth class of defiers. The
estimate of the effect in the class of compliers is given by δ1 and is actually
the complier average causal effect (CACE) as referred to above. Similarly, δ4
is the defier average causal effect (DACE), which is not necessarily equal to
the CACE. Under the monotonicity condition, which implies that there are
no defiers, the DACE is not identified; in this case, only the CACE can be
estimated. Note also that in this general model the effects of the auxiliary
explanatory variables X on Y may vary over the classes. Neither have the
regression models to be homoscedastic.
The probability of belonging to a particular latent class may also depend on
some or all of the explanatory variablesX. In general, a multinomial regression
model is postulated for this relationship:
Pr(C = c|X = x) = exp(β0c + x
′βc)∑




To obtain an identified model the β-parameters for one of the classes are all
set equal to zero.
The latent class model as described here is an example of a mixture regres-
sion model (Wedel & DeSarbo, 2002). In the present application, the observed
variables R and D provide partial information about class membership, since
each response pattern (R,D) can only occur in two of the four classes. In
order to fit the latent class model by means of a software program like Mplus
(Muthén & Muthén, 2008), a binary training or learning variable Tc has to
be defined for each class as a function of the response pattern (R,D). The
training variable for a particular latent class is equal to 1 for those response
patterns (R,D) that can occur in that class, and is equal to 0 for response
patterns that cannot occur. In order to apply Mplus, users have to define the
training variables themselves before entering them in the analysis together with
the assigned treatment variable R.
Table 6.4 specifies the definition of the four training variables in terms of
the observed response patterns (R,D).
Table 6.4: Definition of training variables in the general case of four
latent classes
R D T1 T2 T3 T4
(C) (Nt) (At) (D)
0 0 1 1 0 0
0 1 0 0 1 1
1 0 0 1 0 1
1 1 1 0 1 0
From this table it is seen that the response pattern (R = 0, D = 0) can only
occur in the classes of compliers and never-takers, but not in the classes of
always-takers or defiers. Analogous observations can be drawn for the three
other response pattern, showing that each response pattern can only occur in
exactly two classes. If the number of latent classes is reduced, for instance, by
assuming that there are no defiers or always-takers, the corresponding training
variables are removed from the analysis.
The four-class model without auxiliary explanatory variables X is not iden-
tified, but the model with three classes obtained by removing the fourth class
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of defiers is. A limited simulation study indicated that adding explanatory
variables that determine latent class members and the conditional distribution
of Y seems to resolves the identification issue for the four-class model.
For the analysis of an ordinal categorical outcome variable Y , Muthén’s
threshold model (Muthén, 1984) can be used. In this model a categorical
variable Y is derived from a continuous unobserved variable Y ∗, which is cate-
gorized via a threshold model. Suppose Y has m ordered response categories.
Then for m − 1 threshold values θk, the relationship between Y ∗ and Y is as
follows:
Y = 1 ⇔ Y ∗ ≤ θ1
Y = k ⇔ θk−1 < Y ∗ ≤ θk for 2 ≤ k ≤ m− 1
Y = m ⇔ θm−1 ≤ Y ∗ .
In this case, the regression models are formulated for the continuous latent
variable Y ∗ rather than for the categorical observed variable Y .
6.5 Extensions of the basic latent class model
In this section several extensions of the basic latent class model for non-
compliance are discussed:
1. The latent class model with an indirectly measured outcome variable;
2. A non-compliance latent class model for multiple treatments;
3. A non-compliance latent class model for a factorial design.
6.5.1 Estimating the CACE when the outcome status is indi-
rectly measured via indicator variables
In many experimental studies the final outcome variable is not directly mea-
sured by a single variable, but by a set of several indicator variables which can
be thought of as imperfect measures of a underlying latent construct. In such
studies one is not interested in the effect of the treatment on each of the indi-
cator variables, but in its effect on the underlying latent construct. In order to
accommodate for data collected in such experimental design, the basic latent
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class model can be extended by including a measurement model for the latent









Figure 6.2: The non-compliance latent class model with latent outcome variable
In this figure the unobserved latent outcome variable is represented by η,
for which three observed indicator variables Y1, Y2 and Y3 are available. These
three indicator variables are independent conditional on η; moreover, they are
also conditionally independent of R,C,X and D given η. This implies that
effective treatment D has no direct effects on any of the indicator variables,
but only indirect effects that run over η. In general, the latent variable η will be
treated as a continuous variable, but some or all of the indicator variables may
be categorical. In this adaptation of the basic latent class model the effective
treatment D and the explanatory X have a direct effect on the latent outcome
variable η, but not on the indicator variables Yk themselves. The regression
equations from equation 6.7 have to be modified accordingly. When the indica-
tor variables are continuous, their relationship with the latent outcome variable
is usually specified as a factor analytic model with one common factor:
Yk = αkη + υk .
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In order to obtain an identified measurement model, the scale of the latent
variable η has to be fixed, either by setting the factor loading of one of the
indicator variables equal to 1, or by setting the variance of η equal to 1. Not all
indicator variables need to be continuous. For categorical indicator variables
this factor analytic model has to be combined with the same threshold model
as described above.
6.5.2 A non-compliance latent class model for multiple treat-
ments
In many experimental studies several experimental conditions are compared
to a reference condition. Suppose that the experimental manipulation of the
independent variable resulted in three different conditions: R = 0 for a reference
or placebo condition, R = 1 for a first experimental condition, and R = 2
for a second one. The two experimental treatments may, for instance, differ
with respect to the intensity with which a particular stimulus is applied to the
participants, or with respect to the dose of a pharmaceutical drug administered
to patients in a clinical study. On the other hand, the two treatments may
represent qualitatively different interventions that cannot be ordered along a
quantitative intensity continuum. The effective treatment D assumes the same
three values as R, but which value D assumes for a particular participants
depends on the latter’s compliance status. If the participant belongs to the
class of compliers, D = R holds. If, on the other hand, a participant is a never-
taker one may assume D = 0, whatever the value of R. It is less straightforward
to define D for the classes of always-takers or defiers, since R assumes more
than two values. What, for instance, would an always-taker do in this context?
Would he always opt for R = 2 or R = 1? It is even less clear how a defier
would behave in this situation.
So, in a multiple treatment situation it may be wise to consider only models
with the two latent classes consisting of compliers and never-takers. Only two
training variables T1 and T2 have then to be defined given the response patterns
(R,D). This is shown in the following table 6.5.
Note first that the response patterns (0,1), (0,2), (1,2), and (2,1) for (R,D) can
never occur when there are no always-taker or defiers. Moreover, the response
patterns (1,1) and (2,2) can only occur in the class of compliers, whereas the
patterns ((1,0) and (2,0) can only be observed in the class of never-takers.
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Table 6.5: Definition of training variables for a two-class model in an
experiment with three condition
R D T1 T2
0 0 1 1
1 0 0 1
1 1 1 0
2 0 0 1
2 2 1 0
Finally, the response pattern (0,0) is possible in both latent classes.
Let X represent a set of explanatory variables that may affect the proba-
bility of belonging to a particular latent class as well as the expected value of
the outcome variable Y , the model can be further specified by the equations
logit(Pr(C = 1|xi)) = α0 + x′i.α , (6.8)
E(Yi|C = 1, xi) = β0 + δ1D1 + δ2D2 + x′i.β , (6.9)
E(Yi|C = 2, xi) = γ0 + x′iγ . (6.10)
The first equation defines the allocation model by indicating how the prob-
ability of being a complier varies as a function of the explanatory variables
in X. A potential explanatory variables can be excluded from this allocation
model by setting its α parameter equal to zero. The second equation specifies
how in the class of compliers the expected value of the outcome variable Y
varies as a function of the received treatment, after controlling for the relevant
explanatory variables. In this equation the effective treatment is represented
by two dummy variables D1 and D2 with D1 equal to 1 for D = 1 and zero
otherwise, and D2 equal to 1 for D = 2 and zero otherwise. In this way the
reference condition is treated as the reference category with which the effects
of both experimental treatments are compared. In the class of never-takers,
the expected value of Y only depends on the explanatory variables, but their
effects on Y may be different from those in the first class.
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6.5.3 A non-compliance latent class model for a factorial design
Non-compliance problems may also arise in factorial experiments in which two
or more experimental factors are crossed. Consider a 2× 2 design in which two
factors A and B are orthogonally crossed. In principle, one could now define
4× 4 = 16 different classes by combining the four compliance classes for factor
A with the four compliance classes for factor B. Such an extended latent class
model will not work in practice, even if it is identified by including additional
explanatory variables in the model. A more applicable latent class model is
obtained by only allowing a complier and a never-taker class per factor. Let RA
and RB denote the randomly assigned levels for factor A and B, respectively.
In a similar way, let DA and DB be the received levels for factors A and B,
respectively. The two values of the variables R and D are continually denoted
as 0 and 1.
By combining the two compliance status classes for A and B, four different
classes can be defined:
* Class 1 consists of participants who comply to both the A and B treat-
ment and for which then DA = RA and DB = RB hold;
* Class 2 consists of participants who comply to the A treatment, but never
take B: DA = RA and DB = 0;
* Class 3 consists of participants who comply to the B treatment, but never
take A: DA = 0 and DB = RB;
* Class 4 consists of the participants who never take A or B: DA = 0 and
DB = 0.
In order to fit this model, four training variables have to be defined. They
are defined as follows:
T1 = (DA = RA) ∧ (DB = RB)
T2 = (DA = RA) ∧ (DB = 0)
T3 = (DA = 0) ∧ (DB = RB)
T4 = (DA = 0) ∧ (DB = 0) .
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For the model that only allows compliers or never-takers for each factor, seven
of the 16 possible response patterns(RA, DA, RB, DB) cannot occur. Table 6.6
describes the four training variables for the nine remaining response patterns
that can occur.
Table 6.6: Definition of training variables for the two-class model in a
2× 2 design
RA DA RB DB T1 T2 T3 T4
0 0 0 0 1 1 1 1
0 0 1 0 0 1 0 1
0 0 1 1 1 0 1 0
1 0 0 0 0 0 1 1
1 1 0 0 1 1 0 0
1 0 1 0 0 0 0 1
1 0 1 1 0 0 1 0
1 1 1 0 0 1 0 0
1 1 1 1 1 0 0 0
It is interesting to note that four of the eight response patterns can only appear
in one latent class. For participants with these response patterns latent class
membership is observed. The zero response pattern, on the other hand, can
occur in all four classes, whereas the remaining four patterns can arise in two
different classes.
The most obvious way to define an allocation model in this situation is by
postulating a multinomial regression model for the latent class probabilities. An
alternative model might consist of treating the four latent classes as the result of
the crossing of two dichotomous latent variables UA and UB which take on the
value 1 for compliance and the value 0 for non-compliance on the corresponding
factor. Latent class membership can then be modeled by a separate model for
Pr(UA = 1) and Pr(UB = 1). In the model for the outcome variable, a different
regression equation has to be specified for each of the four latent classes. In
the first class the regression model has to include the main effects both factor
A and B, and eventually their interaction effect. In the second and third class
only the main effect of either A or B is implied according to the compliance
status of the subjects belonging to these classes. Finally, in the fourth class
none of the effects of A and B have to be taken into account. Moreover, in all
four classes partially or completely overlapping subsets of covariates may enter
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the regression equations but their regression coefficients need not be invariant
over the classes.
6.6 A real data application
In this section, an application of the latent class model for non-compliance in
situations is discussed in which a latent outcome variable is indirectly observed
via several indicators in a 2× 2 factorial design. In this application, two of the
extensions discussed in the previous section are combined in a single analysis.
Moreover, two explanatory variables are included in the model which might
have a potential effect on latent class membership as well as on the distribution
of the latent outcome variable. The data come from a randomized controlled
factorial trial conducted by the EMGO Institute for Health and Care Research
in the Netherlands (van Uffelen, Chin A Paw, van Mechelen, & Hopman-Rock,
2008).
This study examined the effects of two different treatments, vitamin B
supplementation (R1) and aerobic exercise (R2) on cognitive function in older
adults with mild cognitive impairment. A sample of 152 participants were ran-
domly assigned to the interventions: (1) a twice-weekly, group-based, moderate-
intensity walking program (n = 77) or a low-intensity placebo activity program
(n = 75) for one year; and (2) daily vitamin pill containing 5 mg folic acid, 0.4
mg vitamin B-12, 50 mg vitamin B-6 (n = 78) or placebo pill (n = 74) for one
year. Cognitive functioning was measured with eight neuropsychological tests
at baseline and after six and 12 months. Here, only the data is used collected
at 12 months.
The Abridged Stroop color word test (SCWT-A) is used as a measure of
complex processing (Klein, Ponds, & Jolles, 1997). The SCWT-A consist of
three tasks; 1) SCWT-A1: word reading, 8 rows of 5 written colors; 2) SCWT-
A2: color naming, naming the colors of 8 rows of 5 red, green, blue or yellow
colored rectangles; 3) SCWT-A3: combination task, the words red, green, blue
or yellow have been printed in a different color of ink, the subject is asked
to name the color of the ink. The Auditory Verbal Learning Test (AVLT) is
used as a measure of memory for direct and delayed recall (Rey & Muthén,
1964). During this test, a list of monosyllabic words is read aloud by the
examiner for 5 times. After each trial, the subject is asked to repeat the words
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he or she remembers. After fifteen minutes with other questions, delayed recall
is assessed by asking the participant which words he or she still remembers.
Both the versions AVLT15 and AVLT6 were used. General cognitive function
is measured with the Mini Mental State Examination (Folstein, Folstein, &
McHugh, 1975). The MMSE consists of 11 questions concerning orientation,
registration, attention and calculation, recall and language. The maximum
score is 30 and a score below 24 is considered abnormal for dementia screening.
The digit symbol substitution test (DSST) is used as a measure of attention,
perceptual speed, motor speed, visual scanning and memory (Uiterwijk, 2001).
The subject is given a piece of paper with nine symbols corresponding with nine
digits. Next on this piece of paper are three rows of digits with empty spaces
below them. The subject is asked to fill in as many corresponding symbols
as possible in 90 seconds. Expressive language was assessed using the verbal
fluency test (VFT) (Lezak, 2004). The subject is given a letter and is asked to
name words beginning with the particular letter in one minute.
In our model, also information about the age and gender of participants
were included. Subjects with missing data were excluded, leaving a sample
of 131 subjects. Thirty (30) subjects were assigned into the walking program
with a placebo for vitamin intake, 33 subjects were assigned into the low-
intensity placebo activity program with a placebo for vitam intake, 34 subjects
were assigned into the walking program with a daily vitamin intake, and 33
subjects were assigned into the low-intensity placebo activity program with a
daily vitamin intake. At baseline, the patients from the four study groups did,
on average, not significantly differ on age (F=0.271, df=3, p =0.885) and gender
(χ2=6.522, p=0.089). Compliance with the walking program is assessed as the
percentage of attended lessons (less than 75%). Compliance with the vitamin
supplementation is verified by pill counts and determining blood vitamin levels.
6.6.1 The model
The analysis reported in this section is based on the model schematically shown
in figure 6.3.
Since all elderly were randomized to either the reference or the experimen-
tal group of both experimental factors, the distributions of the randomized
treatments R1 and R2 are perfectly known. R1 represents allocation to the
condition of the vitamin factor: R1 = 0 for assignment to the placebo pill






Figure 6.3: The non-compliance latent class model with two manipulated fac-
tors and eight indicators
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condition, R1 = 1 for assignment to the daily vitamin pill condition on this
factor. The dummy variable R2 represents random assignment to the Exer-
cise factor: R2 = 0 for the low-intensity placebo activity program condition,
R2 = 1 for the moderate-intensity walking program condition. For both factors
compliance the effective treatments D1 and D2 can be treated as completely
observed, given the operational definitions of compliance as stated above.
The latent outcome η represents cognitive functioning and is measured via
the eight cognitive tests represented by Y1 to Y8. Two explanatory variables
X1 (Gender) and X2 (Age) are included in the model. Those two explanatory
variables may first determine class membership of the participants; they may
also have direct effects on the latent outcome variable η. The present analysis
is based on the assumption that two latent classes may be defined. The first
latent class C = 1 contains the participants who comply on both factors; the
second class C = 2 contains people who are never-taker on the second factor
but always comply to their assignment on the first one. Note that here the
latent class consisting of compliers on the first factor and never-takers for the
second factor are not included. Due to the limited number of subjects in this
study, analysis with three or four latent classes did not converge properly. From
a substantive point of view, a selection of the two latent classes reflects the fact
that compliance on the second factor requires more effort than compliance on
the first one: for the vitamin intake compliance was almost 100 %, whereas for
the activity program it was only 66 %.
The model being fitted to the data was specified by a series of specific
assumptions:
1. The probability of belonging to the class of compliers is given by a logit
model with X1 and X2 as explanatory variables:
logit(C = 1|X1, X2) = p0 + p1X1 + p2X2 .
The second latent class is treated here as the reference class.
2. The two training variables T1 and T2 are defined by the following logical
operations:
T1 = (D1 = R1) ∧ (D2 = R2)
T2 = (D1 = R1) ∧ (D2 = 0) .
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3. In latent class C = 1 the expect value of η depends on both the status of
the two manipulated variables and their interaction, and the explanatory
variables:
E(η) = a0 + a1D1 + a2D2 + a3D1 ×D2 + a4X1 + a5X2 .
4. In latent class C = 2 the expected value of η only depends on the ex-
planatory variables:
E(η) = b0 + b1D1 + b4X1 + b5X2 .
5. No equality constraints are imposed on the regression coefficients of the
common explanatory variables in the different class: the effects of D1,
X1, and X2 may be different in the two classes.
6. The latent outcome variable η is measured by eight indicator variables
Yk, k = 1, ..., 8. Here a factor model with one common factor is postulated:
Yk = λkη + εk
In order to obtain an identified measurement model the factor loading
of the first indicator was set equal to 1. It is assumed that the same
measurement model applies in all three classes.
6.6.2 Results
Predicting latent class membership Table 6.7 shows the estimates of the
parameters of the logistic regression equation by means of which latent class
membership is predicted on the basis of Gender and Age.
The results indicate that none of these explanatory variables has a significant
effect on the probability of belonging to a particular latent class. Whether
someone is a complier or not does not depend on his age or gender.
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Table 6.7: Estimates for the logit equation for belonging to the class of
compliers
Variable Estimate SE Estimate/SE p-value
Constant -4.46 6.98 -0.64 0.52
Gender 0.16 0.63 0.26 0.80
Age 0.05 0.09 0.51 0.61
Measurement model for latent outcome variable Table 6.8 contains the
unstandardized factor loadings of the eight indicator variables for measuring
the latent outcome variable η. In order to obtain an identified measurement
model, the factor loading of the first indicator (SCWT-A1) was set equal to 1.
These parameters describe the measurement model for η that applies for both
compliers and non-compliers.
Table 6.8: Unstandardized estimates of the measurement model for the
latent outcome variable
Indicator Estimate SE Estimate/SE p-value
SCWT-A1 1.00 - - -
SCWT-A2 1.27 0.18 7.14 0.00
SCWT-A3 4.73 0.89 5.32 0.00
AVLT15 -1.25 0.33 -3.79 0.00
AVLT16 -0.29 0.12 -2.49 0.01
MMSE -0.19 0.06 -3.04 0.00
DST -2.18 0.33 -6.65 0.00
LFT -1.81 0.39 -4.63 0.00
All indicators have significant factor loadings on the latent variable η.
Predicting the latent outcome variable Table 6.9 gives the unstandard-
ized estimates of the regression equations for η for compliers and non-compliers.
The effects of both experimental manipulations and their interaction are only
defined in the class of compliers. In the class of partial compliers only the effect
of the first factor is defined. Note also that the covariates Gender (X1) and
Age (X2) may have both a different effect in the two classes. For the class
of compliers (C=1) there is no main effect for the vitamin B supplementation
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(b = 0.81, p > 0.05), nor for aerobic exercise (b = 0.93, p > 0.05). Moreover,
there is also no interaction between these two factors (b = 0.56, p > 0.05). For
the class of compliers Gender does have a slight effect on the cognitive func-
tioning of the elderly patients, with men having a better cognitive functioning
(b = 1.94, p < 0.10). In the class of partial compliers Age influences the cogni-
tive functioning, with older participants having a better cognitive functioning
(b = 0.03, p < 0.05).
The researchers from the EMGO institute for Health Care Research (van Uffelen
et al., 2008) have analyzed the data in an intention to treat analysis for each out-
come variable separately. As outcome measures they used the results from eight
neuropsychological tests, namely the SCWT-A, SCWT-B, SCWT-C, DSST,
VFT, AVLT1-5 and the AVLT6. They concluded that neither the walking
program nor vitamin supplementation improved cognition in the community-
dwelling older adults with mild cognitive impairment. They suggested that
the lack of a main effect of exercise may have been caused by the moderate
adherence to the exercise programs. Since they analyzed the data according
to the intention-to-treat principle, all randomized participants with available
data were included in the analysis, irrespective of exercise adherence. Even data
from participants which did not attend a single exercise session were included,
thereby underestimating the actual intervention effect. In the re-analysis of the
data still no improved cognition was found for either the walking program or
the vitamin supplementation. Even treating all outcome variables as indicator
for cognitive functioning was of no help in yielding significant treatment effects.
It seems that it is not the lack of treatment adherence that explains the neg-
ative results, but that alternative explanations have to be found. Maybe the
relatively high baseline physical activity level, or the small contrast between
the programs may be responsible for the absence of treatment effects.
6.7 Discussion
A randomized control trial (RCT) is certainly the optimal approach for testing
the effectiveness of treatment interventions. In research practice, however,
planning an RCT is not a guarantee that at the end of the study the intended
causal inferences can be made. Too often, participants in a study think for
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way than the researcher had in mind. Some patients expect the other treatment
which they did not receive to have a more positive impact and try to obtain it.
Other participants may experience negative side-effects of the treatment and
only partially comply to their treatment regimen. With non-compliance of this
kind, the results of a study cannot be simply causally interpreted anymore.
Researchers often try to solve the non-compliance problems by carrying out
both an intention-to-treat and an as-treated-analysis, and argue afterwards
that the true treatment effect lies somewhere in the middle of the two estimates
obtained in this way. This strategy is flawed, however.
In this chapter, the instrumental variable approach has been discussed from
a latent class point of view. By classifying participants into compliers, always-
takers, defiers and never-takers, and by making additional assumptions about
the data generation process, true treatment effects can be estimated for the
class of compliers. It was shown that, with only a little effort, this way of latent
categorization of participants, can easily be modeled in advanced statistical
packages. Suggestions are made about how some extensions of the basic model
can be dealt with by incorporating so called training variables in Mplus. In the
real world example it is shown that the former conclusion of the researchers
of no treatment effect still holds, even after correction for non-compliance in
the latent class model. Hopefully this chapter will help researchers to deal
with non-compliance in a different way in their future research, and give them
a guideline for dealing with non-compliance in a more sophisticated way in
their future analysis. The chapter has shown that the basic model can be
extended in a flexible way, so that non-compliance with multiple treatments
and in factorial designs can be dealt with. It proved to be very difficult to
convince researchers to make their data available to use them as an illustrative
example. Too often, researchers were suspicious and afraid that a re-analysis
of the data would contradict their own conclusions. Therefore plead is made in
favor of a policy where data of previously published studies are made available
for secondary analysis.
All the extensions of the basic latent class model considered in this chapter
assumed that the effective treatment D was perfectly known. As already sug-
gested by the real data application, this may not always be the case. In the
real data example patients were seen as complying to their assigned exercise
treatment if they behave according to their treatment protocol in 75 % of the
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cases. But why 75 %, and not 60 % or 90%? Sharpening or weakening the cut
off point for compliance may alter the results of the analysis. In many other
applications, it may not even be possible to deduce compliance in this way.
Instead, researchers have to be content with some imperfect and unreliable in-
dicators of complying behavior. For instance, patients may be asked to fill in a
questionnaire for measuring compliance behavior. An example of such a ques-
tionnaire is the Compliance Questionnaire for drug taking behavior of patients
with rheumatic diseases (de Klerk, van der Heijde, & Landerwé, 2003). On the
basis of such questionnaire data it will, in general, not be possible to define
D unambiguously, so that the specific approach described in this chapter is
no longer applicable. However, a more drastic modification of the basic latent
class model can be conceived. In this approach, two different latent classes are
postulated: a first one containing the subjects who can be considered as com-
plying to their treatment, and a second one which contains the never-takers. In
the class of compliers, the expected value of the outcome variable Y depends
on the assigned treatment R and the covariates; in the class of never-takers, it
only depends on the covariates. Since D is not directly observed, no training
variables T1 or T2 can be defined, but using the questionnaire data it might
possible to obtain some compliance indicators whose distributions differ among
the classes. Those indicator variables then provide additional information for
separating the latent classes. A model of this kind is another instance of a
mixture regression model, but without any partial observation of latent class
membership. The only information one now has about latent class membership
resides in the distributions of the indicator variables.
Although in this chapter only the case of continuous outcome variables is
discussed, it is made clear that the case of categorical indicators can also be
handled by means of the threshold model proposed by Muthén (1984). This
approach, implemented in Mplus, is however quite restrictive since it assumes
that the categorical variables arise as a consequence of categorizing a set of
multinormally distributed continuous variables. If these assumptions are not
met in a particular data set, alternative analysis based on a loglinear formu-
lation of the models described here could be considered. Such mixture latent
class models can be fitted by software as ` EM (Vermunt, 1997) or by Latent
Gold (Vermunt & Magidson, 2008).
Chapter 7
Adjusting for non-verification
in screening studies with
repeat testing
7.1 Summary
In medical screening, subjects are often pre-screened by one or multiple non-
invasive diagnostic tests and only subjects with at least one positive test are
verified for disease status. This strategy may lead to verification bias in esti-
mating the performances of the non-invasive tests. Several methods have been
developed to adjust for verification bias in cross-sectional studies. A repeat test-
ing setting is considered where some subjects are directly verified and some are
invited for non-invasive retesting at a later time point depending on the base-
line test results. A path model is presented which accounts for non-verification
and dependencies among the non-invasive tests. For parameter estimation, an
expectation maximization (EM) algorithm is presented. The model is applied
to data collected in a large cervical cancer screening trial in the Netherlands.
A main goal of this trial was to compare the accuracy of cytological testing
to human papillomavirus (HPV) DNA testing. It is illustrated how the cross-
sectional and longitudinal dependencies of the two tests can be modeled and
non-verification can be studied by fitting missing at random (MAR) and not




An important area in medical research is the evaluation of diagnostic tests. To
evaluate the performance of a diagnostic test, the test results are compared
to the measurements of a gold standard test and the false negative and false
positive rates are computed. Here, the false negative rateis the probability of
a negative test result in a diseased subject and the false positive rate is the
probability of a positive result in a healthy subject. Unfortunately, in many
studies, the gold standard test, which provides a definite disease verification,
is available only for a subset of the subjects because verification may be bur-
densome. In a näıve approach where the analysis is based only on the subjects
with a gold standard verification, the results are biased because subjects with
a positive test result are more often verified than subjects with a negative test
result. This type of bias is known in the literature as verification bias (Begg &
Greenes, 1983).
For cross-sectional data, several methods for countering verification bias
are available. In the setting of only one diagnostic test, Begg and Greenes
(1983) propose a stratified estimator where the strata are defined on the basis
of the results of the diagnostic test. For each test result, a conditional dis-
ease probability is estimated and the false negative and false positive rates are
estimated by combining these disease probabilities. The method gives unbi-
ased estimates of the false positive and false negative rates if the probability
of verification varies only with the test results. Kosinski and Barnhart (2003)
choose a different approach and formulate a model where the test results are
defined conditional on the (partially unobserved) disease status. The false pos-
itive and negative rates are regression parameters in a logistic regression model
that may contain both categorical and continuous covariates. Kosinski and
Barnhart (2003) present an expectation maximization (EM) algorithm for es-
timating the model parameters. Baker (1995), Zhou (1998) and Alonzo (2005)
consider the problem of verification bias in the assessment of two diagnostic
tests. As in Begg and Greenes (1983), Baker (1995), Zhou (1998) and Alonzo
(2005) formulate the disease probability. Baker (1995), Kosinski and Barnhart
(2003) and Zhou and Castelluccio (2004) allow the verification probability to
depend on test results and on the disease status.
In the present study, verification bias in a repeat testing setting is consid-
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ered. This is a common situation in medical screening and occurs when some
of the subjects who are not verified immediately, are retested at a later time
point. The motivating data have been collected in a cervical cancer screening
trial in the Netherlands (Bulkmans et al., 2007). In this trial, two different
screening tests were compared. The data have a repeated testing structure
because women without severe abnormalities on the baseline tests were not
immediately verified but were retested after 6 and 18 months.
For modeling disease verification, different missingness mechanisms are as-
sumed including not missing at random (NMAR) mechanisms (Rubin, 1976).
In the NMAR models, the probability of disease verification depends not only
on observed variables but also on the partially unobserved disease status. Re-
garding the relation between test results and disease, the same approach as
Kosinski and Barnhart (2003) will be followed and the test results conditional
on the disease status are modeled. The repeat testing data structure will be
explicitly incorporated in the model by formulating a path model. The associ-
ation among the variables in the model will be described by a series of logistic
regression equations (Kosinski & Barnhart, 2003; Goodman, 1978; Baker &
Laird, 1988).
The remainder of the chapter is organized as follows. In section 7.3, the
data will be described and the verification problem will be explained. In section
7.4, path models for verification bias will be presented. In section 7.5, the data
will be analyzed and the results will be presented. The final section 7.6 contains
a discussion.
7.3 Cervical cancer screening study
7.3.1 Data description
In a Dutch screening trial (Bulkmans et al., 2007), 44,102 women aged 30-60
years were screened by a cytologic inspection of the cervix or by a combination
of cytology and a molecular test. The molecular test checks for DNA of human
papillomavirus (HPV) which is the causal agent of cervical cancer. Because a
direct comparison is made between cytology and the HPV DNA test, only the
data from the experimental group (N=21,950) is used. The screening manage-
ment protocol is presented by the flow chart in figure 7.1. It can be read from
the figure that participants can be immediately referred to the gynecologist,
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dismissed from further follow-up or invited for retesting. The first and second
retest are targeted at 6 and 18 months after baseline. Positive and negative
HPV DNA test results are denoted by HPV+ and HPV-. Normal, mild, and
severe cytologic abnormalities are denoted by cyt-, cyt+, and cyt++, respec-
tively. If a woman is referred to the gynecologist, a cervical specimen will be
taken from cellular abnormal tissue which will be analyzed by the pathologist
for disease verification (gold standard test). A woman is considered as diseased
































second  retest 
first retest first retest 
No further retesting
No further retesting No further retesting
Figure 7.1: Management flow chart of the trial in the experimental group
7.3.2 Verification
Verification is incomplete for three reasons. First, according to the screening
protocol, some women will not be verified depending on the test results at
baseline and/or after repeat testing. Second, some women do not show up
at retesting at 6 and 18 months. Third, not every woman who is referred to
the gynecologist actually receives the gold standard test. The latter type of
non-verification may occur for two reasons: a woman does not show up at the
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gynecologist or the gynecologist decides not to take a sample for verification.
The three different types of non-verification are illustrated in figure 7.2.
test results
cytology and HPV 
Decision: Retesting
Decision: Referral Colposcopy Biopsy
No test results
No visit No biopsy
test results
cytology and HPV 
Protocol decision: 
No referral or retesting
Figure 7.2: Graphical representation of the reasons for incomplete verification
7.4 Path models
7.4.1 Model for cross-sectional data
Incomplete verification can be seen as a missing data problem. For variables
that are partially observed, Fay (1986) and Baker and Laird (1988) propose a
log-linear path model, consisting of a series of logit models, where missingness
is specified by an indicator variable (Goodman, 1978).
First, the path model for cross-sectional data is explained within the context
of the cervical screening example. The outcomes of the cytology and HPV test
are denoted by categorical variables A (scores 0, 1, and 2 for cyt-, cyt+, and
cyt++, respectively) and B (scores 0 and 1 for HPV- and HPV+, respectively).
The true disease status is denoted by Y (0 if healthy and 1 if diseased). Also
the verification variable R is introduced (1 if verified and 0 if not verified). The
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model parameters are in vector θ. The joint probability of observing Y = y,
A = a, B = b, and R = r, i.e. p(y, a, b, r|θ) is modeled as the product of
p(y, a, b|θ) and the conditional probability of verification p(r|y, a, b;θ):
p(y, a, b, r|θ) = p(y, a, b|θ) p(r|y, a, b;θ) . (7.1)
The i-th subject is identified by index i. The log-likelihood of the data is








{Ri log p(yi, ai, bi, Ri = 1|θ) +
= (1−Ri) log p(ai, bi, Ri = 0|θ) }
. (7.2)
The right-hand side of equation 7.2 can be further evaluated. Following equa-
tion 7.1, the probability of observing Yi = yi, Ai = ai, Bi = bi can be written
as
p(yi, ai, bi, Ri = 1|θ) = p(yi, ai, bi|θ) p(Ri = 1|yi, ai, bi;θ) ,
and the probability of observing only test results Ai = ai and Bi = bi can be
written as
p(ai, bi, Ri = 0|θ) =
1∑
j=0
p(Yi = j, ai, bi|θ) p(Ri = 0|Yi = j, ai, bi;θ) .
The probability p(y, a, b|θ) can be modeled in two ways. Baker (1995) and
Zhou (1998) use
p(y, a, b|θ) = p(a, b|θ) p(y|a, b;θ), (7.3)
where p(y|a, b;θ) is the probability of disease outcome y given test results a
and b. Kosinski and Barnhart (2003) use
p(y, a, b|θ) = p(y|θ) p(a, b|y;θ) . (7.4)
Kosinski and Barnhart (2003)’s approach is the most useful one for this sit-
uation with two possibly dependent tests because the relation between the
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test results can be modeled in a sensible way after conditioning on the disease
status (Sasieni, 2001). As put forward by Kosinski and Barnhart (2003) the
components from equation 7.4 can be modeled by a series of logistic equations.
Because cytology scores are trichotomous, a variant of Kosinski and Barnhart’s
model for nominal responses needs to be set up by pairing response categories to
a baseline category (Agresti, 2002). If it is assumed that the outcome B of the
HPV test depends on the outcome A of the cytology test, and also assumed
that verification depends on both cytology and the disease status (NMAR),
then a model might be set up with the following 3 components.
Disease component:





= α0m + α1myi , m = 1, 2,
logit p(Bi = 1|yi;β) = β0 + β1yi + β2ai0 + β3ai0 × yi .
Verification component:
logit p(Ri = 1|yi, ai, bi,γ) = γ0 + γ1ai1 + γ2ai2 + γ3bi + γ4yi , (7.6)
where ai0, ai1, and ai2 are dummies with score 1 for cytologic results cyt-,
cyt+, and cyt++, respectively. Model parameter vector θ consists of φ, α
= (α01, α11, α02, α12)
′, β = (β0, . . . , β3)
′, and γ = (γ0, . . . , γ4)
′. Independence
between cytology and the HPV test can be imposed by setting β2 and β3 equal
to zero. Setting γ4 equal to zero leads to a Missing at Random (MAR) model,
and setting γ1, . . . , γ4 equal to zero leads to a Missing Completely at Random
(MCAR) model.
7.4.2 Model for repeat testing data
To set up the model for the cervical screening trial with repeated testing, time
index variable t = 0, 1, 2 are introduced corresponding to respectively the base-
line, the first repeat testing moment, and the second repeat testing moment.
The test and the verification variable are extended with the time index and
have cytology variable Ai = (Ai(0), . . . , Ai(ti))
′ for subject i, where ti is the
time index of the last test. Also the HPV test variable Bi = (Bi(0), . . . , Bi(ti))
′
and verification variable Ri = (Ri(0), . . . , Ri(ti))
′ will be defined. Furthermore
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variable Si = (Si(0), . . . ,Si(ti))
′ will be defined, the t-th element of which in-
dicates whether, according to the screening protocol in figure 7.1, woman i is
referred to the gynecologist at time index t (score 1 if decision is referral and 0
if decision is no referral). Note that Si is determined by the variables Ai and
Bi.
If logistic regression link functions are imposed, a model for subject i with
the following 3 components may be defined as:
Disease Component:
logit P (Yi = 1|φ) = viφ . (7.7)
Diagnostic test components:




= zi(t)αm(t), m = 1, 2, (7.8)
logit p(Bi(t) = 1|xi(t);β(t)) = xi(t)β(t) . (7.9)
Verification component:
t = 0, . . . , ti:
p(Ri(t) = 1|Si(t) = 0) = 0 ,
logit p(Ri(t) = 1|wi(t), Si(t) = 1;γ(t)) = wi(t)γ(t) . (7.10)
The predictor matrices vi, zi(t), x(i)t, and wi(t) may consist of manifest
continuous and categorical predictors but also of the partially observed disease
status yi. The regression coefficients αm(t) (m = 1, 2), β(t), and γ(t) may vary
across time. In the verification component, the verification probability can be
positive only for women that are referred to the gynecologist (i.e. Si(t) = 1).
The model parameters can be estimated with the EM algorithm (Dempster,
Laird, & Rubin, 1977). In the E-step, the expectation of the logarithm of
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the complete data likelihood at the current estimate of the model parameters









log p(yi,ai, bi, ri|θ∗) ,
is taken with respect to the unobserved disease scores. Let us denote yi and






rilog p(yi,ai, bi, ri|θ∗) + (1− ri)
1∑
j=0
yij log p(Yi = j|ai, bi, ri;θ∗)
 .
The E-step involves calculating the conditional expectation of the disease status
yij , yielding E [yij |ai, bi, ri;θ∗] = p̃ij = p(Yi = j|ai, bi, ri;θ∗). The conditional
expectation p̃ij can be computed by writing p̃ij as
p̃ij =
p(ai, bi, ri|Yi = j;θ∗) p(Yi = j|θ∗)∑1
j=0 p(ai, bi, ri|Yi = j;θ
∗) p(Yi = j|θ∗)
,
and substituting the current estimates retrieved from the disease, diagnostic,
and verification component. In the M-step, the expected complete data likeli-




ri log p(yi,ai, bi, ri|θ) + (1− ri)
1∑
j=0
p̃ij log p(Yi = j,ai, bi, ri|θ)
 .
Estimated standard errors for the model parameters can be obtained by invert-
ing the observed information matrix which is minus the matrix of second-order
derivatives of the log-likelihood function with regard to the model parameters.
The EM algorithm can be run in standard packages for latent categorical
data such as Mplus (Muthén & Muthén, 2008) or Lem (Vermunt, 1997). How-
ever, estimation can become difficult as there is a limitation to the number of
repeated testing moments and the number of restrictions imposed on the model
parameters. The inclusion of both continuous and categorical predictors in the
logistic regression equations may also lead to computational difficulties. Fast
computation of the M-step is possible by defining pseudo-data. The idea of
constructing a pseudo data set was put forward by Lambert (1992) and was
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suggested for cross-sectional data by Kosinski and Barnhart (2003) for esti-
mating a model with partial verification. Suppose that only the first N − U




log p(yi,ai, bi, ri|θ) +
N∑
i=N−U+1
p̃i1 log p(Yi = 1,ai, bi, ri|θ) +
N∑
i=N−U+1
p̃i0 log p(Yi = 0,ai, bi, ri|θ) . (7.11)
It is easy to see that the function Q(θ) is equal to a function that would be
obtained by weighted summing of the log-likelihoods of pseudo-data of N + U
subjects. The pseudo data of the N +U subjects in the weighted log-likelihood
function are as follows. The first N − U subjects correspond to the verified
subjects from the original data (Yi = yi, Ri = 1) and have weight 1. The
next U subjects are the non-verified subjects of the original data and they
are labeled as diseased (Yi = 1, Ri = 0) and receive weight p̃i1. The last U
subjects are again the non-verified subjects of the original data but now they
are labeled as healthy (Yi = 0, Ri = 0) and receive weight p̃i0. Thus, the non-
verified subjects of the original data appear twice in the pseudo-data, once as
diseased and once as healthy subjects. The three subgroups correspond to the
three terms at the right-hand side of equation 7.11. Although the connection
between the log-likelihood of the observed data and the weighted log-likelihood
of the pseudo-data of N+U subjects is purely technical, the connection is useful
computationally as it enables us to fit the data using a weighted generalized
linear regression module. Such a module is incorporated in many statistical
packages. Moreover, because the disease, testing and verification components
do not share model parameters, separate regressions can be fit to the different
model components. R-code of the EM algorithm is available from the authors
upon request.
7.5 Example: results
Five nested models are fitted to the cervical screening trial data. In model 1
(the simplest model), the regression equation for disease status (equation 7.7)
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only has an intercept. The disease status yi is included as a covariate in the re-
gression equations for cytology (equation 7.8) and the HPV test (equation 7.9).
Besides, time-invariant regression coefficients of cytology are included in the
regression equation for the verification variable (equation 7.10). Because cytol-
ogy has three levels, the verification model component contains two cytology
dummies. All regression coefficients are restricted to be time-invariant.
In models 2 to 4, dependencies among repeated cytology and HPV test
outcomes are modeled. Only model dependencies in healthy women are mod-
eled with the assumption that the outcomes of the cytology and HPV test are
independent in diseased women. The independence between the test outcomes
in healthy women is likely to be violated for at least two reasons. First, a
woman may carry a transient HPV infection that will eventually disappear
without causing cervical disease. Second, a woman may present with abnormal
cytology because of a non-HPV related lesion that will eventually regress to
normal. Both types of dependencies will lead to a positive association between
consecutive test results. The dependencies between the test results cannot be
explained by the disease status and can only be captured by explicitly modeling
the dependency.
In model 2, the dependency among repeated HPV test results is modeled by
including the previous HPV test result in the regression equation for the HPV
test (equation 7.9). Two lagged covariates bi(t−1)(1− yi) and (1− bi(t−1))(1−
yi) are included. The value of bi(t−1) at t = 0 is set equal to 0. In model
3, the dependency between repeated cytology scores is modeled by including
the lagged covariates bi(t−1)(1 − yi) and (1 − bi(t−1))(1 − yi) in the regression
equations (equation 7.8) for the multinomial cytology scores. Also the following
two lagged cytology covariates are included in equation 7.8: ai0(t−1)(1 − yi)
and (1−ai0(t−1))(1−yi) where ai0(t−1) is 1 if cytology is normal at the previous
time point. At t = 0, ai0(t−1) is set equal to 0. In model 4, the cross-sectional
dependency between HPV and cytology test result is modeled by including
two dummy variables for the trichomotous cytology score ai0(t)(1 − yi) in the
regression equation at time t (equation 7.9). The regression coefficients of the
current and lagged variables are restricted to be time-invariant. Model 5 is an
extension of model 4 where the verification regression equation (equation 7.10)
is extended with covariate disease status yi. Therefore, models 1-4 are MAR
and model 5 is NMAR.
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Figure 7.3: Expected minus observed frequencies of women with double nega-
tive test results and women with CIN3+
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The parameters of key interest are the disease prevalence (i.e. the prob-
ability that the woman has CIN3+) and the sensitivities and specificities of
cytology and the HPV test. The sensitivity and specificity of a test are widely
used in the medical field and are 1 minus the false negative rate and 1 minus
the false positive rate, respectively. For cytology and the HPV test, the sen-
sitivities are p(a > 0|y = 1;θ) and p(b = 1|y = 1;θ), respectively, and the
specificities are p(a = 0|y = 0;θ) and p(b = 0|y = 0;θ).
The disease prevalence is presented in figure 7.4 together with the 95%
confidence intervals. The CIN3+ prevalences obtained under models 1 to 5
are presented in figure 7.5. It is seen that the prevalences are much higher in
models 1-3 than in models 4 and 5. The CIN3+ prevalences in models 4 and
5 are similar. This indicates that the decision about the dependency structure
has a stronger effect on the CIN3+ prevalence than the decision about the
verification mechanism. The test sensitivities are presented in figure 7.5. Both
for cytology and the HPV test, the sensitivities are the lowest for models 1 and
2. Again, the estimates are sensitive to decision about the dependency structure
but are not sensitive to the decision about the verification mechanism. Finally,
the estimated (marginal) specificity of cytology ranges from 97.4% to 98.0% in
models 1 to 5 and the (marginal) specificity of the HPV test ranges from 95.7%
to 97.1%.
If the models are compared by likelihood ratio testing, it follows that the
models differ significantly in fit. The smallest improvement (χ2(1) = 7.86, p =
.005) is obtained when comparing model 5 (NMAR verification) to model 4
(MAR verification). To check whether the models are consistent with the data,
the predicted number of women with CIN3+ as well as the number of women
with double negative test results are computed (negative on cytology and the
HPV test) at 0, 6, and 18 months (figure 7.3). It is seen that models 4 and 5
predict the number of women with CIN3+ well, but the other models overesti-
mate the number of women with CIN3+ at 6 and 18 months. The number of
double negative women is reasonably well predicted by models 3 to 5. Models 1




Figure 7.4: Estimated CIN3+ prevalences and log-likelihood values




Figure 7.5: Estimated test sensitivities
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7.6 Discussion
The development of the model has been motivated by the field of medical
screening, where there is an increasing awareness of the patient burden and
costs induced by invasive verification techniques. Consequently, diagnostic
guidelines are more and more often developed where patients that have positive
test results are not immediately verified, but are retested at a later time. It is
shown how to analyze the outcomes of studies in which such a repeat testing
strategy is adopted. The focus of this chapter was on the setting of two screen-
ing tests, but the model can also be set up for a different number of screening
tests. The model has large flexibility as the disease status, the test results, and
the verification status may depend on both continuous and categorical covari-
ates. The estimation of the model parameters is likelihood-based which enables
us to draw inferences about the disease prevalence and the test sensitivity and
specificity.
In this model, the test outcome is defined conditional on the disease status.
This approach is useful because it enables us to define dependencies between
the test results separately for diseased and healthy subjects. In the cervical
screening example, it was assumed that the cytology and HPV test results were
independent in diseased subjects. This assumption was necessary to obtain an
identifiable model as subjects with a double negative test result (negative on
cytology and the HPV test) at baseline or at 18 months were not verified. The
independence assumption seems reasonable as a working assumption although
it is unlikely to hold exactly. Therefore, the interpretation of the estimated
parameters should be done with care recognizing the underlying independence
assumption.
The cervical screening example showed that it is important to accurately
model the dependencies among the screening tests, also when the test results
are formulated conditional on the disease status. Two types of dependencies
were considered: a longitudinal dependency between the outcomes at consec-
utive testing moments and a cross-sectional dependency between the cytology
and HPV test. Omitting either type of dependency had a large effect on the
estimates of the test sensitivity and the disease prevalence. The model pre-
dictions were consistent with observed test results and CIN3+ prevalences. If
the number of repeated measurements had been larger than three, it would
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have been easier to violate the observed data. For such data, it may be worth-
while to include higher-order lagged effects in the diagnostic testing regression
equations (Diggle, 1994).
In this model loss-to-follow up was not modeled. A loss-to-follow-up com-
ponent is ignorable when loss-to-follow-up is independent of the disease status
and the loss-to-follow up component does not share parameters with the other
components (Rubin, 1976). In the example, there was no necessity to model
loss-to-follow-up because cervical screening takes place in an asymptomatic
population and loss-to-follow up is only related to the screening test results.
However, in a setting where the attendance at follow-up tests depends on the
manifestation of clinical symptoms, then it makes sense to formulate a loss-
to-follow-up component in addition to the disease, testing, and verification
component. This component could for example be defined by taking a selec-
tion model approach where follow-up is predicted by the test results and the
disease status (Little, 1993).
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Randomized controlled trials are considered the best proof of effectiveness.
Randomization assumes that all known and unknown characteristics of par-
ticipants are balanced between experimental groups, except for the treatment
condition. With randomization, treatment effects can, theoretically, be es-
timated by merely subtracting the mean responses of the treatment groups.
However, ethical, practical or financial considerations often force researchers
in the (para)medical fields to look for alternative research designs, such as a
quasi-experimental design. In the case of non-random allocation of participants
into experimental groups, there is a large risk that persons in different treat-
ments conditions differ, on average, on pre-treatment characteristics such as
age, or motivation. These differences may lead to a selection bias. Selection
bias is the bias introduced into a (quasi-)experimental study by the selection
of different types of individuals into treatment program(s) and reference pro-
gram(s). Consequently, the pre-existing differences between participants in the
different treatment programs may explain the results of a study, as opposed to
true treatment effects.
There are two forms of bias; overt bias and hidden bias. Overt bias is bias
due to observed differences, and hidden bias is due to unobserved differences
between experimental groups.
Also, when randomization is perfectly carried out using a rather large num-
ber of individuals, the intended randomization plan may fail because of what
happens later during the implementation of the research design. Selective drop-
out or non-compliance can also result in selection problems. Researchers in the
(para)medical field may therefore encounter a range of selection bias problems
in their research and are forced to use statistical techniques that take possible
biasing effects in account. The focus of this thesis is on discussing a range of
selection bias problems and on presenting statistical techniques that counter
159
160 Summary
for these selection bias problems.
Chapter 1 discusses in a very general way, the nature, causes and conse-
quences of selection bias problems in experimental and non-experimental stud-
ies and ways to overcome these problems. Since, in this thesis, selection bias
is studied from the viewpoint of biased causal conclusions, Rubin’s precise and
well known model of causality is first presented. Next, a few general, well-known
methods for countering overt bias are discussed such as matching, stratification
and regression adjustment. These traditional approaches are critically evalu-
ated, improved and extended in the remaining chapters of this dissertation.
Chapter 2 discusses the dimensionality problem of matching and stratifi-
cation in situations where the number of pre-treatment variables is large. As
an alternative method, the propensity score method (PS) is discussed. The
propensity score is the probability of assignment into the experimental group,
given a set of pre-treatment variables. The propensity score method is illus-
trated step-by step with data coming from a large a Dutch research project
named the ”Study on Cost-Effectiveness of Personality Disorder Treatment”
(SCEPTRE ). Since the propensity score is mainly used in two-arm studies, the
data are divided into a short-term therapy program (up to six months) and a
long-term therapy program (more than six months). This has been done for
illustrative purposes, although the original treatment variable contained more
categories. Differences between the two treatment groups (short versus long
treatment duration) in pre-treatment characteristics before and after PS cor-
rection is examined to reveal the impact of the PS on outcome differences. In
this quasi-experimental study, the PS offered statistical control over the ob-
served pre-treatment differences. When randomization is not possible, a quasi-
experimental study using the PS could be a feasible alternative. If implemented
carefully, this method is promising for future effectiveness research.
The standard propensity score method has been well developed for (quasi-
)experiments with two treatment programs. Since clinicians are often interested
in the comparison of multiple (more than two) treatments, there is a need to
extend the PS method to multiple treatments. It has been shown that the
(multiple) propensity method is possible. So far, its practical application is rare
and a practical introduction is lacking. Chapter 3, provides a practical guideline
to illustrate the (multiple) multiple propensity score. The method is illustrated
step-by-step using data from the SCEPTRE study, where the effectiveness
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of five different therapies or patients with cluster C personality disorders are
compared, differing in setting and duration. With the multiple propensity
method, balance was achieved in all relevant pre-treatment variables. The
corrected estimated treatment effect was somewhat different than the ’näıve’
results. The results indicate that the multiple PS is a feasible method to
adjust for observed pre-treatment differences in non-randomized studies where
the number of covariates is large and multiple treatments are compared.
In chapter 4, the results from the large and complicated SCEPTRE study
are discussed from a more clinical point of view. The multiple propensity score
is used to compare the effectiveness of five different therapies, differing in set-
ting and duration, for patients with cluster C personality disorders. Since the
study had a repeat testing structure, the multiple propensity scores are in-
cluded in a random intercept multilevel model. In this model, the results are
adjusted for (1) the dependency of the data due to repeat testing and for (2)
the confounding effect of a large number of observed pre-treatment differences
across the psychotherapy programs. Patients in all treatment programs im-
proved on all outcomes 12 months after baseline. Patients receiving short-term
inpatient treatment showed more improvement than patients receiving other
treatment modalities.
Whereas chapters 1 to 4 discuss statistical methods that counter for overt
bias, in chapter 5, attention is paid to two statistical methods that control for
hidden bias in quasi-experimental studies. Dealing with hidden bias is more
difficult. Existing methods that control for hidden bias are rather unknown
in the (para) medical research field. The methods discussed in chapter 5 are
(1) the original Heckman two-step method and (2) an extended version using
Structural Equation Modeling (SEM). By using four artificial data-sets, the
performances of both methods are compared to the results of regression analysis
and the propensity score method. In addition, the SCEPTRE data are used
to compare and illustrate both methods. It is concluded that, especially the
Heckman method is very sensitive to misspecification of the selection model and
to violations of the normality assumption. When good indicators for a latent
tendency to participate in the study are available, SEM analysis is preferred
over the Heckman method.
In the occurrence of a perfectly carried out randomization using a rather
large number of individuals, the intended randomization plan may fail because
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of what happens later during the implementation of the research design. Se-
lective drop-out or non-compliance may also lead to selection problems. Tradi-
tional methods for handling differential non-compliance behavior like Intention-
To-Treat, Analysis-As-Treated or Per-Protocol-Analysis have been shown to be
defective in several aspects. Chapter 6, discusses a latent class version of the
instrumental variable approach which yields an unbiased estimate of the com-
plier average causal effect. The chapter presents a number of elaborations of
this latent class model. These elaborations pertain to situations in which (a)
the outcome variable is only measured indirectly via indicator variables, (b)
the experimental interventions has more than two levels and/or (c) a factorial
designs is implemented. These methods are applied to data from an exper-
iment that has studied the effects of various physical programs on cognitive
functioning in the elderly.
Chapter 7 discusses a different type of selection problem often occurring
in diagnostic testing, named verification bias. In medical screening, subjects
are often pre-screened by one or multiple non-invasive diagnostic tests and
only subjects with at least one positive test are verified for disease status.
This strategy may lead to verification bias in estimating the sensitivity and
specificity of the tests. Several methods have been developed to adjust for
verification bias in cross-sectional studies. In chapter 7, a repeat testing setting
is considered where some subjects are directly verified and some other subjects
are invited for non-invasive retesting at a later point of time, depending on
baseline results. A path model is presented which accounts for non-verification
and dependencies among the non-invasive tests. For parameter estimation, an
expectation maximization (EM) algorithm is presented. The model is applied
to data collected in a large Dutch cervical cancer screening trial. A main
goal of this trial was to compare the accuracy of cytological testing to human
papillomavirus (HPV) DNA testing. It is illustrated how the cross-sectional and
longitudinal dependencies of the two tests can be modeled. Non-verification




Gerandomiseerde studies worden beschouwd als het beste bewijs van effec-
tiviteit. Door het toepassen van randomisatie wordt ervan uit gegaan dat alle
bekende en onbekende kenmerken van de deelnemers gelijk verdeeld zijn tussen
de verschillende behandelingen, behalve voor de ontvangen behandeling. Na
randomisatie kan, in theorie, het effect van de behandeling worden geschat door
de gemiddelde uitkomsten in behandelgroepen direct met elkaar te vergelijken.
Echter, vanwege ethische, praktische of financiële overwegingen, zijn onder-
zoekers binnen het (para)medische onderzoeksveld vaak aangewezen op alter-
natieve onderzoeksdesigns, zoals een quasi-experimenteel onderzoek. Wanneer
deelnemers op een onwillekeurige manier zijn toegewezen aan de experimentele
groepen, is het risico aanzienlijk dat personen op groepsniveau van elkaar ver-
schillen, zoals in de gemiddelde leeftijd of motivatie. Dit verschil in baseline
kenmerken kan leiden tot selectie bias. Selectie bias is de vertekening die in
een (quasi-)experimenteel onderzoek ontstaat door de selectie van verschillende
typen van personen in het behandelprogramma en het referentieprogramma.
Als gevolg hiervan kunnen eventuele verschillen in behandeluitkomsten verk-
laard worden door het verschil in baseline karakteristieken, in plaats van door
verschillen in de behandelingen zelf.
Er zijn twee vormen van vertekening, namelijk open (overt) bias en ver-
borgen (hidden) bias. Open bias is vertekening door waargenomen en gemeten
verschillen tussen de behandelgroepen en verborgen bias is vertekening door
niet-waargenomen verschillen tussen behandelgroepen.
Ook wanneer in studies de randomisatie procedure perfect is uitgevoerd
met een vrij groot aantal personen, kan het randomisatieplan mislukken door
hetgeen gebeurt gedurende de uitvoering van het onderzoek. Te denken valt
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aan selectieve drop-out of aan een gebrek aan therapietrouw van de deelnemers.
Deze kunnen leiden tot selectieproblemen. Onderzoekers in het (para) medisch
onderzoeksgebied kunnen een aantal selectieproblemen ondervinden tijdens het
uitvoeren van hun onderzoek. Dit noodzaakt ze statistische technieken ter
voorkoming van vertekening van de resultaten te hanteren. De focus van dit
proefschrift ligt op de bespreking en presentatie van een reeks van statistische
technieken die het oogmerk hebben om voor verschillende vormen van selectie
bias in de analyse te corrigeren.
Hoofdstuk 1 geeft een algemeen overzicht van de aard, oorzaken en gevol-
gen van selectieproblemen in experimentele en niet-experimentele studies en
methoden om deze problemen aan te pakken. Aangezien dit proefschrift selec-
tie bias vanuit het oogpunt van vertekende causale conclusies bespreekt, wordt
allereerst Rubin’s causale model gepresenteerd. Vervolgens worden enkele al-
gemene en traditionele methoden voor het tegengaan van open bias besproken,
zoals matching, stratificatie en regressie analyse. Deze traditionele benaderin-
gen worden kritisch geëvalueerd, verbeterd en uitgebreid in de hoofdstukken 2
tot en met 7 van dit proefschrift.
Hoofdstuk 2 bespreekt het dimensionaliteit probleem dat kan ontstaan bij
het gebruik van matching en stratificatie methoden als het aantal baseline ver-
schillen erg groot is. Als een alternatieve methode wordt de propensity score
methode (PS) besproken. De propensity score is de kans op toewijzing aan de
experimentele groep, gegeven een set van baseline variabelen. De propensity
score methode wordt stap–voor–stap gëıllustreerd met gegevens afkomstig uit
een groot Nederlands onderzoek genaamd ”Studie over de kosten-effectiviteit
van Persoonlijkheid Stoornissen” (SCEPTRE ). Aangezien de propensity score
voornamelijk wordt gebruikt bij studies die twee behandeleffecten vergelijken,
zijn de gegevens ter illustratie ingedeeld in (1) korte-termijn therapie (max-
imaal zes maanden) en (2) lange termijn therapie (meer dan zes maanden).
De oorspronkelijke behandelingen bestonden echter uit meerdere categorien.
Verschillen tussen de twee behandelde groepen (korte versus lange duur van
de behandeling) in baseline kenmerken vóór en na correctie met de PS zijn
onderzocht om de impact van de PS op de resultaten zichtbaar te maken. In
deze quasi-experimentele studie heeft de PS tot statistische controle van de
waargenomen baseline karakteristieken geresulteerd. Wanneer randomisatie
niet mogelijk is, is een quasi-experimentele studie gebruik makend van de
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PS een goed alternatief. Indien zorgvuldig uitgevoerd, is deze methode veel-
belovend voor toekomstig effectiviteit onderzoek.
De standaard propensity score methode is voornamelijk ontwikkeld voor
(quasi-)experimenten waarin twee behandelprogramma’s vergeleken worden.
Aangezien men in de klinische praktijk vaak gëınteresseerd is in de vergelijking
van meerdere (meer dan twee) behandelingen, is er behoefte aan het geschikt
maken van de PS-methode voor onderzoek dat meerdere behandelingen vergeli-
jkt. Het is aangetoond dat de meervoudige PS mogelijk is. Tot nu toe is de
praktische toepassing hiervan echter zeldzaam en ontbreekt hiervoor een prak-
tische handleiding. In hoofdstuk 3 wordt een praktische handleiding gegeven
voor het gebruik van de meervoudige propensity score. De methode wordt
stap-voor-stap gëıllustreerd, gebruik makende van de gegevens van de SCEP-
TRE studie, waarin de effectiviteit van vijf verschillende therapien of patiënten
met cluster C persoonlijkheidsstoornissen, variërend in setting en duur, worden
vergeleken. Met de meervoudige PS methode wordt statische controle op alle
relevante baseline variabelen verkregen. Het gecorrigeerde geschatte effect van
de behandeling bleek enigszins af te wijken van de ongecorrigeerde resultaten.
De resultaten geven aan dat de meervoudige PS een haalbare methode is in
niet-gerandomiseerde studies waarbij het aantal baseline verschillen groot is en
er meerdere behandelingen worden vergeleken.
In hoofdstuk 4 worden de resultaten van het grote en uitgebreide SCEPTRE
onderzoek besproken vanuit een klinisch oogpunt. De meervoudige propensity
score wordt gebruikt om de effectiviteit van vijf verschillende therapieën voor
personen met cluster C persoonlijkheidsstoornissen, variërend in duur en set-
ting, te vergelijken. Aangezien de studie uit herhaalde metingen bestond, zijn
de meervoudige (PS) meegenomen in een random intercept multilevel model.
In dit model zijn de resultaten gecorrigeerd voor (1) de afhankelijkheid van
de gegevens door herhaalde metingen en (2) het vertekende effect van een
groot aantal baseline verschillen tussen de deelnemers in de verschillende psy-
chotherapie programma’s. In alle programma’s verbeterden de patiënten op alle
uitkomstwaarden 12 maanden na start van de therapie. Patiënten die de korte
termijn intramurale behandeling volgden, vertoonden een grotere verbetering
dan patiënten die andere vormen van behandeling volgden.
Hoofdstuk 1 tot en met 4 bespreken statistische methoden die corrigeren
voor open bias. Echter, voor verborgen bias is het moeilijker om te corrigeren.
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Bovendien worden reeds bestaande methoden voor de correctie voor verborgen
bias maar zelden toegepast in het (para)medische onderzoeksgebied. In hoofd-
stuk 5 wordt aandacht besteedt aan twee statistische methoden die controleren
voor verborgen bias in quasi-experimentele studies. Deze methoden zijn (1) de
traditionele Heckman methode en (2) een alternatieve versie gebruik makend
van Structural Equation Modeling (SEM). In vier kunstmatig gegenereerde
data-sets worden de prestaties van beide methoden vergeleken met de resul-
taten van regressieanalyse en de propensity score methode. Daarnaast worden
de SCEPTRE gegevens gebruikt om de methoden te vergelijken en te illus-
treren. Geconcludeerd wordt dat vooral de Heckman methode zeer gevoelig
is voor misspecificatie van het selectiemodel en voor schendingen van de nor-
maliteit assumptie. Wanneer goede indicatoren voor de neiging tot deelname
aan de studie beschikbaar zijn, heeft SEM analyse de voorkeur vergeleken met
de Heckman methode.
Zelfs wanneer de randomisatie procedure perfect wordt uitgevoerd met
een groot aantal personen, kan het voorgenomen randomisatieplan mislukken
gedurende de uitvoering van het onderzoek, vanwege selectieve drop-out of
een gebrek aan therapietrouw van de patiënten. Ook dit kan leiden tot selectie
problemen. Traditionele methoden ter correctie van differentiële therapietrouw,
zoals intention-to-treat analyse, analyse-as-treated of per-protocol analyse, bli-
jken op verschillende aspecten gebreken te vertonen. Hoofdstuk 6 bespreekt
een latente klasse model dat gebaseerd is op de instrumentele variabele aan-
pak. Dit resulteert in een onvertekende schatting van het causale effect voor
de groep van compliers. In dit hoofdstuk worden diverse uitbreidingen van
dat latente klasse model besproken. Deze uitbreidingen hebben betrekking op
situaties waarin (a) de uitkomstvariabele alleen indirect gemeten wordt via de
zogenaamde indicator variabelen, (b) de experimentele interventies uit meer
dan twee niveaus bestaan en / of (c) een factorieel design wordt gebruikt. De
methoden zijn toegepast op gegevens uit een experiment dat de effecten van
verschillende fysieke programma’s op het cognitief functioneren bij ouderen on-
derzocht.
Hoofdstuk 7 bespreekt het probleem van verificatie bias, een selectie prob-
leem ten gevolge van het selectief verifiëren van de ware ziektestatus van de
deelnemers met een gouden standaard test, op basis van diagnostische screening
test uitslagen. In screening onderzoek worden deelnemers vaak vooraf gescreend
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met één of meerdere niet-invasieve diagnostische testen. Alleen patiënten met
tenminste één positieve testuitslag worden vervolgens gecontroleerd op de aan-
wezigheid van de ziekte met een invasieve test. Deze strategie kan leiden tot
verificatie bias (vertekening) bij de schatting van de sensitiviteit en specificiteit
van de diagnostische testen. Verschillende methoden zijn ontwikkeld om veri-
ficatie bias in cross-sectioneel onderzoek tegen te gaan. In dit hoofdstuk wordt
een herhaalde metingen design besproken waarin een aantal deelnemers direct
wordt geverifieerd op ziektestatus na screening en een aantal andere deelne-
mers niet direct wordt geverifieerd op ziektestatus. Deze deelnemers worden,
afhankelijk van de baseline resultaten, uitgenodigd voor een niet-invasieve na-
controle op een later tijdstip. In dit hoofdstuk wordt een pad model gepresen-
teerd waarin gecorrigeerd wordt voor non-verificatie en afhankelijkheden tussen
de niet-invasieve tests. Voor het schatten van parameters, is een EM algoritme
ontwikkeld. Het model wordt toegepast op gegevens die zijn verzameld in een
groot Nederlands bevolkingsonderzoek naar baarmoederhalskanker. Eén van
de belangrijkste doelen van dit onderzoek was om de precisie van de cytologis-
che test te vergelijken met die van de human papillomavirus (HPV) DNA-test.
De manier waarop cross-sectionele en longitudinale afhankelijkheden van de
twee testen kunnen worden gemodelleerd, is gëıllustreerd. Non-verificatie is




Toen ik afstudeerde gaf John mij een zelfgemaakt schilderijtje met daarop de
tekst ”In een wereld vol ambitie, zit ik fluitend op mijn fietsie!”. Zo zag hij
mij. Helaas kan John mijn promotie niet meer meemaken. Aan hem draag ik
mijn proefschrift op (John, † 2005).
Mijn proefschrift is een feit! Hoog tijd voor een dankwoord. Iedereen die hoe
dan ook heeft bijgedragen aan de totstandkoming van mijn proefschrift wil ik
bedanken en een aantal mensen in het bijzonder.
Allereerst richt ik me tot mijn promotor Jacques Hagenaars en copromotor
Marcel Croon.
Jacques, ik dank je voor alle begeleiding en steun die je me de afgelopen
jaren hebt gegeven. Ik wil je bedanken voor de vrijheid die je mij hebt gegeven
om mezelf tijdens mijn promotie verder te ontwikkelen, met name door een
combinatie mogelijk te maken van promoveren en werken bij de vakgroep epi-
demiologie en biostatistiek van het VU Medisch Centrum. Je hebt mij door de
laatste loodjes heen gesleept.
Marcel, jouw onuitputtelijke kennis van methodologie en statistiek en je
sterke analytische vermogen hebben mij zicht gegeven op waar mijn proef-
schrift echt over ging en moest gaan. Ik heb veel geleerd van jouw eigenschap
je vast te bijten aan een methodologisch probleem. Ook jou wil ik uitdrukkelijk
bedanken voor alle begeleiding die je me hebt gegeven en het vertrouwen dat
je in mij hebt getoond.
Ik dank de vakgroep Epidemiologie en Biostatistiek van het VU Medisch Cen-
trum.
Maarten, Dick en Bernard, bedankt dat ik tijdens mijn promotie in deeltijd
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bij jullie mocht komen werken. Jullie hebben mij aangenomen als biostatisticus
en hebben een groot vertrouwen in mij gehad. De combinatie was voor mij
ideaal.
Jos, bedankt voor je rol als mijn mentor en voor alle methodologische kennis
die je met mij hebt gedeeld.
Hans, samen hebben we veel energie gestoken in het analyseren van de HPV
data-set. Het laatste hoofdstuk heb ik helemaal te danken aan de samenwerking
met jou. Ik heb veel geleerd van je kritische blik en ”helicopter view”. Ik heb
veel aan jouw hulp gehad en mijn waardering voor jou is groot.
De overige collega’s bedank ik voor hun interesse en voor de goede, warme
en motiverende sfeer waarin ik heb mogen werken.
De Hogeschool Zuyd en de Universiteit van Maastricht wil ik ook bedanken.
Daar heb ik de kans gekregen om de laatste punten op de ’i’ te zetten van mijn
proefschrift.
Luc, bedankt dat je op dit moment voor mij de weg vrijmaakt om een mooie
combinatie van praktisch en academisch werk mogelijk te maken.
Voor mijn proefschrift was ik grotendeels afhankelijk van de bereidheid van
onderzoekers om aan mij hun data beschikbaar te stellen. Het was niet al-
tijd gemakkelijk om dit voor elkaar te krijgen. Sommige onderzoekers waren
bang dat, met de ’nieuwe’ methoden, hun oorspronkelijke onderzoeksresultaten
zouden veranderen en waren daarom huiverig om deze data aan mij beschikbaar
te stellen. Iedereen bedankt die deze stap wel heeft gezet. Allereerst wil ik het
psychotherapeutisch centrum ’De Viersprong’ bedanken voor het beschikbaar
stellen van de SCEPTRE data. In het bijzonder wil ik hierbij Anna noemen.
Anna, jij hebt mij altijd weer weten te inspireren in tijden waarin ik het zelf
niet meer zag zitten. Dat ik jou ben tegengekomen bij de EMGO cursus van
Jos Twisk is een geschenk uit de hemel geweest. Jouw gedrevenheid en energie
werkten voor mij erg stimulerend. Het leek voor mij of wij samen een puzzel
aan het maken waren. Het eerste deel van mijn proefschrift is dan ook geheel
in samenwerking met jou tot stand gekomen. Het is fijn om je te kennen en ik
hoop je in de toekomst in de privésfeer te mogen blijven ontmoeten.
Ik wil ook graag Jan, Helene en Theo bedanken voor hun vertrouwen, steun
en altijd vriendelijke woorden.
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Tot slot, wil ik Marijke Chin a Paw en Evert Verhagen van het EMGO
instituut en Chris Meijer van het VU Medisch Centrum bedanken voor het
beschikbaar stellen van hun data-sets.
Natuurlijk kan ik nog een hele lijst mensen noemen die de afgelopen jaren be-
langrijk voor mij zijn geweest, zowel binnen als buiten mijn promotieproject. Ik
noem enkelen speciaal bij naam, maar ik besef dat nog vele anderen belangrijk
zijn geweest.
Joost, je bent jarenlang mijn kamergenoot geweest en je was mijn steun
en toeverlaat. Bedankt voor alle kopjes thee die je voor mij hebt gemaakt, de
leuke en fijne gesprekken op ons kamertje en je leuke humor. Jammer dat we
elkaar nog maar zo zelden zien.
Meike en Carmen, bedankt voor alle genegenheid en gesprekjes over ’ditjes
en datjes’.
Luc, je bent in de loop der jaren mijn maatje geworden. Vandaar dat je
vandaag ook mijn paranimf bent. Ik zal al onze gesprekken nooit vergeten. Ik
zal blijven proberen je over te halen om naar Zuid–Limburg te komen!
Liesbeth, van jou en Luc heb ik het lesgeven geleerd. Ik heb jouw lieve en
open karakter erg gewaardeerd en hoop je toch wat vaker tegen te komen.
Wilco, Andries, Wobbe, Marcel en John, bedankt voor jullie uitputtende
interesse en de leuke liedjes die we samen hebben gemaakt. Ik verwacht dan
ook een geweldig lied voor mijn promotie!
Marieke, bedankt voor alle secretariële ondersteuning die je de afgelopen
jaren hebt gegeven. Alle overige collega’s van de Universiteit van Tilburg, vak-
groep methoden en technieken van onderzoek, dank ik voor hun collegialiteit.
Tenslotte nog een paar persoonlijke opmerkingen.
Cor en Dingena, mijn dank aan jullie kan ik moeilijk onder woorden bren-
gen. Ik heb van jullie een goede basis meegekregen en die zal ik altijd met me
mee dragen. Bedankt dat jullie al naar mijn ”eigen wijsje” wilden luisteren
toen ik nog heel jong was. Papa, bedankt voor je liefde, je vertrouwen, je luis-
terende oor en je kritische blik. Mama, bedankt voor alle moederlijke adviezen
die je me de afgelopen jaren hebt gegeven, je onuitputtelijke liefde en voor alle
hulp in mijn ”huishouden van Jan Steen”.
Maarten & Kristel en Jaap & Mam, jullie belangstelling en liefde voor mij
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is groot.
Pier & Monique, Joep & Fleur, Han en René, jullie zijn echt mijn familie
geworden!
Ze zeggen dat echte vrienden maar op één hand te tellen zijn, maar: Nancy
& Robert, Judith & Guido, Elke & Martijn, Floris, Marcel, Bas & Vivian,
Meke, Koen, Kasper, Marrigje & Co, Orm, Moon, Dino & Stefan, Carlijn,
Faisca & Dave en Tanja: bedankt voor jullie vriendschap! Jullie zorgen altijd
voor een goed gesprek of feestje en houden mij met beide benen op de aarde!
Sabine, je bent vandaag mijn paranimf, maar eigenlijk sta je altijd achter
me op alle mooie en moeilijke momenten. Bedankt voor je vriendschap!
Kasper, bedankt voor alle avonden en nachten dat je, zo trouw als een hond
kan zijn, bij mijn voeten hebt gelegen terwijl ik aan het werken was, zelfs bij
het schrijven van dit dankwoord. Met jou zit ik nooit alleen. De wandelingen
met jou vind ik heerlijk!
Geert, je bent mijn lief. Ik wil je bedanken voor het jou-mij zijn. We
hebben samen aan ons thuis gebouwd (letterlijk en figuurlijk) waar het warm,
veilig en fijn is. Je houdt voor mij de weg vrij voor de toekomst. Praktisch
gezien bedank ik je voor alle heerlijke maaltijden die je voor mij hebt gekookt
en alle kopjes thee die vervolgens niet opgedronken en koud bleven staan naast
mijn computer. Ik geef je nog antwoord op alle onbeantwoorde vragen die je
me hebt gesteld. Je bent het belangrijkste in mijn leven. Ik ben dik tevreden




additive effect assumption, 5
allocation probabilities, 101
always-takers, 100
as-treated analysis, 95, 97
average causal effect, 4–5, 7, 96
balance, 27
bias, see selection bias
caliper matching, 11, 12, 28
causality, 2
complier average causal effect, 95, 102
compliers, 100
confounder, see confounding
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